Functional Annotation and Mechanistic Characterization of Enzymes with Unknown Functions: Studies on Adenine Deaminase, N-6-Methyladenine Deaminase and the C-P Lyase Pathway by Kamat, Siddhesh
 FUNCTIONAL ANNOTATION AND MECHANISTIC CHARACTERIZATION OF 
ENZYMES WITH UNKNOWN FUNCTIONS: STUDIES ON ADENINE 
DEAMINASE, N-6-METHYLADENINE DEAMINASE AND THE C-P LYASE 
PATHWAY 
 
A Dissertation 
by 
SIDDHESH SHASHIKANT KAMAT 
 
 
Submitted to the Office of Graduate Studies of  
Texas A&M University 
in partial fulfillment of the requirements for the degree 
 
DOCTOR OF PHILOSOPHY 
 
August 2012 
 
Major Subject: Chemistry 
  
 
 
 
 
 
 
 
 
 
 
 
Functional Annotation and Mechanistic Characterization of Enzymes with Unknown 
Functions: Studies on Adenine Deaminase, N-6-methyladenine Deaminase and the C-P 
Lyase Pathway 
Copyright 2012 Siddhesh Shashikant Kamat 
FUNCTIONAL ANNOTATION AND MECHANISTIC CHARACTERIZATION OF 
ENZYMES WITH UNKNOWN FUNCTIONS: STUDIES ON ADENINE 
DEAMINASE, N-6-METHYLADENINE DEAMINASE AND THE C-P LYASE 
PATHWAY 
 
A Dissertation  
by 
SIDDHESH SHASHIKANT KAMAT 
 
Submitted to the Office of Graduate Studies of  
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
Approved by: 
Chair of Committee,   Frank M. Raushel 
Committee Members,  Paul A. Lindahl 
    David P. Barondeau 
    Jean-Philippe Pellois 
Head of Department,   David H. Russell 
 
 
August 2012 
 
Major Subject: Chemistry 
iii 
 
ABSTRACT 
 
Functional Annotation and Mechanistic Characterization of Enzymes with Unknown 
Functions: Studies on Adenine Deaminase, N-6-Methyladenine Deaminase and the C-P 
Lyase Pathway. (August 2012) 
Siddhesh Shashikant Kamat, B. Tech., University of Mumbai 
Chair of Advisory Committee: Dr. Frank M. Raushel 
 
Adenine deaminase (ADE) catalyzes the conversion of adenine to hypoxanthine. 
Mechanistic characterization of ADE from Escherichia coli was performed along with 
biophysical studies. The structure of ADE was solved from A. tumefaciens. The 
structure, along with the biochemical and biophysical characterization, enabled the 
elucidation of the mechanism of the deaminase reaction of ADE. Elucidation of the 
origin of the oxygenation reactions within ADE led to the discovery of a promiscuous 
catalase reaction. The diiron ADE from all tested bacterial species exhibited this unusual 
reaction, along with the generation of superoxide and hydroxyl radicals, the latter being 
responsible for the oxygenation of the protein. The residues that were identified to be 
oxygenated were primarily the metal binding residues implying the origin of this 
reaction was the binuclear iron center.  
A group of bacterial enzymes that are co-localized in the same genomic operon 
as ADE but of unknown function were identified. The enzyme Bh0637 from Bacillus 
halodurans, a representative member of this group of enzymes was characterized. This 
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enzyme was shown to preferentially catalyze the deamination of epigenetic base, N-6-
methyadenine.  
Lastly, gram-negative bacteria have a highly conserved phn operon composed of 
14 genes to break the C-P bond of inert alkylphosphonates. The genes phnGHIJKLM are 
absolutely critical for this activity. We discovered that methylphosphonate reacts first 
with MgATP to form α-D-ribose-1-methylphosphonate-5-triphosphate (RPnTP) and 
adenine by the action of PhnI, PhnG, PhnH and PhnL. PhnI by itself was shown to 
perform a novel nucleosidase reaction converting MgATP to ribose-5-triphosphate and 
adenine.  The triphosphate moiety of RPnTP is then hydrolyzed to pyrophosphate and α-
D-ribose-1-methylphosphonate-5-phosphate (PRPn) by PhnM.  The carbon-phosphorus 
bond of PRPn is subsequently cleaved via a radical-based reaction to α-D-ribose-1,2-
cyclic-phosphate-5-phosphate (PRcP) and methane in the presence of S-adenosyl-L-
methionine by PhnJ.  
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This dissertation follows the style of Biochemistry. 
CHAPTER I 
INTRODUCTION 
 
The advent of genome sequencing technologies has led to the explosion of the 
number of available gene sequences from various organisms. The databases bearing 
protein sequences translated from the available genes seem to be increasing 
exponentially. In September 2011, there were in excess of 16 million protein sequences 
available in the UniProtKB/ TrEMBL databases (1). This explosion in the publicly 
available protein sequences is of great benefit to biology and biochemical science 
community. It allows better understanding of cellular metabolism, identifies newer 
cellular metabolic pathways and enables simple comprehension of complex cellular 
physiology.  A thorough knowledge of these physiological pathways might allow design 
of antibiotics that target harmful organisms and would advance fields of medicinal 
chemistry, pharmacokinetics, and synthetic biology. However, with the explosion in the 
number of protein sequences, there remains only a small fraction of these that have been 
experimentally validated. 
The enormous number of protein sequences in various databases can be only 
partially annotated even with current high throughput methodologies. As a consequence, 
computational methods are required to predict protein functions for the millions of 
proteins that have yet to be experimentally characterized. Since the 1990s, the vast 
majority of the protein sequences found in public databases have been annotated using 
computational methods alone. This raises a major issue concerning the annotation 
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accuracy. Concomitant with the exponential increase in the protein sequences in the 
public databases, there has been an increased sophistication in the computational 
methodologies. However, with the over reliance on such computational methods, there 
has been significant annotation errors of molecular functions of protein throughout all 
these databases. Since computational methods assume that an annotation is the “true” 
annotation, errors made by the computational annotation seem to propagate through the 
databases almost proportional to the rate at which sequences are deposited to these 
databases. In a recent study by Babbitt and co-workers (2), a survey of 37 enzyme 
superfamilies were studied as a gold standard for comparing the accuracy of functional 
annotations in four public databases: Two large databases Genbank NR and TrEMBL, a 
secondary database KEGG and a manually curated database Swiss-Prot. Their research 
established that there is serious problem of misannotation of molecular function within 
all the databases except Swiss-Prot, which is the only manually curated database of the 
study. Figures 1.1 and 1.2 (adapted from PLoS Comp. Biol. 5, e1000605) emphasize 
the problems from this study with regards to the amidohydrolase superfamily (discussed 
later in this chapter). 
With the degree of the misannotations as high as 40% in various public 
databases, there arises a need for establishing more reliable methods to establish correct 
molecular function annotations to proteins that are experimentally uncharacterized. In a 
recent review outlining the goals of the Enzyme Function Initiative in Biochemistry (1), 
a few strategies currently employed for protein function annotation have been enlisted: 
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Figure 1.1: The constituent families within the amidohydrolase superfamily.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Percent misannotations for the families within the amidohydrolase 
superfamily in the various public databases. (from the studies of Babbitt and co-
workers) 
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1. Sequence similarity approach: Comparing the protein sequences of orthologs and 
paralogs and determining the sequence specific elements, that form the basis set for 
establishing the constraints that determine a particular activity. This approach allows 
for computational approaches such as homology modeling and computational 
docking approaches. 
2. Co-localization of genes: In prokaryotes, a particular metabolic activity is governed 
by the number of proteins that act simultaneously. These proteins are encoded by 
genes that are localized one after another at a particular location in the genome of the 
organism, thereby suggesting a particular molecular function in the metabolic 
reaction cascade. 
3. Transcriptional analysis: This analysis is largely automated and is performed using 
chip-based technologies or RNA-sequencing technologies. These transcriptional 
levels indirectly infer the protein expression levels within cells thereby suggesting a 
metabolic molecular function under an array of conditions. 
4. Gene knockout studies: Deleting genes from the genome of organisms and analyzing 
the phenotypes obtained from studies, suggest physiological effects of the genes in 
the genome. This deletion study can also be used to build up of certain cellular 
metabolites, which remain unused in the absence of the gene product, hinting at 
putative protein functions. 
5. Protein-Protein interactions: Physiologically some reactions may require more than a 
single protein to occur. Hence in vitro reconstitution of such reactions may not be 
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possible without the partner protein. The knowledge of protein-protein interactions 
might help overcome such problems in annotating functions. 
6. Multi-domain proteins: Some large proteins/ enzymes physiologically expressed 
within the organisms may contain more than one catalytic center. The two or more 
catalytic center performs various reactions; where in the product of one center would 
serve as substrate for the subsequent center. The knowledge of such systems might 
help in functional annotation studies. 
7. The identification of upstream DNA binding motifs that might co-regulate 
transcription might help establish the basis of regulation of certain proteins, thereby 
limiting the available molecular functions for that protein. 
With these strategies in mind, this study tries to annotate functions within the 
amidohydrolase superfamily and assess functions to the C-P lyase pathway. 
The amidohydrolase superfamily (AHS) (3) was first identified in 1997, by Holm 
and Sander based on the striking structural similarities of the then available structures of 
phosphotriesterase (PTE) (1pta) (4), adenosine deaminase (ADA) (1ada replaced now 
with 2ada) (5) and urease (URE) (1krc) (6). This superfamily consists of a remarkable 
set of enzymes that catalyze hydrolytic reactions across a wide set of substrates at carbon 
and phosphorus centers. Members of this superfamily are involved in reactions involving 
metabolism of sugars, nucleic acids, amino acids, and organophosphorus esters.  The 
most striking feature of the members of the AHS is a (β/α)8-barrel structural fold 
embedded within it a mononuclear or binuclear metal center, which serves as the active 
site for the hydrolytic reactions. The metal center of the AHS has dual function: (1) to 
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activate the scissile bond of the substrate for bond cleavage (2) to deprotonate the 
hydrolytic water molecule for the nucleophilic attack (7).  In all cases studied to date, the 
nucleophilic water is activated through complexation with the metal center. Members of 
the AHS, have highly conserved metal binding ligands, depending on the nature of the 
metal center [binuclear – e.g. PTE (4), URE (6); α-mononuclear – e.g. ADA (5), 
cytosine deaminase (CDA) (8); β-mononuclear – e.g. N-acetyl-D-glucosamine-6-
phosphate deacetylase (NagA) (9)]. Most metal binding residues are positioned to the C-
terminal ends of the β-strands and are fine tuned to produce and deliver the nucleophilic 
hydroxide to the acceptor substrate in the appropriate orientation. The diversity in the 
reactions catalyzed and substrate specificities arise from the loops connecting the α-
helices and β-strands. The eight loops are found immediately after the residues that serve 
as ligands that bind the metal center. These loops vary immensely in size, length, and 
conformation. The substrate diversity is dictated by the conformational restrictions 
imposed by the eight loops. As of 2011, the AHS consists of more than 12,000 non-
redundant protein sequences from the approximately 1200 fully sequenced bacterial 
genomes as per the NCBI database. The AHS has been subclassified into 24 clusters of 
orthologous groups (COGs) (10). 
 The COGs database (http://www.ncbi.nlm.nih.gov/COG) has been designed as 
an attempt to classify proteins from completely sequenced genomes on the basis of 
orthology (11). Orthologs are direct evolutionary counterparts related by vertical descent 
as opposed to paralogs which are genes within the same genome related by gene 
duplication events. Orthologs typically have the same overall protein fold, similar 
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domain architectures and same or similar functions. The exception to orthologs having 
the same or similar functions arises in multicellular eukaryotic system. The COG 
database has been established so that one might transfer functional information from 
experimentally verified and/or characterized proteins to their homologs from organisms 
that are poorly studied based primarily on the similarity of the protein sequences. The 
organization within COGs implies one-to-many, many-to-many as well as one-to-one 
type relationships between protein sequences.  
 The COGs were constructed based on the protein sequences available from the 
fully sequenced genomes. This database was first established and publicly available in 
2000. The rationale behind assembly of the COG database was that if a group of at least 
three proteins from the distant genomes are more similar to one another than they are to 
any other protein from the same genome they comprise an orthologous family. COGs 
were generated using the NCBI freeware BLAST, where in an all-by-all BLAST was 
performed using all the protein sequences from the completely sequenced genomes. The 
COGs account for a low-overall sequence similarity between sequences and thus can 
account for slow and fast evolving genomes. With the increasing number of fully 
sequenced genomes, the NCBI has developed an automated software, COGNITOR. This 
program gathers proteins sequences from the newly sequenced organisms and 
categorizes them into appropriate COGs that have been previously classified. This 
program also generates new COGs for protein sequences that lack homology to existing 
sequences beyond a certain pre-established threshold. Thus the COGs database serves as 
a very convenient platform in studying protein superfamilies like the AHS.  
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Table 1.1: The COGs within the AHS. This table also has the predicted and/or 
experimentally validated metal centers, and their respective annotations in the NCBI 
database. 
COG 
number 
Metal center Annotations available in NCBI database 
 
0044 Binuclear  Dihydroorotase, Dihydroorotate like cyclic 
ring opening amidohydrolase, hydantoinase, 
dihydropyrimidinase, allantoinase 
0084 Binuclear TatD Mg-dependent deoxyribonuclease 
0402 Mononuclear  
(alpha site) 
Cytosine deaminase, guanine deaminase, N-
formimino-L-glutamate deiminase, S-
adenosylhomocysteine deaminase, N-
isopropylammelide 
isopropylaminohydrolase, Chlorohydrolase, 
Selenium utilizing proteinSsnA, 8-
oxoguanine deaminase, isoxanthopterin 
deaminase 
0418 Binuclear Dihydroorotase 
0613 Trinuclear Putative metal-dependent phosphoesterases, 
PHP family 
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Table 1.1 Continued 
COG 
number 
Metal center Annotations available in NCBI database 
 
0804 Binuclear Urease 
1001 Binuclear Adenine deaminase, isoaspartyl dipeptidase, 
enamidase 
1099 Unknown Putative metal-dependent hydrolase, TatD-
related deoxyribonuclease 
1228 Binuclear Imidazolonepropionase, isoaspartyl 
dipeptidase, enamidase, peptidase M38, 
prolidase, carboxypeptidase 
1229 Unknown  Formylmethanofuran dehydrogenase  
1387 Trinuclear Histidinol phosphate phosphatase, 
polymerase-histidinol phosphatase (PHP) 
domain-containing protein 
1574 Unknown Putative metal-dependent hydrolase with TIM 
barrel fold 
1735 Binuclear Phosphotriesterase, phosphotriesterase 
homology protein, phospho-sugar lactone 
hydrolase, aryldialkylphosphatase 
1816 Mononuclear  
 
Adenosine deaminase 
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Table 1.1 Continued  
COG 
number 
Metal center Annotations available in NCBI database 
 
1820 Binuclear,  
Mononuclear  
(alpha or beta site) 
 
N-acetyl-D-glucosamine deacetylase 
1831 Unknown TatD-related deoxyribonuclease 
 
1904 Mononuclear 
(alpha site) 
D-glucuronate isomerase, uronate isomerase 
2159 Mononuclear  
(alpha site) 
γ-resorcylic acid decarboxylase, α-amino-β-
carboxymuconate-ε-semialdehyde 
decarboxylase, isoorotate decarboxylase, 5-
carboxyvanillic acid 
2355 Binuclear Zn-dependent dipeptidase 
3454 Mononuclear 
(alpha site) 
Putative metal-dependent hydrolase involved 
in phosphonate metabolism (PhnM) 
3618 Metal independent Sugar lactonase, 2-pyrone-4,6-dicarboxylic 
acid hydrolase 
3653 Binuclear N-acyl-D-amino acid deacelyase 
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Table 1.1 Continued 
COG 
number 
Metal center Annotations available in NCBI database 
 
3964 Binuclear  Putative metal-dependent hydrolase, 
dihydroorotase like 
4464 Unknown Capsular polysaccharide biosynthesis protein 
with a polymerase-histidinol phosphate 
(PHP) like C-terminal domain 
 
This study focuses on the functional annotations within COG 1001 (putative 
adenine deaminase) and COG 3454 (putative enzymes involved in phosphonate 
metabolism, PhnM), as well as annotations to functions on the carbon-phosphorus lyase 
pathway (C-P lyase) (both the COGs mentioned in bold red in table 1.1). 
 The COGs are better visualized using the Cytoscape software (12). Cytoscape is 
an open source bioinformatics software platform for visualizing molecular interaction 
networks and biological pathways. Cytoscape integrates these networks with gene 
annotations, gene expression profiles as well as other data. Although Cytoscape was 
initially designed for visualizing complex biological networks, it uses now stretch 
beyond biology. Additionally there are several plugins available with this software that 
allow for generating a myriad of networks based on different constraints. The most 
useful for the COG visualization is the BLAST plugin. This BLAST plugin is analogous 
to the NCBI blast program but it performs the same function for the sequences 
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incorporated into the cytoscape file being assessed, which in this case are the sequences 
within a COG. Several cytoscape networks can be generated by varying a single 
parameter called the E-value or the expectation value. The expectation value is simply a 
parameter that describes the number of hits within a sequence one might “expect” to see 
by chance when one is searching a database of defined size. The E-value takes into 
account both the number of matches as well as the length of the queries. The E-value 
decreases exponentially as the number of matches within a sequence increase. The lower 
the E-value, or closer the E-value to zero, the more significant the match. For a generic 
translation, an E-value of 10-70, implies a sequence identity between proteins of 
approximately 35%. Using the Cytoscape software, sequence similarity networks were 
made for COGs 1001 and 3454 (represented in figures 1.3 and 1.4 respectively). 
 
Figure 1.3: Sequence similarity network of COG 1001 at an E-value of 10
-80 (sequence 
similarity ~ 40 %).  
Groups 1 and 4 are annotated as adenine deaminases, group 2 is annotated as 
adenine deaminase, adenine deaminase-like, or unknown amidohydrolase, group 3 is 
13 
 
annotated as isoaspartyl dipeptidase and group 5 is annotated as enamidase. (This figure 
is adapted from J. Am. Chem. Soc. 133, 2080-2083 (2011)). More details on the 
functional annotations of the members within COG 1001 are presented in chapters 2, 3 
and 5. 
 
Figure 1.4: Sequence similarity network of COG 3454 at an E-value of 10
-70 (sequence 
similarity ~ 35 %).  
Groups 1-4 are annotated as metal-dependent hydrolase of the amidohydrolase 
superfamily involved in phosphonate metabolism (PhnM). The reason this COG splits 
into different groups even though all of the members are expected to perform the same 
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function, is due to the high constraint on the E-value. Since groups 1, 3 and 4 contain 
non-redundant sequences from closely related organisms, they split into smaller groups 
from group 2 at an E-value of 10-70. More details on the functional annotations of the 
members within COG 3454 are presented in chapter 6. 
 
Scheme 1.1: Proposal by Koch and Vallee in 1959, for the 3-step deamination of 
adenine to hypoxanthine. 
 COG 1001 consists of approximately 250 non-redundant protein sequences. The 
majority of sequences within this COG are annotated as adenine deaminase. Adenine 
deaminase catalyzes the hydrolytic deamination of adenine to form hypoxanthine. Prior 
to genome sequencing, adenine deaminase was presumed to be non-existent. Studies 
from Koch and Vallee in the 1950s suggested the lack of any adenine deaminase activity 
in E. coli cell free extracts (13). They proposed from their studies that there were no 
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enzymes within the E. coli proteome that could attack adenine. They proposed adenine 
deamination to be a 3-step process, where adenine was firstly converted to adenosine, 
then adenosine was deaminated to inosine and finally inosine was cleaved to ribose and 
hypoxanthine (shown in Scheme 1.1). In another study by Schramm and co-workers 
(14) studying the degradation of adenylate in E. coli, they arrived at a similar conclusion 
that E. coli lacks adenine deaminase activity. Scheme 1.2 shows the proposed 
mechanism for the degradation of adenosine 5’-monophosphate based on the enzymes 
identified in their study. However, with the availability of newer bacterial genomes, 
newer purine degradation and purine salvage pathways were discovered. In 1996, a 
study by Nygaard and co-workers found that certain mutants in Bacillus subtilis were 
deficient in metabolizing adenine (15). This study led to the discovery of the first 
adenine deaminase activity within bacteria. Their research suggested that adenine 
deaminase was the only enzyme in B. subtilis that could deaminate adenine, a reaction 
which was important for the utilization of adenine as a purine source. Their research also 
suggested that in some bacteria like B. subtilis, adenine was the only source for 
synthesizing guanine nucleotides via the purine salvage pathway.  Their research 
culminated into the identification of the cryptic ade gene, responsible for the adenine 
deaminase in bacteria. Sequence analysis of the protein classified adenine deaminase as 
a member of the AHS and categorized it within COG 1001. The preliminary 
characterization of the ade gene product found that the adenine deaminase activity was a 
metal dependent activity, like the other members of the AHS. Finally in 2001-2002, two 
research groups found a gene in E. coli analogous to the ade gene in B. subtilis, the yicP 
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gene. Matsui and co-workers were the first to clone and express the yicP gene 
recombinantly and establish that it had adenine deaminase activity (16). Petersen and co-
workers also arrived at the same conclusion, but their study was more complete (17). 
They found that adenine deaminase was part of a more silent purine salvage pathway, 
which is upregulated upon external abundance of purines. Escherichia coli auxotrophic 
mutants can utilize adenine as sole source of purines, and can biosynthesize guanine 
nucleotides from the adenine. This pathway was termed the purine salvage pathway 
(scheme 1.3). The first step of this pathway is the deamination of adenine to 
hypoxanthine by adenine deaminase. Either adenine or hypoxanthine is then ribosylated 
by the gene product of deoD, purine nucleoside phosphorylase to form adenosine or 
inosine respectively. Adenosine is later acted upon by adenosine deaminase to form 
inosine. Deletion and gene knockout studies from their research have suggested that the 
flux of this pathway is towards adenine deaminase and that was found to be the major 
pathway, but there was still contribution from the adenosine deaminase pathway.  
More recently the nadA gene from Aspergillus nidulans, was found to encode the 
adenine deaminase for that organism and was found to lie at the cross-roads to purine 
salvage and purine degradation pathways (18). In this purine catabolism pathway or the 
purine degradation pathway (scheme 1.4), adenine is first converted to hypoxanthine by 
the action of adenine deaminase. Hypoxanthine is further used by xanthine 
dehydrogenase (also xanthine oxidase) to eventually form uric acid via a xanthine 
intermediate. Uric acid is then converted to allatoin by the enzyme urate oxidase. 
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Allatoin is then converted by allantoinase to allantoic acid, which is further transformed 
into urea and glyoxalic acid by allantoicase.  
 
Scheme 1.2: The proposed adenylate degradation pathway proposed by Schramm and 
co-workers based on the identification of the various enzymes on the degradative 
pathway. Adenine deaminase activity was hypothesized but not found from the cell free 
extracts of E. coli. 
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Scheme 1.3: The purine salvage pathway. The red arrows represent the major flux 
within this pathway of which the first committed step is the deamination of adenine to 
hypoxanthine by adenine deaminase.  
Figure 1.3 illustrates that COG 1001 consists of 5 groups within it. Groups 1 and 
4 are annotated as adenine deaminase within the NCBI database. Functional and 
mechanistic studies have proved that groups 1 and 4 are adenine deaminases (20, 21) 
(Details of the study available in chapters 2 and 3). The adenine deaminases clustered 
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within COG 1001 have been shown to be the only members with the AHS that perform a 
deamination reaction with a binuclear metal center. 
 
Scheme 1.4: The purine catabolism pathway (19). 
 All other deaminases have a mononuclear metal center. Also unique to adenine 
deaminases from COG 1001 is that they were shown to perform an aberrant catalase 
type reaction also catalyzing the disproportionation of hydrogen peroxide to oxygen and 
water, with the production of reactive oxygen species, superoxide and hydroxyl radical, 
during the catalase reaction (21). Based on the crystal structures, the identification of the 
critical residues in catalysis and the conservation of these residues, groups 3 and 5 were 
annotated as isoaspartyl dipeptidase (22) and enamidase (23) respectively. Within COG 
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1001 is a group of 32 bacterial protein sequences that are annotated as adenine 
deaminase, adenine deaminase like, or amidohydrolase of unknown function. Functional 
annotation studies have found that these protein sequences preferentially catalyze the 
deamination of the epigenetic base N-6-methyladenine (24) (Details of this study 
available in chapter 5). Thus COG 1001 has now been fully annotated for molecular 
functions to the corresponding protein sequences within the COG. 
 Figure 1.4 represents all the non-redundant protein sequences within COG 3454. 
This COG contains close to 180 non-redundant protein sequences. All the members of 
this COG contain enzymes classified as PhnM, a member of the carbon-phosphorus 
lyase (C-P lyase) pathway, a pathway that metabolism phosphonates. PhnM is annotated 
within the NCBI as a metal-dependent hydrolase involved in phosphonate metabolism. 
At an expectatation value of 10-70 (~ 35 % sequence identity), COG 3454 is divided into 
4 distinct groups. Group 1 consists of 22 non-redundant protein sequences arising from 
phylogenetically related α-proteobacterium species, living in marine environment or 
involved in nitrogen fixation. Group 3 consists of 10 non-redundant protein sequences 
coming solely from closely related Rhizobium species, a set bacterial species that are 
nitrogen fixing and found largely within the root nodules of leguminous plants. Group 4 
consists of 5 protein sequences that are non-redundant from Roseobacter species,   
another α-proteobacterial species first isolated from marine algae. Their name arises 
from their ability to biosynthesize pink-pigment bacteriochlorophyll-A. Group 2 consists 
of an array of closely related non-redundant protein sequences coming from 
proteobacteria. All the 180 or so sequences from this COG fall within the highly 
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conserved C-P lyase pathway amongst proteobacteria and there appears to be a single 
function arising from the members within this COG, the putative hydrolytic function of 
PhnM. Hence the knowledge of the C-P lyase pathway as a whole would help elucidate 
the function of the COG 3454. 
Carbon, nitrogen, oxygen, and phosphorus are essential elements required by all 
living organisms for survival.  Of these elements, phosphorus is incorporated as a 
derivative of phosphate where it is an integral component of nucleic acids, 
carbohydrates, and phospholipids.  Phosphorus has many roles in metabolic pathways 
and cell signaling.  Most organisms have evolved to obtain phosphorus, as phosphate, 
directly from the environment.   In the biosphere, phosphorus is bioavailable in its 
highest oxidation state (+5) as inorganic phosphate (Pi). However, under cases of Pi 
starvation most proteobacteria including Escherichia coli, have developed pathways to 
scavenge other forms of phosphorus from the external environment. In E. coli there 
exists a two component regulator system called the Pho system that regulates and 
mobilizes phosphorus sources across membranes and within cells. The genes associated 
with this regulatory system are PhoR and PhoB (25). The Pho system also broadly called 
the Pho regulon consisted of 31 validated genes organized in nine transcriptional units as 
of 2011. More genes and transcriptional units as expected to be governed by the Pho 
regulon (26). One such phosphorus source regulated by the Pho regulon is 
phosphonates. Phosphonates are organophosphorus compounds that contain a one C-P 
bond.  This bond is chemically inert and hydrolytically stable. Phosphonates are 
ubiquitous and include antibiotics (fosfomycin and phosphonothrixin), herbicides 
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(glyphosate) and industrial detergent additives (amino-trimethylene phosphonate) 
(Scheme 1.5).  It is estimated that more than 20,000 tons of phosphonates are released 
annually in the US alone from herbicide and detergent wastes (27, 28).  The large 
quantities of phosphonates that are being deposited into the environment suggest that 
there needs to be a greater understanding of how these compounds are metabolized and 
degraded. Biogenic phosphonates are found mainly in primitive life forms. They usually 
exist as 2-aminoethylphosphonic acid and 2-amino-3-phosphonoproionic acid, which are 
integral components of the membrane phosphonolipids. The presence of phosphonates 
within the lipid membranes confers rigidity to the membranes as well as protects them 
from enzymatic degradation from enzymes like phosphatases. The C-P bond of 
phosphonate is also resistant to photolysis and thereby confers protection against light as 
well for these primitive organisms (29). 
 All known biological sources of phosphonates arise from a single reaction 
converting phosphate to phosphonate. The reaction is catalyzed by the enzyme 
phosphoenolpyruvate (PEP) mutase, where there is an intramolecular transfer of the 
phosphoryl group from PEP to form phosphonopyruvate. PEP is a product readily 
available from the glycolysis reaction cascade. The phosphoryl transfer reaction 
catalyzed by PEP mutase, is an equilibrium reaction, with the equilibrium highly 
favoring the C-O-P bond of PEP and not the C-P bond of phosphonopyruvate (Scheme 
1.6). However, most proteobacteria requiring phosphonates couple the reaction of PEP 
mutase to an enzyme phosphonopyruvate decarboxylase and drive the equilibrium 
towards the synthesis of phosphonates. The enzyme phosphonopyruvate decarboxylase 
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irreversibly converts phosphonopyruvate to phosphonoacetate and carbon dioxide 
(Scheme 1.6). Phosphoacetate is the first useful phosphonate metabolite available to 
cells from PEP (30).  
 
 
Scheme 1.5: Some of the more common phosphonates. The bonds highlighted in red in 
the characteristic C-P bond of phosphonates. 
 Phosphonate biosynthesis has just a single reaction, however depending on the 
nature of the phosphonates, microorganisms have developed several ways to break the 
C-P bond of phosphonates. Given the chemically inert, hydrolytically stable nature of 
phosphonate, there are two primary classes of enzymes that break C-P bonds: 1. 
Phosphonate hydrolases. 2. C-P lyases 
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Scheme 1.6: Biogenic synthesis of phosphonoacetate from phosphoenol pyruvate (PEP), 
the central reaction for all phosphonate biosynthesis. 
 Phosphonate hydrolases are the more extensively studied class of enzymes of the 
two generic classes of enzymes breaking a C-P bond. These hydrolases are highly 
specific for their substrates phosphonoacetate, phosphonopyruvate or 
phosphonoacetaldehyde. All the hydrolytic reactions proceed through a similar 
mechanism. All the substrates listed above: phosphonoacetate, phosphonopyruvate and 
phosphonoacetaldehyde have a β-carbonyl group next to the C-P bond. This group is 
electron withdrawing in nature and allows for the heterolytic cleavage of the C-P bond 
(31) (Scheme 1.7). Phosphonate hydrolases are expressed by organisms under normal 
growth and are part of the transcriptional units of the global Pho regulon.  
 The second class of enzymes involved in breaking a C-P bond is called C-P 
lyase. C-P lyases enzymes conserved across all the proteobacteria and are quite 
promiscuous and enigmatic in their activity. These enzymes can cleave of unactivated 
alkyl and phenyl phosphonates to their corresponding alkanes and benzene products 
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(Scheme 1.8). In E. coli, one of the nine transcriptional units regulated by the Pho 
regulon encodes a 14-cistronic operon called the Phn operon. This operon encodes all of 
the components of the C-P lyase pathway. The C-P lyase pathway is involved in the 
cellular uptake and metabolism of phosphonates, and is expressed strictly under limiting 
environmental phosphorus conditions. 
 The C-P lyase is the most widespread amongst bacterial genomes of all the 
enzymes capable of catabolizing phosphonates. The Phn operon consists of 14 genes 
responsible for this activity in E. coli. 
 
 
Scheme 1.7: The reaction catalyzed by the phosphonate hydrolase enzymes for their 
specific substrates. When R = H, susbtrate: phosphonoacetaldehyde, when R = OH, 
susbtrate: phosphonoacetate, and when R = COOH, susbtrate: phosphonopyruvate. 
  
 
Scheme 1.8: The reaction catalyzed by the C-P lyase pathway.  
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This pathway uses unactivated phosphonates like methylphosphonate, 
ethylphosphonate, phenylphosphonate etc. and forms the corresponding alkane like 
methane, ethane and benzene (phenyl product) and phosphate. 
 Of the 14 genes, phnC, phnD and phnE constitute putative protein binding 
phosphonate transporters, based on sequence analysis and phenotype studies of 
transposon mutants (32, 33). The gene phnF was found to be a global regulator of the C-
P lyase pathway. The genes phnG, phnH, phnI, phnJ, phnK, phnL and phnM were found 
to constitute the minimal catalytic set for the C-P activity, whereas the genes phnN, 
phnO and phnP were found to encode proteins that were responsible for metabolizing 
the products and intermediates of this pathway (32, 33). Of the genes absolutely essential 
for the C-P lyase activity, PhnM is a member of the AHS and classified within COG 
3454 as described earlier. Chapter 6 of this study describes studies that functionally 
annotate of the essential genes of the C-P lyase pathway and identify in turn a function 
for COG 3454.  
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CHAPTER II 
CATALYTIC MECHANISM AND THREE DIMENSIONAL STRUCTURE OF 
ADENINE DEAMINASE* 
 
 Adenine deaminase (ADE) catalyzes the conversion of adenine to hypoxanthine 
and ammonia.  The enzyme isolated from Escherichia coli using standard expression 
conditions was largely inactive towards the deamination of adenine (kcat ~2 s
-1).  When 
iron was sequestered with a metal chelator (2,2’-dipyridyl) and the growth medium was 
supplemented with Mn2+ prior to induction, the purified enzyme was substantially more 
active for the deamination of adenine with values of kcat and kcat /Km of 200 s
-1 and 5 x 
105 M-1s-1, respectively.  The apo-enzyme was prepared and reconstituted with Fe2+, 
Zn2+, or Mn2+.  In each case, two enzyme-equivalents of metal were necessary for 
reconstitution of the deaminase activity.  This work provides the first example of any 
member within the deaminase sub-family of the amidohydrolase superfamily (AHS) to 
utilize a binuclear metal center for the catalysis of a deamination reaction.  [FeII/FeII]-
ADE was oxidized to [FeIII/FeIII]-ADE with ferricyanide with inactivation of the 
deaminase activity.   
 
 
 
 
*Reprinted with permission from “Catalytic mechanism and three-dimnsional 
structure of adenine deaminase” by S. S. Kamat, A. Bagaria, D. Kumaran, G. P. 
Holmes-Hampton, H. Fan, A. Sali, J. M. Sauder, S. K. Burley, P. A. Lindahl, S. 
Swaminathan and F. M. Raushel, Biochemistry 50, 1917-1927, 2011. Copyright 2011 
by American Chemical Society 
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Reducing [FeIII/FeIII]-ADE with dithionite restored the deaminase activity and 
thus the di-ferrous form of the enzyme is essential for catalytic activity.  No evidence for 
spin-coupling between metal ions was evident by EPR or Mössbauer spectroscopies.  
The three-dimensional structure of adenine deaminase from Agrobacterium tumefaciens 
(Atu4426) was determined by X-ray crystallography at 2.2 Å resolution and adenine was 
modeled into the active site based on homology to other members of the amidohydrolase 
superfamily.  Based on the model of the adenine-ADE complex and subsequent 
mutagenesis experiments, the roles for each of the highly conserved residues were 
proposed. Solvent isotope effects, pH rate profiles and solvent viscosity were utilized to 
propose a chemical reaction mechanism and the identity of the rate limiting steps. 
INTRODUCTION 
Adenine deaminase (ADE) catalyzes the conversion of adenine to hypoxanthine 
and ammonia as shown in Scheme 2.1 (16, 17, 20).   ADE is part of the purine 
degradation pathway where hypoxanthine is subsequently oxidized to uric acid by 
xanthine oxidase via a xanthine intermediate (18, 19).   This enzyme also participates in 
the purine salvage pathway for the synthesis of guanine nucleotides (17).   ADE from 
Escherichia coli is a member of the amidohydrolase superfamily (AHS) and is clustered 
within cog1001 in the NCBI database (3, 7).   Enzymes capable of deaminating 
adenosine, guanine, cytosine, and S-adenosyl homocysteine (SAH) are also found within 
the AHS.   All structurally characterized deaminases in the AHS have a distorted (β/α)8-
barrel structural fold and have a single divalent cation in the active site that is utilized for 
the activation of the nucleophilic water molecule (7).   For these enzymes, the lone 
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divalent metal ion is coordinated to two histidines at the end of β-strand 1, another 
histidine at the end of β-strand 5, an aspartate at the end of β-strand 8 and a water 
molecule.   A triad of conserved active site residues catalyzes proton transfers from the 
metal ligated water molecule to the reaction products, ammonia and hypoxanthine (7, 34, 
35).   These three residues include a glutamate in the loop that follows β-strand 5 (HxxE 
motif), a histidine at the C-terminal end of β-strand 6 and the aspartate at the C-terminus 
of β-strand 8.     
 
 
 
Scheme 2.1: Reaction catalyzed by adenine deaminase 
 Based on amino acid sequence alignments, the putative adenine deaminases 
found within cog1001 are predicted to bind two divalent cations in the active site to form 
a binuclear metal center structurally similar to those found in phosphotriesterase (4, 36, 
37), urease (6) and iso-aspartyl dipeptidase (22, 38).   In the known adenine deaminases 
from cog1001, there are four invariant histidine residues at the C-terminal ends of β-
strands 1, 5 and 6, and an aspartate at the C-terminus of β-strand 8.   A conserved 
glutamate residue that resides at the end of β-strand 4 is positioned to bridge the two 
divalent cations.   For E. coli ADE, these residues are predicted to be His-90, His-92, 
Glu-185, His-214, His-235, and Asp-284.  Adenine deaminase does not have the 
signature HxxE motif at the end of β-strand 5 that is conserved in all of the other known 
deaminases in the amidohydrolase superfamily (7).   Therefore, the mechanism for the 
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deamination of adenine by ADE is expected to be somewhat different than the reactions 
catalyzed by adenosine, cytosine, and guanine deaminases. 
Previous attempts to isolate and characterize ADE from E. coli using standard 
expression and purification protocols have shown that slightly more active enzyme could 
be obtained when the growth medium was supplemented with Mn2+ (16, 17, 20).   
However, the specific activity of the purified enzyme was substantially lower when 
compared with the turnover numbers exhibited by other deaminases from the 
amidohydrolase superfamily (16, 17, 20).   The turnover number for the deamination of 
adenine by ADE from E. coli was approximately 2 s-1 and the enzyme isolated with a 
mixture of zinc, manganese and iron in the active site.   Presented in this chapter is a 
novel iron-free expression and purification protocol resulting in the isolation of adenine 
deaminase with a turnover number of approximately 200 s-1.  The three dimensional 
structure of ADE from Agrobacterium tumefaciens (Atu4426) and proposed a novel 
catalytic reaction mechanism for the deamination of adenine is also proposed. 
MATERIALS AND METHODS 
Materials.  All chemicals were purchased from Sigma-Aldrich unless otherwise 
stated.  The genomic DNA for E. coli str. K12 substr. MG1655 was purchased from 
ATCC.  E. coli BL21(DE3) and XL1-blue competent cells were obtained from 
Stratagene (Agilent).   The expression vector pET30(+) and Pfx DNA polymerase were 
purchased from Invitrogen.   All oligonucleotides were obtained from the Integrated 
DNA Technologies (IDT) from the Gene Technology Lab at Texas A&M University 
(GTL-TAMU).  
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Cloning of Adenine Deaminase from E. coli.  The DNA sequence for adenine 
deaminase from E. coli K12 was cloned (gi|16131535).   The PCR product was 
amplified utilizing the primer pair 5’-
AGGCTATTAATGAATAATTCTATTAACCATAAATTTCATCACAT-3’ and 5’-
CCGGAATTCTTATTCCGTGACTTCCAGCGTAGTGAAG-3’.   AseI and EcoRI 
restriction sites were introduced into the forward and the reverse primers, respectively.   
The PCR product was purified with a PCR cleanup system (Promega), digested with 
AseI and EcoRI, and ligated into a pET30a(+) vector that was previously digested with 
AseI and EcoRI.   The cloned gene fragment was sequenced at the GTL-TAMU to verify 
the fidelity of the PCR amplification. 
Standard Protein Expression and Purification of E. coli ADE.  The recombinant 
plasmid bearing the gene for adenine deaminase was transformed into E. coli BL21 
(DE3) competent cells by electroporation.  A single colony was grown overnight at 37 
oC in 5 mL of LB medium containing 50 µg/mL kanamycin.  Five mL aliquots were 
used to inoculate 6 L of the same medium.   The cell cultures were grown at 37 oC and 
induced with 0.5 mM isopropyl-β-thiogalactoside (IPTG) when the A600 reached ~ 0.6 in 
the presence of 1.0 mM MnCl2.   Protein expression was confirmed by SDS-PAGE.   
The cells were centrifuged and then resuspended in 50 mM HEPES, pH 7.5, containing 
0.1 mg/mL phenylmethylsulfonyl fluoride (PMSF) and lysed by sonication.   The 
soluble proteins were separated from the cell debris by centrifugation at 12,000 x g for 
15 minutes at 4 oC.   The nucleic acids were removed by dropwise addition of 2% w/v 
protamine sulfate.   After centrifugation, solid ammonium sulfate was added to 60% 
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saturation to the supernatant solution.   The precipitated protein was dissolved in buffer 
and then applied to a High Load 26/60 Superdex 200 prep grade gel filtration column 
(GE HealthCare).   The active fractions were pooled and loaded onto a ResourceQ 
(anion exchange) column (6 mL) and eluted with a gradient of NaCl in 20 mM HEPES, 
pH 7.5. The identity of the purified protein was verified by N-terminal amino acid 
sequencing at the Protein Chemistry Lab, Texas A&M University (PCL-TAMU). 
 Iron-Free Protein Expression of E. coli ADE.  The iron content of our LB 
medium (Research Products International Corp.) was determined to be approximately 36 
µM by inductively coupled plasma mass spectrometry (ICP-MS).   The iron-specific 
chelator 2,2’-dipyridyl was used to remove this metal during protein expression.   A 
single colony was grown overnight at 37 oC in 5 mL of LB medium containing 50 
µg/mL kanamycin and then added to 6 L of the same medium.   When the A600 reached 
0.15 – 0.20, 50 µM 2,2’-dipyridyl was added to sequester the iron, followed by the 
addition of 0.5 mM IPTG and 1.0 mM MnCl2 when the A600 was ~ 0.6.  
 Cloning, Expression and Purification of Atu4426. The gene (Atu4426) for 
adenine deaminase (gi|15890557) was obtained from A. tumefaciens genomic DNA 
(ATCC 33970D) (ADE from A. tumefaciens is abbreviated as Atu4426) and cloned, 
expressed and purified by the protein production team at New York Structural GenomiX 
Research Consortium (NYSGXRC) (20). The expression plasmid is available through 
the PSI Material Repository (dnasu.asu.org) as NYSGXRC clone ID 9206a1BCt6p1, and 
other experimental information is available in the Protein Expression Purification 
Crystallization Database (PepcDB.pdb.org) as TargetID "NYSGXRC-9206a" (20).   
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 Protein and Metal Analysis.  The concentration of ADE from E. coli was 
estimated by measuring the absorbance at 280 nm using an extinction coefficient of 
42,000 M-1 cm-1 (39).   The metal content of the protein was determined by ICP-MS 
(40).  The protein samples for ICP-MS were digested with HNO3 by refluxing for ~45 
minutes to prevent protein precipitation during the measurement.   The protein 
concentration was adjusted to ~1.0 µM with 1% v/v HNO3. 
Preparation and Reconstitution of Apo-Enzyme. Apo-ADE was prepared by 
dialyzing the enzyme purified from the iron-free expression protocol against 10 mM 
1,10-phenanthroline in 20 mM HEPES, pH 7.0, for 36 hours with two changes of buffer.   
The apo-enzyme was separated from 1,10-phenanthroline using a PD-10 column (GE 
HealthCare) and then reconstituted with various amounts of Mn2+, Zn2+ or Fe2+ at 4 oC 
for 48 hours.   In these experiments, 1.0 µM apo-ADE was titrated with 0-5 µM of the 
above mentioned metals.   Iron was added anaerobically to prevent air oxidation.   All 
samples were passed through a PD-10 column to remove any unbound metal and then 
assayed for adenine deaminase activity. The same experiment was performed with 
Atu4426 to verify the metal requirement for this enzyme. 
 Adenine Deaminase Activity.  The deamination of adenine was determined using 
a coupled assay with glutamate dehydrogenase (GDH).   Formation of ammonia was 
followed at 340 nm using a SpectraMax-340 UV-vis spectrophotometer in the presence 
of 20 mM HEPES, pH 7.5, 0.15 mM NADH, 25 mM α-ketoglutarate, 4 µg/mL 
glutamate dehydrogenase (GDH) and various concentrations of adenine in a final 
volume of 0.25 or 1.0 mL (41).   All the assays were carried out at 30 oC. 
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 Crystallization and Structure Determination of Atu4426. The crystal structure of 
Atu4426  was  solved by the Swaminathan laboratory from the Biology department, 
Brookhaven National Laboratory, NY. The details for the crystallization, refienement 
and structure elucidation are reported (20). The atomic coordinates and structure factor 
amplitudes were deposited in the Protein Data Bank (PDB ID: 3nqb).  
 Model for Binding of Adenine to Atu4426. Since all the attempts to crystallize 
Atu4426 with adenine, hypoxanthine and 6-chloropurine failed, docking was employed 
as the means to develop a model for binding of adenine in the active site of Atu4426. 
The ligand-free structure of Atu4426 (chain A) was used for structural modeling (20).  
The modeling studies were performed by the Sali laboratory at the Department of 
Pharmaceutical Sciences, University of California, San Francisco. 
Oxidation and Reduction of Iron Center.  The binuclear metal center of 
[FeII/FeII]-ADE (100 µM) was oxidized with varying amounts of potassium ferricyanide 
ranging from 25 to 500 µM  at room temperature in 20 mM HEPES, pH 7.5.  Aliquots of 
the enzyme were assayed for catalytic activity after 3 hours.   [FeIII/FeIII]-ADE was 
reduced to [FeII/FeII]-ADE through the anaerobic addition of solid sodium dithionite and 
the deaminase activity was determined after 20, 40, and 60 minutes of incubation.  As a 
control, 2.0 equivalents of ferricyanide (40 µM) were added to [MnII/MnII]-ADE (20 
µM).  
 Mössbauer and EPR Spectroscopy.  [FeII/FeII]-ADE was prepared for Mössbauer 
spectroscopy by reconstituting apo-ADE (300 μM) with 2 equivalents of 57FeCl3 
(IsoFlex USA) and 2.0 equivalents of ascorbic acid at 4 oC for 48 hours at pH 7.0 in a 
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volume of 1.2 mL.   Samples were passed through a PD-10 column to remove excess 
metal and then concentrated by ultrafiltration with a YM30 (Millipore) membrane.   The 
spectra were collected with a MS4 WRC spectrometer (SEE Co, Edina, MN) at either 5 
K or 100 K and then analyzed using the WMOSS software package provided by the 
manufacturer.   Chemical shifts were calibrated relative to Fe metal at 298 K.   EPR 
spectra were collected on an EMX X-band spectrometer in perpendicular mode equipped 
with an Oxford ER910A cryostat (Bruker Biospin, Billerica, MA). Spin concentrations 
were determined using a 1.0 mM CuEDTA standard.  For the g = 4.3 signal, double 
integral values were multiplied by 3 to account for the total spin population of all three 
doublet levels of the S = 5/2 manifold. The Mössbauer and EPR studies were performed 
in the Lindahl laboratory at Texas A&M University.  
 Mutation of ADE from E. coli.  All single site mutations were constructed using 
the standard QuikChange PCR protocol according to the manufacturer's instructions.  All 
of the mutants were expressed and purified using the iron-free expression protocol.   The 
apo-proteins (20 μM) were purified as described earlier and reconstituted with 2.0 
enzyme equivalents of Fe2+ (40 μM) under anaerobic conditions.   Excess metal was 
removed using a PD-10 column and the metal content was measured using ICP-MS.   In 
an attempt to rescue the loss of activity of the E185G mutant, various concentrations of 
propionic acid (0.5 – 10 mM) and Mn2+ (0.1-1.0 mM) were added to the apo-E185G 
mutant and allowed to incubate for 6 hours in 200 mM HEPES, pH 7.5, at 4 oC. 
 pH-Rate Profiles. The dependence of kcat and kcat/Km as a function of pH was 
determined for the Mn2+, Zn2+ and Fe2+ reconstituted ADE over the pH range of 6.0-9.0. 
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The buffers used for this study were 20 mM MES (pH 6.0-6.6), 20 mM HEPES (6.8-8.2) 
and 20 mM CHES (pH 8.4-9.0).  The pH values of the final solutions were measured 
before and after the completion of the assays.  Above pH 9, the coupling system was 
inefficient and below pH 6, ADE was unstable.  Equivalent profiles were also obtained 
in 100% D2O. 
Solvent Viscosity Effects.  The effects of solvent viscosity on kcat and kcat/Km of 
Mn/Mn-ADE were determined at pH 7.5 with 50 mM HEPES at 30 oC.  The viscosity 
was varied by increasing the concentration of sucrose (42). 
Inhibition of ADE by 6-Chloropurine. The inhibition of ADE by 6-chloropurine 
was evaluated by incubating Mn/Mn-ADE (4 nM) with varying concentrations of 6-
chloropurine at 30 oC for 1 hour.  Aliquots were removed and assayed for the 
deamination of 5.0 mM adenine at pH 7.5 at 30 oC.    
Data Analysis.  Initial velocity data were fit to equation 2.1 using the non-linear 
least squares fitting program SigmaPlot 9.0 where v is the initial velocity, [A] is the 
substrate concentration, Et is the total enzyme concentration, kcat is the turnover number 
and Km is the Michaelis constant.   For pH rate profiles, equation 2.2 was used to fit the 
bell-shaped pH profiles to determine values of Ka and Kb, for the ionization of groups at 
low and high pH values respectively.  In equation 2.2, c is the maximum value for either 
kcat or kcat/Km, depending on the fit, and H is the proton concentration.   The tight binding 
inhibition constant of 6-chloropurine to ADE was obtained using equation 2.3 (43).   In 
this equation, Et is the total enzyme concentration, I is the inhibitor concentration, vo is 
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the activity of the enzyme in the absence of inhibitor, and vi is the activity of the enzyme 
in the presence of varying inhibitor concentrations.  
v / Et = kcat [A] / (Km + [A])                                                       (Equation 2.1) 
 
log y = log(c/(1 + [H]/Ka + Kb/[H]))                                         (Equation 2.2) 
 
vi/vo = ([Et] – Ki – [I] + (([I] + Ki – [Et])
2 + (4Ki[Et]))
1/2)/(2[Et])        (Equation 2.3) 
RESULTS 
           Purification and Properties of ADE.  ADE from E. coli was purified to apparent 
homogeneity.  The enzyme purified in the presence and absence of added Mn2+ 
displayed similar kinetic properties and heterogeneous metal content.  The kinetic 
constants for the enzyme purified without Mn2+ supplementation were 1.6 ± 0.2 s-1, 0.81 
± 0.08 mM and (2.0 ± 0.2) x 103 M-1 s-1 for the values of kcat, Km, and kcat/Km, 
respectively.  The metal content of this enzyme contained 0.25 ± 0.05 equivalents of Fe 
and 0.20 ± 0.03 equivalents of Zn per subunit.   The kinetic constants for the enzyme      
purified with Mn2+ supplementation in the growth medium were 2.0 ± 0.3 s-1, 0.76 ± 0.1 
mM and (2.5 ± 0.2) x 103 M-1 s-1 for the values of kcat, Km, and kcat/Km, respectively.  The 
metal content of this sample was 0.31 ± 0.04 equivalents Fe and 0.24 ± 0.03 equivalents 
Mn per subunit.  The kinetic constants for Atu4426 purified using the standard 
expression protocol were 1.8 ± 0.2 s-1, 0.40 ± 0.08 mM and (4.5 ± 0.4) x 103 M-1 s-1 for 
kcat, Km, and kcat/Km, respectively.  The metal content for Atu4426 purified using 
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standard protocols was 0.80 ± 0.05 equivalents of Fe and 0.41 ± 0.05 equivalents of Mn 
per subunit.  
          Sequestration of Iron.  The addition of 50 µM 2, 2’-dipyridyl to the growth 
medium was utilized to sequester the iron at the time of induction.   The cells were 
supplemented with Mn and the purified enzyme contained 2.0 ± 0.1 equivalents of Mn 
per protein subunit.  The kinetic constants for the deamination of adenine by E. coli 
ADE were determined to be 200 ± 5 s-1, 0.40 ± 0.04 mM, and (5 ± 0.4) x 105 M-1 s-1 for 
kcat, Km, and kcat/Km, respectively.  The kinetic constants for the deamination of adenine 
by Atu4426 were determined to be 155 ± 5 s-1, 0.32 ± 0.04 mM, and (4.8 ± 0.4) x 105 M-
1 s-1 for kcat, Km, and kcat/Km, respectively.  The iron free expression protocol yielded a 
protein with 2.4 ± 0.1 equivalents of Mn per protein subunit for Atu4426.  All of the 
remaining experiments were conducted with protein expressed in E. coli from cells 
grown in the presence of the iron chelator. 
Reconstitution of Apo-Enzyme.  Apo-ADE from E. coli was prepared by dialysis 
of [Mn/Mn]-ADE with 10 mM 1,10-phenanthroline at pH 7.0.  The apo-enzyme had less 
than 0.2% of the original adenine deaminase activity and removal of manganese was 
confirmed by ICP-MS.   Apo-ADE was reconstituted with variable amounts of Mn2+, 
Zn2+ or Fe2+ for 48 hours at pH 7.5 and 4 oC to determine the stoichiometry of metal ion 
and protein required for optimal catalytic activity.  There was a linear increase in 
catalytic activity as the concentration of the divalent cation was increased from zero to 
two equivalents relative to the subunit concentration.  The titrations are shown in Figure 
2.1.  These titrations confirm that two metal ions are required for optimal catalytic 
39 
 
activity of ADE and the linearity of the titration curve is consistent with a cooperative 
assembly of the binuclear metal center (44).   The kinetic constants and metal content of 
the reconstituted forms of ADE from E. coli are presented in Table 2.1.   The Mn2+-
reconstituted ADE has essentially the same turnover number (196 s-1) as the enzyme 
isolated from E. coli (200 s-1).  The elution of adenine deaminase from the gel filtration 
column supports an oligomeric structure as a homodimer (data not shown). The apo-
Atu4426 could also be prepared by dialysis and the lack of metal for apo-Atu4426 was 
confirmed by ICP-MS. The reconstitution of Atu4426 with Mn2+ and Fe2+ 
(anaerobically) resulted in profiles identical to those obtained for the E. coli ADE shown 
in figure 2.2.  
Table 2.1: Kinetic parameters and metal content of metal-reconstituted forms of E. coli 
ADE
a 
enzyme 
 
kcat (s
-1) kcat/Km (M
-1 s-1) metal/subunit  
[Mn/Mn]-ADE 
 
185 ± 5 (6.1 ± 0.5) x 105 2.0 ± 0.1 
[Zn/Zn]-ADE 
 
123 ± 8 (5.4 ± 0.5) x 105 1.9 ± 0.1 
[Fe/Fe]-ADE 
 
196 ± 3 (5.9 ± 0.5) x 105 1.9 ± 0.1 
apH 7.5 and 30 oC 
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Figure 2.1: Metal titration with apo-ADE. Titration of varying enzyme equivalents of 
Mn2+ (open circles) and Fe2+ (closed circles) to apo-ADE (1.0 µM) at 4 oC.  The enzyme 
assays were performed after allowing the mixture of apo-ADE and metal to equilibrate 
for 48 hours at pH 7.5.  The reconstitution with iron was done anaerobically. 
Three-Dimensional Structure of Atu4426.  The asymmetric unit contains two 
protomers that are very similar to one another (rmsd of 0.26 Å).  Each protomer contains 
three domains: an N-terminal  sandwich, a TIM barrel and a C-terminal / domain 
shown in Figure 2.3 (20).  The active site of Atu4426 contains three Mn2+ ions (Figure 
2.4). A stereoview of the active site is presented in Figure 2.4. The first two metal ions 
form a binuclear metal center that is similar, but not identical, to other members of the 
amidohydrolase superfamily (3, 7).  The HxH motif (His-92 and His-94) from β-strand 1 
and the aspartate (Asp-289) from β-strand 8 coordinate the α-metal ion.  The β-metal ion 
is ligated by His-218 from β-strand 5, His-239, and Glu-240 (both from β-strand 6).  The 
two metal ions are bridged to one another by Glu-187 (from β-strand 4) and a 
hydroxide/water from solvent.  The third metal ion is coordinated to His-122, Glu-123, 
[metal] / [ADE]
0 1 2 3 4 5
k
c
a
t 
(s
-1
)
0
50
100
150
200
250
41 
 
His-477 and Asp-478 and is 6.6 Å from the α-metal and 8.2 Å from the β-metal of the 
binuclear metal center.   
 
Figure 2.2: Metal titration with apo-Atu4426. Titration of varying enzyme equivalents 
of Mn2+ (open circles) and Fe2+ (closed circles) to apo-Atu4426 (1.0 µM) at 4 oC.  The 
enzyme assays were performed after allowing the mixture of apo-Atu4426 and metal to 
equilibrate for 48 hours at pH 7.5.  The reconstitution with iron was done anaerobically.  
The polypeptide segments consisting of residues 9-87 and 338-375 of the N-
terminal domain are shown in purple and cyan color, respectively. TIM barrel and C-
terminal domains are shown in green and marine blue, respectively.  The loop residues 
376 to 386, connecting the N- and C-terminal domains are shown in brown.  The 
manganese ions are shown as magenta spheres. In the stereoview, metal ions and 
coordinating water molecules are shown in grey and red, respectively.  
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Figure 2.3:  Ribbon representation of the structure of Atu4426.  
 
 
Figure 2.4: Stereoview of the Atu4426 active site residues.   
 Model of Adenine Bound in Active Site.  A comparison between the binding site 
in the ligand-free crystal structure and the binding site in the proposed model is 
presented in Figure 2.5A.  The model of the binuclear metal center (His-92, His-94, 
Glu-187, His-218, His-239 and Asp-289) is nearly identical to that in the crystal 
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structure.  The differences include the side chain of Arg-220 that is rotated by ~90 so 
that the guanidino group is not in proximity of the binuclear metal center.  Model side 
chains of Glu-240 and Asp-290 were adjusted to result in more favorable electrostatic 
interactions between the carboxylate groups and the two metals.  Furthermore, His-122, 
Glu-123 and His-477 form a more closed ligand-binding site in comparison to the open 
conformation in the crystal structure.  The best-scored binding pose of adenine in the 
modeled binding site is shown in Figure 2.5B.  The tetrahedral intermediate was formed 
by the bridging hydroxide attacking C-6 on the re-face of adenine.  In this complex, the 
ammonia leaving group hydrogen bonds with the side chains of Asp-289 and Asp-290.  
The protonated N-1 nitrogen of adenine hydrogen bonds with the side chain of Glu-240.  
In addition, the N-7 nitrogen of adenine coordinates the -metal and the N-9 (NH) 
nitrogen hydrogen bonds with the side chain of Glu-123.  The N nitrogen in His-122, 
which was assigned to be protonated during modeling, is adjacent to the adenine N-3 
nitrogen (3.7 Å) and Glu-123 OE2 oxygen (3.1 Å).  
Substrate Specificity.  A number of compounds having adenine like moieties 
were tested as substrates or competitive inhibitors for ADE from E. coli.  Among these 
compounds were 2-hydroxyadenine, N-6-methyladenine, 6-chloropurine, 7-
methyladenine, 2,6-diaminopurine, adenosine, 6-methoxypurine, 6-methylpurine, 6-
mercaptopurine and 6-methylmercaptopurine.  6-Chloropurine was a very effective tight 
binding inhibitor for ADE from E. coli. However none of the other compounds was 
either a substrate or competitive inhibitor for ADE.  
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Figure 2.5:  Model of adenine in the active site of Atu-4426 (A) Binding site 
conformation in the model of Atu4426 (transparent sticks) compared to the binding site 
in the ligand-free crystal structure of Atu4426 (solid line).  The two metal ions in the 
model are depicted in dark blue, occupying identical places as the two metal ions in the 
crystal structure.  (B) The binding mode of the tetrahedral intermediate formed during 
the deamination of adenine in the modeled binding site of Atu4426. Polar contacts 
between adenine and binding site residues are indicated by dashed lines with distances 
given in Ångstroms.   
EPR and Mössbauer Spectroscopy of [Fe/Fe]-ADE.  The 5 K low-field 
Mössbauer spectrum of the reconstituted and fully active [Fe/Fe]-ADE (Figure 2.6) 
exhibited a quadrupole doublet typical of high-spin FeII ions (45).  Lineshapes and 
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linewidths revealed no evidence of multiple species.  Given the presence of two irons per 
protein, this suggests a very similar ligand environment for both ferrous ions.   
 
 
 
 
 
 
Figure 2.6: Mössbauer spectrum of [Fe
II
/Fe
II
]-ADE (265 μM).  The spectrum was 
collected at 5 K, 400 G magnetic field applied parallel to the radiation.  The red line 
represents a simulation with δ= 1.39 mm/s, ΔEq= 3.27 mm/s with line width of 0.47 
mm/s. 
 
 
 
 
 
 
Figure 2.7: EPR spectrum of Mn/Mn-ADE (220 µM).  EPR parameters: temperature, 10 
K; microwave 9.46 GHz, 0.02 mW.   
The enzyme in the [FeII/FeII] state was EPR-silent.  To determine whether 
[FeII/FeII]-ADE is air-sensitive, this protein was incubated aerobically at room 
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temperature and then assayed for catalytic activity.  There was no loss of activity after 
24 hours and the Mössbauer spectrum (not shown) demonstrated that the iron remained 
high-spin ferrous.  The EPR spectrum of [Mn/Mn]-ADE showed a prototypical six-line 
pattern for Mn2+ (Figure 2.7) with no evidence of antiferromagnetic coupling (46).  
Oxidation and Reduction of [Fe/Fe]-ADE.  Potassium ferricyanide was used to 
oxidize the binuclear metal center to determine if the di-ferric state of the binuclear 
metal center is active for the deaminase reaction.  Increasing concentrations of 
ferricyanide to [FeII/FeII]-ADE (100 µM) linearly inactivated the catalytic activity 
(Figure 2.8) with two equivalents of the reagent being sufficient to fully inactivate the 
enzyme.  The Mössbauer spectrum of iron bound ADE treated with two equivalents of 
ferricyanide exhibited a six-line pattern typical of a high-spin ferric oxidation state 
(Figure 2.9A).  The EPR spectrum of [FeIII/ FeIII]-ADE exhibited a signal at g = 4.3, 
typical of FeIII ions with rhombic symmetry (Figure 2.9B).  The spin concentration of 
the signal corresponded to 1.9 spins/mol protein, suggesting that the ferric ions are not 
magnetically interacting and that each ion affords the EPR signal.   [FeIII/FeIII]-ADE was 
reduced back to the di-ferrous state with the anaerobic addition of sodium dithionite and 
the deaminase activity was fully reconstituted within 1 hour.  The Mössbauer spectrum 
of this sample (data not shown) resembled the spectrum of [FeII/FeII]-ADE shown in 
Figure 2.6.  Addition of 0.25 mM H2O2 to 1.5 µM [Fe
II/FeII]-ADE resulted in the 
irreversible oxidation of the iron center and oxygenation of the protein.    
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Figure 2.8: The loss of adenine deaminase activity after the addition of various amounts 
of potassium ferricyanide to [Fe
II
/Fe
II
]-ADE (100 µM). 
 
 
 
 
 
 
Figure 2.9: Mössbauer and EPR spectrum of [Fe/Fe]-ADE after treatment with 
ferricyanide (A) Mössbauer spectrum of [Fe/Fe]-ADE (200 µM) after the addition of 
two equivalents of ferricyanide (400 µM).  Collection parameters:  temperature, 5 K; 
field, 700 G; counts of radiation, 2.2 x 107. The red line is a simulation assuming a single 
species (B) EPR spectrum of 200 µM [FeIII/FeIII]-ADE after treatment with ferricyanide.  
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The figure 2.9 has a Mössbauer spectrum (A) that was fit to standard single 
species simulation explained previously and the EPR parameters (B) were same as 
described in figure 2.7.  
Mutagenesis of ADE.  Amino acid sequence alignments and the X-ray structure 
of Atu4426 indicate that His-90, His-92, Glu-185, His-214, His-235, Glu-236 and Asp-
284 are the direct metal ligands to the binuclear metal center of ADE from E. coli.  
Mutation of His-92, His-214, His-235 and Glu-185 resulted in the total loss of catalytic 
activity as well as the ability to bind divalent metals in the active site.  The D284A and 
E236Q mutants were able to bind two equivalents of Mn2+ or Fe2+ in the active site but 
these mutants were unable to catalyze the deaminase reaction.  The H90N mutant was 
able to bind ~2 equivalents of Mn2+ or Fe2+ per monomer and had a kcat of about 5% of 
the wild-type enzyme.   The H90C and H90D mutants were unable to bind either iron or 
manganese. The S95A, D118N, H120N, E121Q, E236Q, D285A, H473N and D474N 
mutants were constructed based upon the conservation of residues in the active site and 
the working model of adenine bound in the active site of Atu4426 (Figure 2.5).  All of 
these mutants are able to bind ~2 metals per active site.  The kinetic constants and metal 
content for the mutants are presented in Table 2.2.   The reconstitution of apo-E185G 
with propionic acid and Mn2+ was conducted to establish the role of the carboxylate side 
chain of Glu-185 as a bridge for the binuclear metal center.  The addition of 10 mM 
propionic acid and 1.0 mM Mn2+ to 5.0 nM apo-E185G, resulted in the reconstitution of 
~85 % of the activity of the wild type enzyme (kcat ~168 s
-1).  
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Table 2.2:  Catalytic constants and metal binding properties of E. coli ADE mutants.  
mutant kcat (s
-1) kcat/Km (M
-1 s-1) Metal content 
(Mn)  
H90D 0.036 ± 0.004 82 ± 8 0.022 ± 0.004 
H90C 0.053 ± 0.008 103 ± 9 0.032 ± 0.003 
H90Q 0.8 ± 0.1 (2.0 ± 0.2) x 103 0.043 ± 0.002 
H90N 8.0 ± 1.2 (2.2 ± 0.3) x 104 1.8 ± 0.2 
H92D 0.8 ± 0.1 (2.1 ± 0.3) x 103 0.12 ± 0.05 
H92C 0.69 ± 0.08 (1.4 ± 0.2) x 103 0.23 ± 0.05 
H92Q 0.08 ± 0.03 166 ± 12 0.08 ± 0.01 
H92N 0.05 ± 0.01 119 ± 10 0.13 ± 0.03 
S95A 78 ± 2 (1.6 ± 0.2) x 105 2.1 ± 0.1 
D118N 173 ± 2 (5.6 ± 0.3) x 105 2.1 ± 0.1 
H120N 0.13 ± 0.01 361 ± 17 2.1 ± 0.1 
E121Q 57 ± 1 (1.3 ± 0.2) x 105 2.0 ± 0.1 
E185Q 0.06 ± 0.005 38 ± 4 0.030 ± 0.001 
H214Q 1.3 ± 0.2 (4.0 ± 0.5) x 103 0.33 ± 0.05 
H214N 0.5 ± 0.2 (1.3 ± 0.3) x 103 0.12 ± 0.06 
H235D 1.2 ± 0.08 (2.5 ± 0.3) x 103 0.42 ± 0.05 
H235C 1.5 ± 0.1 (1.3 ± 0.2) x 103 0.34 ± 0.05 
H235Q 1.3 ± 0.1 (1.6 ± 0.3) x 103 0.23 ± 0.05 
H235N 0.5 ± 0.1 609 ± 35 0.33 ± 0.05 
E236Q 0.072 ± 0.002 170 ± 16 1.8 ± 0.1 
D284A 0.022 ± 0.005 26 ± 5 1.9 ± 0.2 
D285A 37 ± 2 (1.3 ± 0.2) x 105 2.1 ± 0.1 
H473N 178 ± 2 (5.6 ± 0.3) x 105 2.0 ± 0.1 
D474N 171 ± 2 (5.5 ± 0.2) x 105 1.9 ± 0.2 
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pH-Rate Profiles.  The kinetic constants for the deamination of adenine by ADE 
were obtained as a function of pH and the profiles are shown in Figure 2.10.  The pH 
profiles for kcat (A) and kcat/Km (B) are bell-shaped.  Similar results were obtained for the 
profiles in D2O, with the exception that the values of kcat and kcat/Km are doubled in D2O 
with an inverse solvent isotope effect of 0.49 ± 0.02 at pH 7.5.  The pKa values are listed 
in Table 2.3. 
Table 2.3: Kinetic pKa values obtained for ADE in H2O and D2O. 
H2O 
Metal 
reconstitution 
kcat kcat /Km 
pKa pKb pKa pKb 
Fe/Fe 6.6 ± 0.1 8.5 ± 0.1 6.3 ± 0.1 8.2 ± 0.1 
Zn/Zn 6.4 ± 0.1 8.6 ± 0.1 6.6 ± 0.1 8.5 ± 0.1 
Mn/Mn 6.2 ± 0.2 8.3 ± 0.1 6.9 ± 0.1 8.2 ± 0.1 
 
D2O 
Metal 
reconstitution 
kcat kcat /Km 
pKa pKb pKa pKb 
Fe/Fe 6.1 ± 0.1 8.7 ± 0.1 6.5 ± 0.1 8.3 ± 0.1 
Zn/Zn 6.7 ± 0.1 8.4 ± 0.1 6.9 ± 0.1 8.1 ± 0.1 
Mn/Mn 6.5 ± 0.1 8.6 ± 0.1 6.5 ± 0.1 8.3 ± 0.1 
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Figure 2.10: pH-rate profiles for the different metal reconstituted forms of ADE. 
[Fe/Fe]-ADE (●) is indicated in red, [Zn/Zn]-ADE (○) is indicated in blue and [Mn/Mn]-
ADE (▼) is indicated in black.  The lines represent fits of the data to equation 2. 
Solvent Viscosity Effects.  Increasing solvent viscosity had a small effect on the 
relative values of kcat and kcat/Km for the deamination of adenine.   At pH 7.5, the slope 
for the kcat profile was 0.020 ± 0.002 and the slope for kcat/Km the profile was 0.18 ± 0.02 
(data not shown). 
Inhibition by 6-Chloropurine. ADE was incubated with various concentrations of 
6-chloropurine for 1 hour at, pH 7.5, 30 oC and then assayed for catalytic deaminase 
activity.   The deaminase activity decreased with an increase in the concentration of 6-
chloropurine when the adenine concentration was fixed at 5.0 mM.   The apparent Ki for 
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6-chloropurine was determined to be 130 ± 15 nM from a fit of the data to equation 3 
(43).    
DISCUSSION 
Metal Requirement.  Fully active ADE was successfully purified from E. coli 
only when the iron in the growth medium was sequestered with a suitable chelator (2,2’-
dipyridyl).  The isolated enzyme under these conditions contained two manganese ions 
in the active site.  The turnover number for the deamination of adenine (~200 s-1) is 
approximately two orders of magnitude greater than that for any ADE previously 
reported in the literature (16, 17, 20).  [Mn/Mn]-ADE is stable and apo-ADE can be 
prepared from this enzyme form by chelation of the metal ions with o-phenanthroline.  
Apo-ADE can be reconstituted with two equivalents of Zn2+, Fe2+ or Mn2+.  The linear 
increase in the catalytic activity when zero to two equivalents of these cations are added 
to apo-ADE is consistent with the cooperative formation of a binuclear metal center 
(44).    [FeII/FeII]-ADE prepared in this manner is as active for the deamination of 
adenine as [Mn/Mn]-ADE and [Zn/Zn]-ADE, and this enzyme also remains catalytically 
active in the presence of oxygen overnight at room temperature.  Similar results were 
seen for the metal reconstitution of apo-Atu4426, indicating that the binuclear metal 
center is critical for the deaminase activity of Atu4426. 
Seven amino acid residues in the active site and that bind to either of the two 
divalent cations were changed and the mutant proteins characterized.   Metal binding and 
catalytic activity were lost upon the single-site mutation of His-92, Glu-185, His-214, or 
His-235.  Metal binding was also disrupted when His-90 was mutated to aspartate, 
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cysteine, or glutamine, but not asparagine.  Mutation of Asp-284 and Glu-236 to alanine 
and glutamine, respectively, did not disrupt the binding of metal to the active site.  
However, the D284A and E236Q mutants were inactive as an adenine deaminase.   
These results are consistent with the formation of a binuclear metal center where one 
metal ion is coordinated to His-90 and His-92 while the second metal ion is coordinated 
to His-214 and His-235.  This model is confirmed by the three-dimensional structure 
determination of Atu4426.   The two metal ions are bridged by Glu-185 and a bridging 
water/hydroxide.   The conserved aspartate residue from β-strand 8 and the glutamate 
from β-strand 6 are not essential for metal binding, but they are critical for the activation 
of water and protonation of the transition state to form the reaction products.  
 Oxidative State of Iron.  Mössbauer spectroscopy (in conjunction with the 
absence of an EPR signal) demonstrates that both Fe ions in reconstituted and 
catalytically active [Fe/Fe]-ADE are high spin ferrous.  A single quadrupole doublet was 
observed and the inability of Mössbauer spectroscopy to distinguish between the two 
irons suggests that the environment of both irons is similar.   The presence of a g = 4.3 
EPR signal in the ferricyanide-oxidized state, along with the metal analysis showing two 
irons per ADE and low-field Mössbauer spectra showing a 6-line pattern, indicate that 
the ferric ions are high-spin S = 5/2 and magnetically isolated rather than being 
magnetically coupled.  Our data provide no evidence as to whether the two ferrous ions 
are spin-coupled.   However, given the general lack of coupling in the diferric state, we 
suspect that the two ferrous ions are not spin-coupled.  [FeII/FeII]-ADE can be oxidized 
to [FeIII/FeIII]-ADE by the addition of ferricyanide but this enzyme is unable to catalyze 
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the deamination of adenine.  The [FeIII/FeIII]-ADE can, however, be reduced back to 
[FeII/FeII]-ADE by the addition of dithionite with full recovery of catalytic activity.  
Therefore, oxidation of the metal center with ferricyanide does not irreversibly damage 
the active site.  These experiments demonstrate that the active deaminase is in the di-
ferrous state and that the two metals are not easily oxidized by air to the di-ferric state.   
Addition of H2O2 results in the irreversible oxidation of di-ferrous-ADE to form di-
ferric-ADE and protein damage.   However, the addition of hydrogen peroxide to 
Mn/Mn-ADE has no effect.  Enzyme treated with H2O2 can be reduced to the di-ferrous 
form but no deaminase activity could be reconstituted.  These results suggest that 
irreversible oxygenation reactions are occurring after the addition of H2O2 to [Fe
II/FeII]-
ADE, possibly because of the generation of hydroxyl radicals (47).   
 pH-Rate profiles.  The pH-rate profiles display a bell-shaped profile.  This result 
is consistent with two groups being involved in catalysis, one of which is protonated and 
the other unprotonated for optimal activity.  The pH-rate profiles also indicate a fairly 
broad pH range over which the deaminase activity occurs.  The optimum pH is ~7.5.  
The various metal reconstituted forms of ADE do not significantly change the kinetic 
pKa values of the groups involved in catalysis.  The structure of adenine deaminase from 
A. tumefaciens can be used to assist in the identification of residues involved in catalysis.  
Based on previous studies for other members of the AHS, it is likely that the pKa of ~6.4 
reflects the ionization of Asp-284, the highly conserved residue at the end of β-strand 8, 
or the protonation of the bridging hydroxide.  Asp-284 must be unprotonated and is 
critical for the activation of the hydrolytic water molecule.   Mutation of this residue 
55 
 
(D284A) confirms that this residue is essential for the deamination of adenine.  The 
second ionization with a kinetic pKa of ~8.5 is assigned for the highly conserved 
glutamate residue from β-strand 6 that coordinates one of the metal ions.  The E236Q 
mutant retains the metal binding properties of ADE, but this mutant is inactive to the 
deaminase activity.   This result is consistent with this residue protonating N1 of the 
purine ring during the formation of hypoxanthine.     
 Solvent Isotope Effects.  The reaction catalyzed by ADE in D2O is twice as fast 
as in H2O giving an inverse isotope effect of ~ 0.5 for both kcat and kcat/Km.   Large 
inverse isotope effects have been seen for other members of the AHS catalyzing 
different deaminase reactions.  For example, adenosine deaminase (48, 49) and 
adenosine monophosphate deaminase (50) have inverse solvent isotope effects of 0.45 ± 
0.04 and 0.71 ± 0.07, respectively (48, 50).   In all cases, the large inverse isotope effect 
has been attributed to a compressed hydrogen bond in the transition state, where the pKa 
of the acceptor and donor groups are fairly close or similar (48, 49).  For ADE from E. 
coli, this means that the protonated form of Glu-236 and the N-1 nitrogen of the purine 
moiety of adenine have a fairly close pKa, which enables the protonation of N-1, 
concomitant with hydrolytic attack at C-6.  Analogous to the model described by 
Cleland (49) for adenosine deaminase, once the OH adds to C-6 of the adenine moiety, 
the pKa of N-1 increases relative to that of the protonated form of Glu-236.  This 
increase would enable proton transfer from Glu-236 to the N-1 nitrogen of adenine.
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Proposed Mechanism of Action.  ADE requires two divalent cations for catalytic 
activity. The X-ray structure of Atu4426 also shows a third metal in the active site, 
coordinated to His-120, Glu-121, His-473, and Asp-474 These residues were mutated to 
assess the effects on metal binding capacity and catalytic activity.  The metal binding 
capacity of these mutants was found to be ~2.0 per monomer of ADE.  These results 
suggest that the binding of the third metal ion in the active site is not required for 
catalytic activity.  Apparently, the third metal appears in the structure as a result of metal 
supplementation during bacterial growth and/or protein crystallography and plays no 
role in the deaminase reaction.    
         A sequence alignment of E. coli ADE and Atu4426 is presented in Scheme 2.2.  
The residues highlighted in yellow are direct ligands to the binuclear metal center.  All 
of the other structurally characterized aromatic deaminases found within the 
amidohydolase superfamily bind a single divalent cation in the active site (3).  These 
deaminases bind a single divalent cation at the α-site and use a conserved HxxE motif 
from the end of β-strand 5 to deliver a proton to a ring nitrogen of the reaction product.  
The conserved aspartate at the end of β-strand 8 protonates the leaving group ammonia.  
The HxxE motif is absent from all of the adenine deaminases from cog1001 and thus the 
details of the catalytic mechanism for ADE must be different from those for the other 
deaminases in the AHS. The residues highlighted in green represent the residues that are 
highly conserved in all the adenine deaminases in cog1001 and are close to the active 
site.  These residues were mutated to determine their significance in catalytic activity. 
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Based upon our model for the binding of adenine in the active site of ADE, we conclude 
that the invariant glutamate from the end of β-strand 6 functions to protonate N-1 of 
adenine during catalysis.  In E. coli, this residue is Glu-236.  This residue is part of the 
highly conserved HE motif found in all adenine deaminases in cog1001.  We also 
conclude that Asp-284 in the E. coli protein is unprotonated and functions in catalysis by 
abstraction of the proton from the tetrahedral intermediate and subsequent delivery of 
this proton to the ammonia leaving group.  Shown in Scheme 2.3 is our working model 
for the chemical mechanism for adenine deaminase from E. coli.  In this scheme a proton 
is transferred from the bridging water molecule to Glu-236.  The bridging hydroxide 
attacks C-6 on the re-face of adenine to form a tetrahedral intermediate with R-
stereochemistry and the proton from Glu-236 is transferred to N-1 of the intermediate.  
Subsequently, the proton from the attacking hydroxide is transferred to Asp-284.  The 
tetrahedral intermediate collapses, leading to the transfer of the proton from Asp-284 to 
ammonia. 
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Scheme 2.2: Sequence alignments of ADE from E. coli and A. tumefaciens 
 
 
Scheme 2.3: Mechanism of the reaction catalyzed by ADE. 
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CHAPTER III 
THE CATALASE ACTIVITY OF DIIRON ADENINE DEAMINASE* 
 
Adenine deaminase (ADE) from the amidohydrolase superfamily of enzymes 
catalyzes the conversion of adenine to hypoxanthine and ammonia.  The enzyme isolated 
from Escherichia coli using standard expression conditions was largely inactive towards 
the deamination of adenine (kcat  ~2 s
-1).  Molecular weight determinations by mass 
spectrometry provided evidence that multiple histidine and methionine residues were 
oxygenated.  When iron was sequestered with a metal chelator and the growth medium 
supplemented with Mn2+ prior to induction, the post-translational modifications 
disappeared.  The enzyme expressed and purified under these conditions was 
substantially more active for the deamination of adenine, with values of kcat and kcat /Km 
of 200 s-1 and 5 x 105 M-1s-1, respectively.  Apo-enzyme was prepared and reconstituted 
with two equivalents of FeSO4; ICP-MS and Mössbauer spectroscopy demonstrated that 
this protein contained two high-spin ferrous ions per monomer of ADE.  In addition to 
the adenine deaminase activity, [FeII/FeII]-ADE catalyzed the conversion of H2O2 to O2 
and H2O.  The values of kcat and kcat/Km for the catalase activity are 200 s
-1 and 2.4 x 104 
M-1s-1 respectively.   
 
 
 
*Reprinted with permission from “The catalase activity of diiron adenine 
deaminase” by S. S. Kamat, G. P. Holmes-Hampton, A. Bagaria, D. Kumaran, S. 
E. Tichy, T. Gheyi, X. Zheng, K. Bain, C. Groshong, S. Emtage, J. M. Sauder, S. 
K. Burley, S. Swaminathan, P. A. Lindahl and F. M. Raushel, Protein Science 20, 
2080-2094, 2011. Copyright 2011 Wiley-Blackwell, The Protein Society 
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[FeII/FeII]-ADE underwent more than 100 turnovers with H2O2 before the enzyme 
was inactivated due to oxygenation of histidine residues critical for metal binding.  A 
model is proposed for the disproportionation of hydrogen peroxide by [FeII/FeII]-ADE 
that involves the cycling of the binuclear metal center between the di-ferric and di-
ferrous oxidation states.  Oxygenation of active site residues occurs from the release of 
hydroxyl radicals.  The three-dimensional structure of [FeII/FeII]-ADE was determined 
by X-ray diffraction methods.  This is the first report of a redox reaction for any member 
of the amidohydrolase superfamily.   
INTRODUCTION   
 Adenine deaminase (ADE), a member of the amidohydrolase superfamily (AHS), 
catalyzes the hydrolytic deamination of adenine to hypoxanthine and ammonia as shown 
in Scheme 3.1.   
 
 
 
Scheme 3.1: Reaction catalyzed by ADE 
One of the apparent roles of this enzyme within bacteria is to recycle purine 
nucleotides and scavenge ammonia.  Other enzymes within the AHS catalyze the 
deamination of S-adenosyl homocysteine, adenosine, guanine, cytosine, 8-oxoguanine 
and additional aromatic substrates (7).  The three-dimensional structure of adenine 
deaminase from Agrobacterium tumefaciens (ADEat; locus tag: Atu4426) has been 
determined (PDB id: 3nqb) and the mechanism of action for the enzyme from 
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Escherichia coli K12 (ADEec; locus tag: b3665) has been elucidated (20).  The adenine 
deaminases from cog1001are unique members of the AHS since they require two 
divalent cations for maximal catalytic activity while the other deaminases from this 
superfamily require a single divalent cation in the active site (7, 20).  The active site 
structure of ADE from A. tumefaciens is presented in Figure 3.1.   
 
Figure 3.1:  Active site structure of [Mn
II
/Mn
II
]-ADEat taken from PDB id: 3nqb.  The 
residue numbers shown in parentheses are for the equivalent residues from adenine 
deaminase from E. coli.  In this structure there is a third manganese ion bound in the 
active site that is currently thought to be unimportant for the catalytic activity of adenine 
deaminase.   
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ADEs from a variety of bacterial sources are highly sensitive to the presence of 
iron in the cell (20, 21).  Unless precautions are made to exclude the incorporation of 
iron into the enzyme during protein expression, the isolated enzyme is damaged and the 
catalytic activity is severely compromised.  However, the diferrous form of ADEec, made 
via the reconstitution of apo-protein, is remarkably stable, even in the presence of O2 
(20, 21).  In this chapter, we demonstrate the extreme lability of ADE in the cell is due to 
the reaction of H2O2 with the diferrous form of the enzyme and suggest that this reaction 
may serve as a marker for oxidative stress in certain bacteria.  [FeII/FeII]-ADE catalyzes 
the disproportionation of H2O2 peroxide to water and O2, and the formation of hydroxyl 
radical and superoxide from the same substrate.  The hydroxyl radicals oxygenate 
multiple amino acid side chains within the active site and the catalytic activity is 
completely abolished.  This is the first report of an enzyme in AHS that is able to 
catalyze an oxidation/reduction reaction.  A chemical mechanism for the reaction of 
hydrogen peroxide with the iron-bound form of ADE is proposed. 
MATERIALS AND METHODS 
Materials.  All chemicals were purchased from Sigma-Aldrich unless otherwise 
stated.  Escherichia coli BL21(DE3) and XL1-blue competent cells were obtained from 
Stratagene.   The expression vector pET30a(+), Pfx Platinum DNA polymerase and Pfu 
Turbo DNA polymerase were purchased from Invitrogen.    
Adenine Deaminase from E. coli and A. tumefaciens.  The cloning of adenine 
deaminase from E. coli (ADEec) and A. tumefaciens (Atu4426; gi|15890557) was 
performed as described (20).  Mutations to these proteins were constructed using the 
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QuikChange PCR protocol according the manufacturer's instructions.  These enzymes 
were expressed and purified using an iron-free expression protocol (20).  The 
deamination of adenine was followed spectrophotometrically at 340 nm (20).   
Adenine Deaminase from Other Sources.  The clones for adenine deaminase 
from Bacillus halodurans (Bh0640; gi|15613203), Bacillus subtilis (Bsu14520; 
gi|16078516) and Clostridium acetobutylium  (Cac0887; gi|15894174) were cloned, 
expressed and purified by the New York Structural GenomiX Research Consortium 
(NYSGXRC) (21).  
Preparation of [Fe
II
/Fe
II
]-ADE.  Apo-ADE was reconstituted by the anaerobic 
addition of two equivalents of Fe2+ (20).  The samples were subsequently passed through 
a PD-10 column to remove unbound metal (20).  The stoichiometry of the reconstituted 
metal center was determined by titration of apo-ADE (10 µM) with Fe
2+. 
Measurement of Catalase Activity.  The formation of O2 was determined with a 
YSI 5300A biological oxygen monitor at 30 oC.  The standard assay conditions were 20 
mM HEPES, pH 7.5, variable amounts of H2O2 and enzyme in a final volume of 3.0 mL.  
The H2O2 concentration was calibrated with an oxygen electrode and bovine liver 
catalase.  The H2O2 concentration was also measured spectrophotometrically at 240 nm 
using a molar extinction coefficient of 43.6 M-1 cm-1 (51).  For control experiments, 250 
μM H2O2 was added to a buffered solution containing 3.0 µM Fe
2+ and 1.0 mM EDTA, 
or 3.0 µM Fe2+, 1.0 mM EDTA, and 1.0 mM ascorbate.  
Redox Titrations.  The reduction potential of [FeII/FeII]-ADEec was determined 
with the redox dye, thymol indophenol (TCI America).  [FeII/FeII]-ADEec (20 μM) was 
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incubated with 2-14 equivalents of thymol indophenol in 20 mM HEPES, pH 7.5, at 
room temperature for 4 hours.  Similar experiments were conducted with [FeII/FeII]-
ADEec treated previously with 5 equivalents of H2O2.  Determination of the reduction 
potential of fully oxygenated [FeII/FeII]-ADEec was conducted with protein that had been 
treated previously with 3.0 mM H2O2.  The excess H2O2 was removed by passage 
through a PD-10 column.  The reduced form of Crystal Violet was used to reduce the 
oxidized binuclear metal center back to the di-ferrous state in 20 mM HEPES, pH 7.5.  
The concentrations of the oxidized and reduced forms of the dye were determined at 590 
nm after 6 hours of incubation.     
Mass Spectrometry.  ADEec (5 µg) was loaded onto a 10% SDS-PAGE gel.  The 
Coomasie Blue-stained protein band was excised from the gel, cut into pieces and 
digested with trypsin (Promega).   The excised gel bands were washed with 25 mM 
ammonium bicarbonate, pH 8.0, dehydrated with 50 µL of a 2:1 mixture of 
acetonitrile/50 mM ammonium bicarbonate for 5 minutes and then dried in a vacuum 
centrifuge.  Gel pieces were further rehydrated for 40 minutes in an ice bath with 20 µM 
trypsin (Promega) in 25 mM ammonium bicarbonate buffer to a final volume of 12 µL.  
Following rehydration, samples were digested for 4 hours at 37 °C. The digested gel 
slices (1-2 μL) were analyzed by tandem mass spectrometry (Agilent 6520 quadrupole 
time-of-flight instrument with chip cube electrospray ionization).  Samples were injected 
using a protein chip (160-nL trap, 75 µm x 150 mm, 5 µm, C-18 SB-Zorbax, 300Å) at a 
flow rate 300 nL/min.  Data acquisition was performed using MassHunter (version 
B.02.00) in a 2-GHz extended dynamic range at a rate of three scans per second 
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followed by data-dependent tandem mass spectrometric fragment scans of the four most 
intense ions.  Precursor ion exclusion was set to 6 seconds after two consecutive tandem 
mass spectrometric scans.  Acquired tandem mass spectrometric spectra were analyzed 
against a trypsin-specific enzyme search within Spectrum Mill (Agilent Technologies) 
with the defined protein sequence.  The mass spectrometry data acquisition was 
performed by Shane E. Tichy at Agilent Technologies, Santa Clara, CA.  For intact mass 
analysis of ADE from B. halodurans, A. tumefaciens, B. subtilis, and C. actobutylium, 
matrix-assisted laser desorption/ionization (MALDI, Voyager-DE) and Liquid 
Chromatography Electrospray Ionization Mass Spectrometry (LC-ESI-MS, Agilent 
1100, API150EX) were used to assess the purity and measure accurate masses of 
proteins by the NYSGXRC (21).   
 EPR and Mössbauer Spectroscopy.  The samples for EPR and Mössbauer 
spectroscopy were made as described previously and the data was collected by the 
Lindahl laboratory, Texas A&M University (20). 
Titration with Hypochlorous Acid.  [FeII/FeII]-ADEec (1.0 µM) was treated with 
hypochlorous acid (HOCl) ranging from 0-20 µM for 5 minutes at 30 oC, pH 7.5.  At the 
end of the reaction, the adenine deaminase activity was determined as described (20).  In 
addition, HOCl (200 µM) was added to 16 µM [FeII/FeII]-ADEec and the absorbance 
spectrum was measured.  The same experiments were performed with [MnII/MnII]-
ADEec as a control.  The concentration of HOCl was determined at 292 nm (ε = 3241 M
-
1cm-1) (52). 
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Detection of Superoxide.  The formation of superoxide was measured using the 
dye hydroethidine (Invitrogen).  The concentration of hydroethidine was determined at 
345 nm (ε = 9.75 x 103 M-1 cm-1) (53).  Hydroethidine reacts with superoxide to form 2-
hydroxyethidium which was monitored at 470 nm (ε = 1.2 x 104 M-1 cm-1) (53).  
[FeII/FeII]-ADEec (1.50 µM) was mixed with 1.0 mM hydroethidine in a final volume of 
3.0 mL in a YSI 5300A biological oxygen monitor system at 30 oC.  Hydrogen peroxide 
(250 µM) was added and the evolution of O2 was measured as a function of time.  After 
O2 production ceased, 1.0 mL from this reaction mixture was removed and the 
absorbance was measured at 470 nm.   
pH-Rate Profiles. The pH dependence of kcat and kcat/Km for the catalase activity 
was determined for [FeII/FeII]-ADEec over the pH range of 5.5-10.0.  The buffers used 
for this study were 20 mM MES (pH 5.5-6.5), 20 mM HEPES (7.0-8.0) and 20 mM 
CHES (pH 8.5-10.0).  The pH values of the solutions were measured before and after the 
completion of the assays. 
6-Chloropurine Inhibition of Catalase Activity.  A solution of [FeII/FeII]-ADEec 
(1.5 µM) was incubated with 3.0 mM 6-chloropurine for 1 hour in 50 mM HEPES 
buffer, pH 7.5 and then assayed for adenine deaminase and catalase activity as described 
previously (20).   
Data Analysis.  Initial velocity kinetic data were fit to equation 2.1 using 
SigmaPlot 9.0 where v is the initial velocity, [A] is the substrate concentration, Et is the 
total enzyme concentration, kcat is the turnover number and Km is the Michaelis constant.  
For pH-rate profiles, equation 3.1 was used to fit the half-bell shaped pH profiles to 
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determine values of pKa for the ionization of residues at low pH.  In equation 3.1, the 
value of c is the maximum value for either kcat or kcat/Km, depending on the fit, and H is 
the proton concentration.   In equation 3.2, E is the reduction potential of the metal 
center, Eo is the reduction potential of the dye, R is the universal gas constant, T is the 
temperature, n is the number of electrons transferred during the redox reaction and F is 
the Faraday constant. Aox is the concentration of the species involved in the oxidation 
reaction of the enzyme and Ared is the concentration of the species involved in the 
reduction reaction of the enzyme. 
v / Et = kcat [A] / (Km + [A])                            (Equation 2.1) 
 
log y = log[c/(1 + H/Ka)]                              (Equation 3.1) 
 
E = Eo – (RT ln [Ared]/[Aox])/nF                          (Equation 3.2) 
Structure Determination of Atu4426.   The iron/manganese hybrid ([FeII/MnII]-
ADEat) and the diferrous form ([Fe
II/FeII]-ADEat) of adenine deaminase from A. 
tumefaciens were crystallized by the sitting drop vapor diffusion method at room 
temperature using conditions similar to [Mn/Mn]-ADEat (20, 21).  The atomic 
coordinates and structure factors were deposited in the Protein Data Bank (PDB Id: 3T81 
([FeII/FeII]-ADEat) and 3T8L ([Fe
II/MnII]-ADEat)). The structures were determined by 
the Swaminathan laboratory at the Brookhaven National Laboratories, NY. The PDB co-
ordinates have now been deposited in the Protein Data Bank and are released to be 
viewed and downloaded. 
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RESULTS 
Isolation of Adenine Deaminase.  The gene for ADEec was expressed in E. coli 
using standard methods (20, 21).  However, the identity of the isolated protein could not 
be verified by mass spectrometry because multiple levels of post-translational 
modification made the spectrum impossible to interpret.  Mass spectrometric analysis of 
the trypsin-generated fragments (70% coverage) identified the following residues as 
oxygenated: His-90, His-92, Met-97, Met-98, Met-186, Met-187, His-235, Met-251, 
Met-254, His-513 and Met-522.  Of these residues, His-90, His-92 and His-235 are 
metal binding residues, based on amino acid sequence identity and the three-dimensional 
structure of ADEat (PDB: 3nqb).  The kinetic constants for the deamination of adenine 
by the oxygenated ADEec are 2 ± 0.3 s
-1, 0.8 ± 0.1 mM and (2.5 ± 0.2) x 103 M-1 s-1 for 
kcat, Km, and kcat/Km, respectively.  The mass spectrum of ADEca from C. acetobutylicum 
(locus tag: Cac0887) also exhibited multiple species from oxygenation when expressed 
in E. coli.  The mass spectrum pinpointed oxygenation sites at His-73, His-75, His-105, 
His-198, and His-219.  Of these residues His-73, His-75, His-198 and His-219 are metal 
binding residues based on the structure of ADEat (21).   
 Sequestration of Iron.  It was initially postulated that oxygenation of amino acid 
residues throughout the protein was initiated by reactions catalyzed by iron bound in the 
active site of adenine deaminase (20, 21).  The addition of 50 µM 2,2’-dipyridyl and 1.0 
mM Mn2+ to the growth medium was utilized to sequester the iron at the time of 
induction.  ADEec purified from iron-depleted medium yielded a single species via 
analysis by mass spectrometry with a molecular weight of 63741 Da.  Trypsin digestion 
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of this protein gave a 91% sequence coverage and no residues were found to be 
oxygenated.  The total metal content was 2.0 ± 0.1 eq of Mn per protein subunit.  The 
kinetic constants for the deamination of adenine by [MnII/MnII]-ADEec, expressed and 
isolated by this protocol, are 200 ± 5 s-1, 0.40 ± 0.04 mM, and (5 ± 0.4) x 105 M-1 s-1 for 
kcat, Km, and kcat/Km, respectively.   The mass spectrum of ADEca, isolated using the iron-
free expression protocol, is presented in (21).  The kinetic constants and average metal 
content for ADE cloned from various bacterial sources and expressed in E. coli in the 
presence and absence of the iron chelator are presented in Table 3.1. 
[MnII/MnII]-ADEec was used to prepare apo-ADEec and this protein was 
reconstituted with variable amounts of Fe2+, Mn2+, or Zn2+.  There was a linear increase 
in the adenine deaminase activity until two equivalents of metal were added (20, 44).  
Beyond two equivalents of metal per subunit, the deaminase activity remained constant 
and ICP-MS confirmed the binding of two equivalents of metal per enzyme subunit.  
Previous Mössbauer spectra of the diiron-reconstituted enzyme indicates that both irons 
are high-spin ferrous, which is denoted as [FeII/FeII]-ADEec (20).    
Inactivation of ADEec by H2O2.  A large molar excess of H2O2 (250 µM) was 
added to the metal-reconstituted forms of ADEec (1.50 µM).  Evolution of O2 was 
observed when H2O2 was added to [Fe
II/FeII]-ADEec but not when it was added to either 
[MnII/MnII]-ADEec or [Zn
II/ZnII]-ADEec.  After the addition of a large excess of H2O2 to 
[FeII/FeII]-ADEec, the enzyme was unable to catalyze the deamination of adenine, 
whereas [MnII/MnII]-ADEec and [Zn
II/ZnII]-ADEec had catalytic activities that were 
unchanged (21).   
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Table 3.1: Kinetic parameters of ADE using a standard and iron-free expression 
protocol 
Standard Expression Protocol 
Locus tag 
 
gi kcat (s
-1) kcat/ Km (M
-1s-1) Metal content 
b3665 16131535 
 
2.0 ± 0.3 (2.5 ± 0.2) x 103 0.3 eq. Fe 
0.2 eq. Zn 
Bh0640 
 
15613203 2.4 ± 0.4 (1.2 ± 0.2) x 104 0.3 eq. Fe 
0.2 eq. Zn 
Atu4426 
 
15890557 1.4 ± 0.1 (5.0 ± 0.4) x 103 0.6 eq. Mn 
0.4 eq. Fe 
Bsu14520 
 
16078516 1.1 ± 0.4 (3.6 ± 0.3) x 103 0.2 eq. Fe 
0.2 eq. Zn 
Cac0887 15894174 
 
0.52 ± 0.02 (5.2± 0.3) x 103 0.5 eq. Fe 
0.1 eq. Zn 
 
Iron-Free Expression Protocol 
Locus tag 
 
gi kcat (s
-1) kcat/ Km (M
-1s-1) Metal 
content 
b3665 16131535 200 ± 5 (5.0 ± 0.4) x 105 2.0 eq. Mn 
Bh0640 
 
15613203 120 ± 4 (4.0 ± 0.3) x 105 1.9 eq. Mn 
0.1 eq. Fe 
Atu4426 15890557 155 ± 5 (4.8 ± 0.3) x 105 2.3 eq. Mn 
Bsu14520 
 
16078516 140 ± 6 (3.5 ± 0.5) x 105 1.6 eq. Mn 
0.1 eq. Fe 
Cac0887 15894174 
 
180 ± 7 (4.5 ± 0.4) x 105 1.5 eq. Mn 
0.1 eq. Fe 
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Disproportionation of H2O2.  The initial rate of O2 evolution catalyzed by 
[FeII/FeII]-ADEec increased with the concentration of H2O2.  The kinetic constants for the 
catalase activity of [FeII/FeII]-ADEec were 200 ± 24 s
-1, 8.8 ± 2.2 mM, and (2.4 ± 0.5) x 
104 M-1s-1 for kcat, Km, and kcat/Km, respectively (based on H2O2 consumption).  The net 
increase in the concentration of O2 produced after the addition of an excess of H2O2 to 
[FeII/FeII]-ADEec was proportional to the concentration of added enzyme (Figure 3.2).  
The ratio of O2 produced, relative to the initial concentration of [Fe
II/FeII]-ADEec, was 
64 ± 3.  No O2 evolution (<1%) was observed for any of the control reactions when 3.0 
μM Fe2+ was incubated with either EDTA or ascorbate, or by Fe2+ itself, when 250 μM 
H2O2 was added.  Therefore, the formation of O2 was due entirely to the catalytic 
activity of the iron bound to the active site of adenine deaminase.  The time course for 
the formation of O2 after adding 250 μM H2O2 to 1.50 μM [Fe
II/FeII]-ADEec was 
followed with an oxygen electrode (Figure 3.4, open circles) and the net change in O2 
concentration was 97 μM (342-245 μM).  After O2 formation ceased, bovine liver 
catalase was added to determine the concentration of H2O2 that remained.  The O2 
concentration increased from 342 to 356.5 μM and thus an additional 14.5 μM O2 was 
produced.  Since bovine liver catalase consumes two molecules of H2O2 for every O2 
produced, the concentration of H2O2 remaining at the time of addition of bovine catalase 
was 29 μM.   Therefore, addition of 1.50 μM [FeII/FeII]-ADEec to 250 μM H2O2 
consumed 221 μM (250-29 µM) hydrogen peroxide and produced 97 μM O2.  The 
formation of 97 μM O2 accounts for 194 μM of the hydrogen peroxide consumed.  
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Addition of 3.0 mM 6-chloropurine to a solution containing 1.5 µM [FeII/FeII]-ADEec 
completely inhibited the disproportionation of H2O2.     
 
[Fe
II
/Fe
II
]-ADE (µM)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6
O
2
 e
v
o
lv
e
d
 (
µ
M
)
0
20
40
60
80
100
 
 
 
Figure 3.2:  Total concentration of O2 evolved from [Fe
II
/Fe
II
]-ADEec.  The addition of 
250 µM H2O2 to variable amounts of [Fe
II/FeII]-ADEec at pH 8.0, 30 
oC.  
Titration of Fe2+ to apo-ADEec (figure 3.3) shows a linear increase in the catalase 
activity with increasing Fe2+ concentration.  Maximum catalase activity is observed at 
two equivalents of FeII per monomer of apo-ADEec.  
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Figure 3.3: The catalase activity after anaerobic addition of Fe
II
 to apo-ADEec. The 
maximal activity is obtained at two enzyme equivalents of iron per monomer of ADEec. 
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Figure 3.4:  Time course for O2 formation as a function of time after the addition of 
[Fe
II
/Fe
II
]-ADEec to an excess of hydrogen peroxide at pH 8.0.  The open circles are in 
the absence of hydroethidine and the closed circles are in the presence of 1.0 mM 
hydroethidine.  After cessation of O2 evolution, catalase from bovine liver was added to 
determine the concentration of the unreacted H2O2.   
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 Aliquots were removed after the addition of H2O2 to [Fe
II/FeII]-ADEec and then 
assayed for adenine deaminase activity.  The activity decreased as a function of time, 
with a first-order rate constant of 0.011 ± 0.001 s-1 (data not shown).  EPR and 
Mössbauer spectra of ADEec after cessation of O2 formation indicated a high spin ferric 
oxidation state (Figures 3.5a and 3.5b) (45, 54).  Mass spectrometry of the tryptic 
peptides from ADEec treated with an excess of H2O2 demonstrated that the following 
amino acids were oxygenated: His-90, His-92, Met-97, Met-98, His-176, Met-186, Met-
187, Met-251, Met-254, His-513 and Met-522.  These are the same amino acid residues 
that were identified as oxygenated in the protein expressed in E. coli without the addition 
of 2,2’-dipyridyl to sequester the iron prior to induction (21). 
Titration of [Fe
II
/Fe
II
]-ADE with Hydrogen Peroxide.  The amount of O2 
produced when 1-5 molar equivalents of H2O2 were added to 20 µM [Fe
II/FeII]-ADEec 
was determined.  After the first equivalent of H2O2 was added, 2.2 µM O2 was formed.  
The second equivalent of H2O2 resulted in the formation of 5.9 µM O2.  The sequential 
addition of three more equivalents of H2O2 resulted in the formation of 9.0 µM O2 with 
each added equivalent.  No O2 was produced when wild-type [Fe
II/FeII]-ADEec was 
oxidized by ferricyanide to [FeIII/FeIII]-ADEec prior to the addition of H2O2.  Mass 
spectrometry of ADEec revealed that the first molar equivalent of H2O2 added to 
untreated [FeII/FeII]-ADEec oxygenated either Met-99 or Met-98 while the second molar 
equivalent oxygenated either His-90 or His-92 (data not shown).  The Mössbauer spectra 
after the addition of one to four equivalents of H2O2 to [Fe
II/FeII]-ADEec are presented in 
Figure 3.6.  In each case the metal center is found in the diferrous oxidation state. 
75 
 
Detection of Superoxide.  The formation of superoxide was probed with the 
reagent hydroethidine (53).  Addition of hydroethidine (1.0 mM) to a solution of 
hydrogen peroxide (256 μM) and [FeII/FeII]-ADE (1.50 μM) reduced the net production 
of O2 from 97 μM (in the absence of hydroethidine) to 81 μM (329-248 µM) as shown in 
Figure 3.4 (closed circles).  After cessation of O2 formation, bovine liver catalase was 
added to the reaction mixture to determine the concentration of the remaining H2O2.  The 
O2 concentration in the solution increased from 329 to 361 μM and thus 64 μM H2O2 
remained from the initial concentration of 256 μM.  The change in absorbance at 470 nm 
was 0.20, which corresponds to the formation of 17 µM 2-hydroxyethidium using an 
extinction coefficient of 1.2 x 104 M-1 cm-1 (53), and thus 17 μM superoxide was formed.  
Overall, the concentration of O2 and superoxide increased by 81 and 17 μM, 
respectively, and the concentration of H2O2 decreased by 192 μM.   
 
 
 
 
 
 
Figure 3.5: EPR and Mössbauer spectrum of [FeIII/FeIII]-ADE after the addition of 15 
mM H2O2  
From the figure 3.5; (A) EPR parameters:  temperature, 10 K; microwave power, 
9.46 GHz, 0.2 mW.  (B)  The spectrum was collected at 4.5 K, 400 G magnetic field 
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applied parallel to the radiation.   Red line represents a simulation of the data with a 
single species with the following parameters:  D = 0.129, E/D = 0.194, gx = gy = gz = 2.0, 
ΔEq = 0 mm/sec, Eta = -1.00, Ax = -222.271 kG, Ay = -247.824 kG, Az = -224.863 kG, δ 
= 0.504, Γ = 0.500 mm/sec. (Data collected by the Lindahl Lab). 
 
Figure 3.6: Mössbauer spectra of [FeII/FeII] –ADE with different H2O2 (A) 1 equivalent 
of H2O2 added,  (B) 2 equivalents of H2O2 added, (C) 3 equivalents of H2O2 added, and 
(D) 4 equivalents of H2O2 added.  All spectra were recorded at 5K with a 700G magnetic 
field applied parallel to the radiation.  All spectra can be fit with a single quadrupole 
doublet with δ = 1.39 mm/s and ΔEq = 3.27mm/s. (Data collected by the Lindahl Lab). 
 Hydroxyl Radical Formation.  Lidocaine is a potent hydroxyl radical scavenger 
(55).  The addition of a large excess of lidocaine (0.5 M) did not affect the rate of O2 
evolution after 250 µM H2O2 was added to 1.5 μM [Fe
II/FeII]-ADEec.  When other 
hydroxyl radical scavengers (thiourea, ethanol, methanol, ethylene glycol and DMSO) 
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were added at a concentration of 0.50 M, no change was observed in the rates of O2 
evolution and ADE inactivation. HOCl has been shown to produce hydroxyl radicals in 
reactions with specific iron complexes (56).  [FeII/FeII]-ADEec was titrated with HOCl 
and ~12 enzyme equivalents of this reagent were needed to inactivate the deaminase 
activity as shown in Figure 3.7.  The formation of chloride was verified by the 
formation of a precipitate after the addition of silver nitrate.  At the end of the reaction of 
[FeII/FeII]-ADEec with HOCl, the iron was found in a high-spin ferric oxidation state 
(figure 3.8). 
Preparation of Mn/Fe Hybrids.  [MnII/MnII]-ADEec is active as a deaminase but 
not as a catalase.  In contrast, [FeII/FeII]-ADEec catalyzes both reactions.  To determine 
whether the binuclear metal center of this enzyme must be occupied with two 
equivalents of iron, or if a manganese/iron hybrid would be sufficient for catalase 
activity, apo-ADEec (1.5 µM) was reconstituted with two equivalents of metal using a 
mixture of manganese and iron of different ratios (3.0 µM total metal concentration).  
ICP-MS verified that the metal content of ADEec after reconstitution was in accordance 
with the ratio of metal ions added to apo-ADEec.  The adenine deaminase activity was 
independent of the ratio of Mn2+ and Fe2+ added to the enzyme (Figure 3.9).   However, 
no catalase activity was observed until the ratio of iron to manganese was greater than 
1.0.  When more than one equivalent of iron was added to apo-ADEec there was a linear 
increase in the catalase activity with an increase in the iron content (Figure 3.9).  These 
results are consistent with the preferential binding of manganese and/or iron at one of the 
two metal sites within the binuclear metal center and a requirement for both sites to be 
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occupied by iron for the catalase activity but not the deaminase activity.  EPR and 
Mössbauer spectra of [MnII/FeII]-ADEec are shown in Figures 3.10 and 3.11.   
 
 
 
 
  
 
Figure 3.7:  The loss of adenine deaminase activity after addition of HOCl to [FeII/FeII]-
ADEec (1.0 µMat 30 
oC).  The deaminase activity was assayed 5 minutes after addition of 
HOCl to [FeII/FeII]-ADEec.  
 
 
Figure 3.8: Mössbauer spectrum of Fe/Fe ADE with 15 equivalents of HOCl (~ 3 mM). 
Spectrum was collected at 5K with a 700G field applied parallel to the radiation. (Data 
collected by the Lindahl Lab). Fe/Fe-ADE = 205 µM 
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Figure 3.9:  ADE and catalase activity and metal dependence. Adenine deaminase (open 
circles) and catalase activities (closed circles) after apo-ADEec (1.5 µM) was 
reconstituted with two enzyme equivalents of total metal (3.0 µM) using various ratios 
of Mn2+ and Fe2+.   
 
 
Figure 3.10: EPR spectrum of Mn/Fe ADE (200 µM).  EPR parameters: temperature, 10 
K; microwave 9.46 GHz, 0.02 mW.  (Data collected by the Lindahl Lab). 
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Figure 3.11: Mössbauer spectra of Fe/Fe-ADE and Fe/Mn-ADE (A) 200 µM Fe/Fe-
ADE. (B) 200 µM Mn/Fe-ADE.  (C) 200 µM Mn/Fe-ADE with 1equivalent of H2O2. (D) 
200 µM Mn/Fe-ADE with 10 equivalents of H2O2. The spectra were collected at 5 K, 
400 G (A-C) or 700G (D) magnetic field applied parallel to the radiation. The data can 
be fit with a single quadrupole doublet with δ= 1.39 mm/sec, ΔEq= 3.27 mm/sec. (Data 
collected by the Lindahl Lab). 
 Mutagenesis of ADE.  Based on the three-dimensional structure of [MnII/MnII]-
ADEat (PDB: 3nqb), the metal coordinating residues His-90, Glu-236 and Asp-284 of 
ADEec were mutated to asparagine, glutamine and alanine, respectively, and the mutant 
proteins were shown to bind two equivalents of metal per protein monomer.  Other 
conserved active site residues, Ser-95, Asp-118, His-120, Glu-121, Asp-285, His-473 
and Asp-474 were subsequently chosen as targets for mutagenesis based on their 
proximity to the binuclear metal center from the structure of ADEat.  Of these seven 
residues, His-120, Glu-121, His-473 and Asp-474 coordinate an adventitiously-bound 
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third metal ion that is ~6-8 Å from the binuclear metal center (see Figure 3.1).  The 
metal-free forms of these mutants were prepared and reconstituted with Fe2+.  The 
adenine deaminase activity and the metal content of the iron-reconstituted mutants were 
measured and the results are presented in Table 3.2.  
 The catalase activity of these ten mutants, except for H473N and D474N, was 
the same as the wild-type enzyme reconstituted with iron.  These two mutants (H473N 
and D474N) were unable to catalyze the disproportionation of H2O2 and were not 
inactivated by H2O2.  The diferrous form of the H90N mutant (20 µM) was titrated with 
1-5 equivalents of H2O2.  Unlike the wild-type enzyme (see above), this mutant 
produced ~9 µM O2 for each equivalent of H2O2 added.  Mössbauer spectroscopy 
confirmed that ferricyanide treatment of  [FeII/FeII]-H90N produced the oxidized 
[FeIII/FeIII]-state.  The oxidized H90N mutant catalyzed the disproportionation of H2O2. 
Measurement of Reduction Potentials.  The reduction potentials for the inter-
conversion of the diferrous and diferric states of ADEec were measured with redox-active 
dyes.  In these titrations it was assumed that both irons in the binuclear metal center are 
oxidized or reduced in pairs and that the deaminase activity could be used as a direct 
measure of the relative concentration of [FeII/FeII]-ADEec.  The titration of freshly 
prepared [FeII/FeII]-ADEec (20 µM) with thymol indophenol is presented in Figure 3.12.  
A total of 7.9 ± 0.2 equivalents of the dye was required to reduce the deaminase activity 
by 50%.  Given the reduction potential of thymol indophenol of +174 mV vs NHE (57), 
substitution into equation 3 provides an apparent reduction potential of +209 ± 4 mV for 
the interconversion of the diferric and diferrous forms of wild-type ADE.  After 
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[FeII/FeII]-ADEec was treated with five equivalents of H2O2 it became easier to oxidize 
the binuclear metal center.   
Table 3.2:  Catalytic constants for deaminase activity and metal content of ADEec 
mutants.  
ADEec 
mutant 
Km (mM) kcat (s
-1) kcat/Km (M
-1 s-1) Metal 
content (Mn)  
Wild type 0.40 ± 0.04  200 ± 5 (5.0 ± 0.4) x 105 2.0 ± 0.1 
H90N 0.33 ± 0.03 10 ± 0.8 (3.0 ± 0.3) x 104 1.8 ± 0.3 
S95A 0.47 ± 0.04 98 ± 3 (2.0 ± 0.2) x 105 1.8 ± 0.1 
D118N 0.36 ± 0.03 170 ± 2 (4.7 ± 0.3) x 105 2.1 ± 0.2 
H120N 0.49 ± 0.05 0.17 ± 0.02 (3.5 ± 14) x 102 2.1 ± 0.1 
E121Q 0.42 ± 0.04 50 ± 1 (1.2 ± 0.2) x 105 1.9 ± 0.2 
E236Q 0.40 ± 0.04 0.012 ± 0.002 30 ± 4 1.8 ± 0.1 
D284A 0.85 ± 0.07 0.042 ± 0.006 49 ± 5 2.0 ± 0.3 
D285A 0.39 ± 0.04 40 ± 2 (1.0 ± 0.2) x 105 1.9 ± 0.1 
H473N 0.34 ± 0.03 170 ± 2 (5.0 ± 0.3) x 105 1.8 ± 0.1 
D474N 0.31 ± 0.03 173 ± 4 (5.6 ± 0.2) x 105 1.8 ± 0.1 
 
The titration of partially oxygenated ADE with the redox active dye thymol 
indophenol is shown in Figure 3.12.  This titration required 2.8 ± 0.1 equivalents of 
thymol indophenol to reduce the deaminase activity by 50%.  This is consistent with a 
reduction potential of +194 ± 2 mV for the binuclear metal center of partially 
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oxygenated ADE.  The addition of thymol indophenol to [MnII/MnII]-ADEec showed no 
change in catalytic activity indicating that the dye cannot oxidize manganese. 
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Figure 3.12:  Titration of [FeII/FeII]-ADE with various amounts of thymol indophenol.  
The open circles are for enzyme (20 µM) prior to the addition of hydrogen peroxide.  
The closed circles are for enzyme after the addition of five equivalents (100 µM) of 
hydrogen peroxide.  Additional details are provided in the text.   
 When [FeII/FeII]-ADEec was treated with a large excess of H2O2, the binuclear 
metal center was left in the diferric state, the deaminase activity was lost and not 
recoverable, even after reduction to the ferrous state using the dithionite.  Since the ratio 
of the diferrous and diferric states of the binuclear metal center could not be determined 
from a direct measurement of the deaminase activity, the distribution of the oxidized and 
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reduced species during the redox titration was determined spectrophotometrically with a 
dye that is colored in the oxidized state and colorless in the reduced state.  The dye 
Crystal Violet has a reduction potential of 167 mV (57).  The oxidized form of the dye 
absorbs at 590 nm with an extinction coefficient of 54,000 M-1 cm-1 (58).  The reduced 
form of Crystal Violet was utilized to reduce the binuclear metal center in fully 
oxygenated ADE.  In this titration 1.4 ± 0.3 equivalents of the reduced dye were required 
to reduce 50% of the binuclear metal centers in ADE.  Therefore, the reduction potential 
for the binuclear metal center of [FeIII/FeIII]-ADEox is +175 ± 4 mV.   
 The reduction potentials of two mutants, [FeII/FeII]-H90N and [FeII/FeII]-H473N 
were measured using the thymol indophenol dye.  The manganese-reconstituted enzymes 
for both of these mutants were used as controls.  [FeII/FeII]-H90N required 2.6 ± 0.2 
enzyme equivalents of thymol indophenol to reduce the adenine deaminase activity by 
50%.  This translates to a redox potential of +192 ± 4 mV.  [FeII/FeII]-H473N required 
8.0 ± 0.3 equivalents of thymol indophenol to reduce the adenine deaminase activity by 
50%.  The redox potential of [FeII/FeII]-H473N from this titration is + 210 ± 6 mV. 
 pH Profiles. The kinetic constants for the catalase activity of [FeII/FeII]-ADEec 
were obtained as a function of pH (Figure 3.13).  The profiles for kcat and kcat/Km 
exhibited a single ionization for a group that is unprotonated for optimal catalytic 
activity.  The pKa of this group from the kcat  profile is 7.6 ± 0.3, and 7.9 ± 0.2 from the 
kcat/Km profile. 
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Figure 3.13:  pH rate profiles for the catalase activity of [Fe/Fe]-ADEec.  The data were 
fitted to equation 2. 
 Structures of [FeII/FeII]-ADEat and [Fe
II
/Mn
II
]-ADEat.  The three-dimensional 
structures of the iron/manganese hybrid ([FeII/MnII]-ADEat) and the diferrous form 
([FeII/FeII]-ADEat) of adenine deaminase from A. tumefaciens were determined to 2.63 Å 
and 2.8 Å resolution, respectively.  Overall, the structures and active sites of [FeII/FeII]-
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ADEat and [Fe
II/MnII]-ADEat are essentially identical to the [Mn/Mn]-ADEat structure 
determined previously (RMSD is < 1 Å for all Cα atom pairs).  In the [Mn/Mn]-ADEat 
structure, the active site contains a binuclear manganese center (Mnα and Mnβ) and a 
third manganese center located 6.6 Å from Mnα (20).  [Fe
II/FeII]-ADEat and [Fe
II/MnII]-
ADEat  were prepared from apo-ADEat and the metal content for both proteins prior to 
crystallization was determined to be 0.95 ± 0.10 Mn, 1.1 ± 0.1 Fe per subunit for the 
iron/manganese hybrid and 2.1 ± 0.1 Fe per subunit for the di-iron ADE by ICP-MS.  
However, in the crystal structure the active sites of both protein preparations contained 
three metal ions, similar to the previous structure determined with the di-manganese 
activated enzyme.   
In the diferrous form of adenine deaminase, Feβ in the binuclear center and the 
third iron are five-coordinate whereas Feα is four-coordinate (Figure 3.14A).  Feα 
coordinates with His-92, His-94 (HxH motif), Asp-289 and Glu-187 (Figure 3.14A).  
Glu-187, His-218, His-239, Glu-240 and water (W1) coordinate with Feβ.  Glu-187 
bridges Feα and Feβ.  Waters that are bridging Mnα and Mnβ in the [Mn/Mn]-ADEat are 
missing in the current structure.  The third iron coordinates His-122, Glu-123 
(bidendate), His-477 and Asp-478 (Figure 3.14A).  In the manganese/iron hybrid 
enzyme it was not possible to determine the preferential binding locations of the two 
different metal ions (Figure 3.14B). The two metal ions in the binuclear metal center are 
four-coordinate and the third metal ion is five-coordinate.  The coordinating ligands are 
the same as for [FeII/FeII]-ADEat except that there is no water coordination with Mβ.  
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Figure 3.14: Close up view of the active site of [FeII/FeII]-ADEat (A) and [Fe
II
/Mn
II
]-
ADEat (B). Grey color ribbon represents the secondary elements at the vicinity of the 
active site. Active site residues that are coordinating to metals are shown as stick 
models. Metals and water are shown as spheres. 
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DISCUSSION 
Oxidative Damage to Adenine Deaminase.  When adenine deaminases from 
cog1001 of the AHS are aerobically expressed in E. coli, the isolated enzymes are 
largely inactive and multiple histidine and methionine residues are damaged by 
oxygenation.  The oxidative damage can be completely eliminated if the iron in the 
medium is sequestered by an iron-specific chelator prior to induction.  Enzymes isolated 
under these conditions contain two manganese ions in the active site and the turnover 
numbers for the deamination of adenine are approximately two orders of magnitude 
greater than any ADE previously reported in the literature (20, 21).  The oxygenation 
reactions are consistent with the generation of a reactive oxygen species (ROS) from the 
iron-bound form of adenine deaminase from a physiological oxidant such as H2O2 (47).  
Apo-ADE can be readily prepared from the undamaged manganese-activated enzyme 
and reconstituted with two equivalents of manganese, zinc, or iron.  The diferrous form 
of adenine deaminase, [FeII/FeII]-ADEec, has been utilized here to unravel the 
mechanism for oxidative damage to this enzyme.    
Inactivation with Hydrogen Peroxide.  In the presence of excess H2O2, [Fe
II/FeII]-
ADEec rapidly loses its ability to deaminate adenine.  EPR and Mössbauer spectroscopy 
of the inactivated enzyme demonstrate that the iron in the active site is in an uncoupled 
high spin ferric oxidation state.  The metal ions can be reduced back to the di-ferrous 
state with dithionite but the deaminase activity is not recovered.  Therefore, the addition 
of an excess of H2O2 to [Fe
II/FeII]-ADEec damages the protein in an irreversible manner 
and stabilizes the [FeIII/FeIII] state.  Mass spectrometric analysis of the trypsin-treated 
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enzyme confirms that multiple histidine and methionine residues within the protein are 
oxygenated and that the labeling pattern is identical to enzyme expressed in E. coli in the 
absence of an iron chelator.  These results are consistent with the generation of a reactive 
oxygen species such as hydroxyl radical or superoxide by the reaction of H2O2 with the 
binuclear iron center of adenine deaminase.   
 Discovery of Catalase Activity.  The addition of H2O2 to [Fe
II/FeII]-ADEec results 
in the formation of O2.  The catalase-like activity diminishes over the course of a few 
minutes and is lost in approximately the same time-frame as the deaminase activity.  
More than 100 turnovers occur before the enzyme is completely inactivated.  The 
promiscuous catalase activity of [FeII/FeII]-ADE is as fast as the deamination reaction, 
but significantly slower than other catalases (59, 60).  There is no effect by H2O2 with 
either [MnII/MnII]-ADE or [ZnII/ZnII]-ADE and thus the oxidation reactions are specific 
for the iron-reconstituted enzyme.   
 The apparent reaction stoichiometry for the catalase-like activity of [FeII/FeII]-
ADEec changes as a function of time.  When one equivalent of H2O2 is added to 
[FeII/FeII]-ADEec that had not been previously exposed to H2O2, ~0.11 equivalents of O2 
are produced.  After the second equivalent of H2O2 is added, ~0.29 equivalents of O2 are 
produced.  Additional H2O2 results in the formation of ~0.45 equivalents of O2 for every 
H2O2 added.  However, the stoichiometry for a physiological catalase is 0.50 equivalents 
of O2 for every H2O2 utilized (59, 60).  These results are therefore consistent with the 
leakage of single electron products from the active site, including hydroxyl radical and 
superoxide.   
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The formation of superoxide was probed with the reagent hydroethidine.  When 
this reagent is added to a reaction mixture containing [FeII/FeII]-ADEec and an excess of 
hydrogen peroxide, the formation of 2-hydroxyethidium is detected.  The amount of 2-
hydroxyethidium produced is consistent with ~11 equivalents (17 μM/1.50 μM) of 
superoxide produced for every enzyme inactivated.  During this process ~54 (81 
μM/1.50 μM) equivalents of O2 are produced and ~128 (192 μM/1.50 μM) equivalents 
of H2O2 are consumed, leaving ~9 equivalents (128-108-11) of H2O2 unaccounted.  This 
latter number approximates the number of oxidized histidine and methionine residues 
sites detected by mass spectrometry that most likely occur from the reaction of hydroxyl 
radicals with the protein. 
It is likely that the oxygenation of methionine residues is of minor importance for 
changes in catalytic activity.  However, the oxygenation of four histidine residues that 
coordinate the two irons in the active site can modulate oxidation/reduction reactions via 
changes in the reduction potential and/or coordination geometry of the binuclear metal 
center.  From the structure of ADE from A. tumefaciens (PDB: 3nqb), the oxygenation 
sites are mapped and shown in Figure 3.15.  These oxygenation sites are predominantly 
in and around the binuclear metal center and seem to migrate from there to other parts of 
the protein.  This result is consistent with the conclusion that the catalase activity 
originates at the binuclear metal center and is further supported by the fact that 6-
chloropurine, a potent inhibitor of the deaminase reaction, inhibits the catalase activity. 
The reduction potential of the binuclear metal center changes with the extent of 
protein oxygenation.  For enzyme not previously exposed to H2O2, the reduction 
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potential for the inter-conversion of the ferric and ferrous forms of [Fe/Fe-ADE] is +209 
mV.  When the protein is partially oxygenated the reduction potential decreases to +194 
mV and decreases further to +175 mV when the protein is fully oxygenated and the 
enzyme is unable to catalyze either the deaminase or catalase reactions.  These results 
are consistent with the continuous modulation of the catalytic properties of the binuclear 
iron center with time as hydroxyl radicals escape and react directly with the metal 
ligands.   
 
 
Figure 3.15:  Map of the oxygenation sites after adding H2O2 to [Fe
II
/Fe
II
]-ADE.  The 
protein backbone is represented in green and the red spheres represent the amino acid 
side chains that were oxygenated. 
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 Proposed Mechanism of Action.  How does the binuclear iron center in ADE 
catalyze the oxidation and reduction of hydrogen peroxide?  EPR and Mössbauer 
spectroscopy demonstrated that the enzyme can cycle between the diferrous and diferric 
states of oxidation.  We have not observed any spectra that are consistent with a ferryl-
oxo species (Fe(IV)=O), although this latter species is likely to be too unstable to be 
detected by the methods employed in this investigation (59-61).  Both metal ions within 
the binuclear metal center must be iron.  A unique Mn/Fe hybrid can be prepared, but it 
is not known which of the two sites within the binuclear metal center is occupied by iron 
and which by manganese.  This hybrid is completely inactive for reaction with hydrogen 
peroxide (Figure 3.9).    
 Scheme 3.2 is a working model to explain the development and decay of the 
catalase-like activity of iron-substituted ADE.  We propose that the observed changes in 
the reactivity of the enzyme are due to changes in the redox properties and structural 
changes to the diiron center as the protein becomes oxygenated.  When H2O2 is first 
added to [FeII/FeII]-ADE, the predominant reaction is the formation of water and a 
hydroxyl radical that is coupled with the transient formation of [FeII/FeIII]-ADE.  The 
hydroxyl radical subsequently reacts with histidine and methionine residues that are near 
the active site.  The initial odd-electron oxygenated product loses an electron that 
subsequently reduces the mixed-valent binuclear center to [FeII/FeII]-ADE.  This form of 
the protein is represented as [FeII/FeII]-ADEox in Scheme 3.2.  This induction phase is 
similar to the reaction of [FeII/FeII]-ADE with HOCl.  With this substrate the reaction 
products are chloride anion and hydroxyl radical, and the protein is initially left as a 
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mixed valent [FeII/FeIII]-ADE complex.  Since the enzyme can react with approximately 
12 molecules of HOCl before the enzyme is inactivated, the active site must therefore 
cycle between the [FeII/FeII]-ADE and [FeII/FeIII]-ADE oxidation states.  The initial odd-
electron products from the reaction of methionine and histidine residues must lose an 
electron that reduces [FeII/FeIII] back to [FeII/FeII].  However, HOCl is different from 
H2O2 since it cannot be oxidized.    
 During the induction phase of the reaction of ADE with H2O2, the direct metal 
ligands to the binuclear metal center become oxygenated (Scheme 3.2).  This lowers the 
reduction potential of the binuclear metal center from +209 V to +194 V that apparently 
enables the enzyme to cycle between the [FeII/FeII] and [FeIII/FeIII] states in a sustaining 
phase.  Mutation of the four histidine residues that coordinate the two irons in the active 
site suggests that the oxidation of His-90 is the key modification for the transition from 
the induction phase to the sustaining phase. During this stage the stoichiometry of the 
catalase reaction is not perfect and there is continual leakage of the reactive oxygen 
species, hydroxyl radical and superoxide, which continue to oxygenate the protein.  
Eventually, the enzyme enters the final death phase after multiple residues within the 
active site become oxygenated.  This form of the enzyme is represented as [FeIII/FeIII]-
ADE ox-ox in Scheme 3.2.  At this point the reduction potential of the metal center is 
lowered to +174 V and the diferric form of ADE can no longer be reduced to the 
diferrous state by hydrogen peroxide.  The modulation of the catalytic properties of the 
binuclear iron center may occur with changes in the reduction potential but the changes 
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in catalytic activity may also be the result of conformational changes to the metal center 
itself.  
induction phase 
[FeII/FeII]-ADE  +  H2O2  +  H
+   →  [FeII/FeIII]-ADE  +  H2O  +  
.
OH 
[FeII/FeIII]-ADE  +  
.
OH  →  [FeII/FeII]-ADEox   +  H+ 
sustaining phase 
[FeII/FeII]-ADEox  +  H2O2  +  2 H
+  →  [FeIII/FeIII]-ADEox  +  2 H2O 
[FeIII/FeIII]-ADEox  +  H2O2  →  [Fe
II/FeII]-ADEox  +  O2  +  2 H
+ 
[FeIII/FeIII]-ADEox  +  H2O2  →  [Fe
II/FeIII]-ADEox  +  HO2  +  H
+ 
[FeII/FeIII]-ADEox  +  H2O2  →  [Fe
II/FeII]-ADEox  +  HO2  +  H
+ 
death phase 
[FeII/FeII]-ADEox  +  H2O2  +  H
+  →  [FeII/FeIII]-ADEox  +  H2O  +  
.OH 
[FeII/FeIII]-ADEox  +  .OH  →  [FeII/FeII]-ADEox-ox  +  H+ 
[FeII/FeII]-ADEox-ox  +  H2O2 →  [Fe
III/FeIII]-ADEox-ox  +  2 H2O 
Scheme 3.2: Working model for the catalase activity of diiron ADE. 
 When an excess of H2O2 is added to ADE in the presence of a superoxide 
scavenger, ~128 enzyme equivalents of hydrogen peroxide are consumed and ~54 
equivalents of O2 are produced.  The other products are hydroxyl radicals and ~11 
equivalents of superoxide.  Since the inclusion of hydroxyl radical scavengers had no 
effect on the kinetics of O2 formation, it appears that the hydroxyl radicals are fully 
trapped by the protein and do not escape to the bulk solvent.  Based on the number of 
residues found to be oxidized after ADE is no longer active, approximately 10-12 
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enzyme equivalents of hydroxyl radicals are produced for every enzyme  inactivated.  
This value is very similar to the number of HOCl molecules that are required to fully 
inactivate ADE. During the sustaining phase, the predominant reaction is the conversion 
of hydrogen peroxide to O2 and water.  However, there is significant formation of 
hydroxyl radical and superoxide that must occur via single electron transfers.  The 
oxidation and reduction of H2O2 during the sustaining phase may occur by two single 
electron transfers to form superoxide and hydroxyl radical intermediates or by a coupled 
two-electron transfer to form O2 and water directly.  The mechanism proposed for the 
disproportionation of hydrogen peroxide by [Fe/Fe]-ADE is similar to that of 
dimanganese catalase found in some organisms, where the enzyme uses MnII/MnII and 
MnIII/MnIII as the metal center to catalyze the conversion of hydrogen peroxide to 
oxygen and water via a coupled two electron transfer process (62, 63). We further 
propose that hydrogen peroxide binds to the binuclear metal center and that single and/or 
coupled two electron transfers occur to and from these two metal ions.  However, in all 
of the crystal structures of ADE obtained thus far there are three metal ions in the active 
site even though the crystallizations were initiated with protein with two metals per 
subunit.  At this point it is not clear how the third metal ion was incorporated into the 
protein.  There are four protein residues that coordinate the third metal ion in ADEec: 
His-120, Glu-121, His-473, and Asp-474.  His-473 and Asp-474 form an invariant and 
fully conserved HD dyad in all adenine deaminases in cog1001 and are absolutely 
critical for the catalase activity but have no role in the deaminase activity.  The pH rate 
profiles for the catalase activity indicate that a single group must be unprotonated for 
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catalytic activity with a pKa of 7.6 - 7.9.  This pKa value is consistent with His-473 
serving in proton transfer reactions in the oxidation and reduction of hydrogen peroxide.  
Computational docking to the three-dimensional structure of ADEtu suggests that His-
120 is required to hydrogen bond to N3 of adenine (20).    
Comparison with Other Catalases.  Catalase activity is supported by various 
types of metal sites, including hemes (59, 60), binuclear manganese centers (62, 63) and 
binuclear iron centers (45, 54).  The latter are found in monooxygenase enzymes and 
model compounds (45, 54, 64).  Perhaps the best studied of these is toluene/o-xylene 
monooxygenase from Pseudomonas sp. OX1 (54).  For this enzyme the two irons are 
antiferromagnetically coupled and the diferric form is stable in air.  The mechanism for 
the disproportionation of H2O2 proposed for [Fe/Fe]-ADE is similar to that of the 
binuclear manganese catalases found in some organisms, where the enzyme cycles 
between the [MnII/MnII] and [MnIII/MnIII] oxidation states.  Interestingly, [MnII/MnII]-
ADE exhibits no catalase activity, presumably because this state may lack sufficient 
reducing power to reduce H2O2 to water.    
 Potential Physiological Significance.  The physiological significance of the 
inherent catalase activity of adenine deaminase substituted with iron is unclear.  
However, it is known that in certain bacteria the deamination of adenine can function as 
a key step in the purine salvage pathway for formation of guanine nucleotides (15, 17).  
Therefore, under conditions of oxidative stress the inactivation of ADE would block 
formation of guanine nucleotides via the purine salvage pathway, which in turn might 
slow cell growth under conditions of oxidative stress.  There are known bacterial 
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transcription factors that use metal-catalyzed oxidation of histidine (via H2O2) as a redox 
sensor for controlling oxidative stress levels in cells.  An example of such a protein is 
PerR, which uses iron in the ferrous oxidation state to oxidize a histidine residue critical 
for DNA binding, thereby regulating the oxidative stress levels within cells (65, 66).  
Another example is the iron enzyme ribulose-5-phosphate 3-epimerase, which is 
irreversibly inactivated with H2O2, presumably from Fenton chemistry catalyzed by the 
Fe2+ in the active site.  This enzyme can be protected by incorporation of manganese in 
the active site (67). It is apparent that there is insufficient catalase in the cell when E. 
coli is grown aerobically to reduce the hydrogen peroxide concentration to a level that 
does not inactivate adenine deaminase.  The catalytic domain of ADE comprises the N-
terminal half of the protein and there is a rather large C-terminal domain of 
approximately 300 amino acids that has no obvious function.  The N-terminal half of the 
protein is required for the coordination of the binuclear metal center and has all of the 
residues necessary for the deaminase activity.  The C-terminal domain has the highly 
conserved HD dyad.  The mutation of either these two residues results in total loss of the 
catalase activity but has absolutely no effect on the deaminase activity.  These two 
residues are postulated to function in proton transfers during the conversion of H2O2 to 
H2O and O2.  The promiscuous catalase activity is not limited to adenine deaminase from 
E. coli.  We have also interrogated the adenine deaminases from B. subtilis (Bsu14520), 
A. tumefaciens (Atu4426), B. halodurans (Bh0640), and C. acetobutylicum (Cac0887).  
All of these enzymes catalyze the deamination of adenine and all catalyze the 
disproportionation of hydrogen peroxide when iron is bound to the active site.  Members 
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of the amidohydrolase superfamily have been show to catalyze hydrolytic, hydration, 
decarboxylation (68), and isomerization reactions (69, 70).  This is the first instance 
from this superfamily of enzymes for a redox-type reaction.  It is thus interesting to 
consider that other enzymes of unknown function within this superfamily will catalyze 
similar reactions.  
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CHAPTER IV 
DISCOVERY OF A LOW-BARRIER HYDROGEN BOND IN ADENINE 
DEAMINASE FROM ESCHERICHIA COLI 
 
 Adenine deaminase (ADE) is a member of the amidohydrolase superfamily 
(AHS). ADE has shown to catalyze two distinct reactions, the hydrolytic deamination of 
adenine and the redox disproportionation of hydrogen peroxide for diiron ADE. Kinetic 
studies for ADE yield similar inverse solvent isotope effects as adenosine deaminase and 
cytosine deaminase, which are the other kinetically characterized members of the AHS. 
Proton inventory studies on ADE show two distinct patterns, for kcat and kcat/Km, 
suggesting involvement of two distinct protons in the kinetic mechanism. A single 
downfield proton with a chemical shift (δ ~ 17.0 to 18.0 ppm) consistent with those 
identified for low-barrier hydrogen bonds (LBHBs) was identified using 1H-NMR 
analysis for the Zn/Zn-ADE. LBHBs have been found to be critical in other enzymes and 
have been extensively studied for serine proteases. Here we use mutagenesis and 
inhibitor studies coupled to 1H-NMR analysis to reveal the nature of the downfield 
proton and found it was associated with the deaminase activity. The exact assignment of 
the downfield proton still remains unknown; however this study reports the first instance 
of any metalloenzyme possessing a LBHB in catalysis. Previous experiments performed 
on serine proteases in the identification of the LBHB might prove useful in finding the 
LBHB of ADE.  
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INTRODUCTION 
 Physical organic chemists have known of the existence of low-barrier hydrogen 
bonds (LBHB) in organic reactions for years. However, the existence of LBHB in 
proteins and enzymes is only recent as compared to organic reactions (71). Researchers 
have proposed that a weak hydrogen bond in the initial enzyme or enzyme-substrate 
complex in converted into a LBHB in the transition state intermediate. In a proposal by 
Cleland, an enzyme converts a weak hydrogen bond into a LBHB by changing the pKa 
of the substrate close to that of the hydrogen bond donor, thereby increasing the strength 
of the hydrogen bond. The strength of the hydrogen bond involved in enzyme catalysis 
via formation of the LBHB depends on the length and linearity of the bond, the micro-
environment of the bond, and the degree to which the pKa values of the heavy atom 
conjugate acids sharing the proton are matched (49, 72). Cleland and Kreevoy have also 
proposed the idea of a special type of hydrogen-bond (H-bond) they termed a low-barrier 
hydrogen bond (LBHB). They suggested that the missing link in most transition states of 
enzyme catalyzed reactions involving a proton transfer, would involve a transition state 
stabilization that is provided by this “special” proton (73). Various physicochemical 
parameters are now used to define and identify the LBHBs associated with enzymes. 
LBHBs are characterized most unambiguously by the characteristic 1H- nuclear 
resonance magnetic (NMR) chemical shift with the proton showing up at extreme low-
field values (δ > 16 ppm). LBHBs are also identified by deuterium isotope effects, low 
isotopic fractionation factors and deuterium isotope effects on the infrared and Raman 
frequencies on the LBHBs (74).  
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 The first class of enzymes that were identified to involve a LBHB in catalysis 
was the serine proteases. Studies from Robillard and Shulman in 1972 identified a single 
proton at low fields in the 1H-NMR spectra of chymotrypsin and chymotryosinogen (75). 
The resonance peak appeared between 15 and 18 ppm relative to dimethyl-silapentane 
sulfonate in the 1H-NMR and, was sharp at extreme pH values and broadens at 
intermediate pH (pK ~ 7). They also found that upon dissolving the protein in D2O there 
was a loss of the resonance signal. A similar study using 1H-NMR performed by 
Markley in 1981 revealed that other serine proteases also had this characteristic 
downfield proton around 18 ppm (76). In this 1H-NMR study by Markley, bovine 
trypsinogen, bovine trypsin, bovine chymotrypsinogen, bovine chymotrypsin Aδ and 
bovine chymotrypsin Aα were tested. The studies revealed that the downfield proton was 
more pronounced at lower pH values (< 4.0) and lower temperatures (< 3oC). In a series 
of subsequent studies from Cleland, Frey and Markley, using various serine protease 
mechanism-based inhibitors, model synthetic compounds, mutagenesis, isotope effects 
and fractionation factors, it was established that the downfield proton was the hydrogen 
atom termed now as the LBHB between the aspartate and histidine (N-δ1) of the 
catalytic triad amongst the various serine proteases (77-80). Scheme 4.1 represents the 
LBHB of chymotrypsin from the studies performed by Frey and co-workers (81).  
1H-NMR spectroscopy was able to identify the existence and nature of the LBHB 
in serine proteases. However, there was much speculation throughout literature about the 
assignment of the LBHB throughout this enzyme superfamily. Finally a study by 
Bachovchin (82) in 1985 on α-lytic protease, a bacterial serine protease answered the 
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issue with regards to the assignment of this LBHB. α-lytic protease was made 
recombinantly using synthetic L-histidine labeled specifically with 15N at Nδ1as the sole 
source of histidine. The resulting α-lytic protease was enriched in 15N at Nδ1 of the 
histidine of the catalytic triad. The resulting downfield proton around 17 ppm at pH 4.0 
split into a doublet resulting from the additional coupling to the 15N of histidine Nδ1. This 
study unambiguously assigned the position of the LBHB to serine proteases.  
 
Scheme 4.1: The catalytic triad of chymotrypsin. The hydrogen atom in red represents 
the downfield proton seen in the 1H-NMR studies and is termed the LBHB of the serine 
proteases. 
 Since the discovery and assignment of the LBHB in serine proteases, several 
other enzymes have been studied for involvement of protons as LBHB in catalysis. 
Phospholipase A2 is a small calcium dependent lipolytic enzyme that catalyzes the 
hydrolysis of phospholipids. Its active site contains an invariant catalytic dyad of an 
aspartate and histidine residue. These residues hydrogen bond with water to form a 
catalytic triad analogous to the serine proteases. Studies from Tsai and co-workers have 
shown, using a variety of 1H-NMR and inhibitor studies, that this enzyme utilizes a 
LBHB in enzyme catalysis (83). Dunn and co-workers have indirect evidence through a 
variety of isotope effects and fractionation factors for the involvement of a LBHB in the 
catalytic mechanism of tryptophan synthase (84). More recently, a newer technique 
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called high-resolution neutron crystallography has been employed in the discovery of 
LBHBs. Kataoka and co-workers have used this technique in detecting a LBHB in 
photoactive yellow protein (PYP) from Halorhodospira halophila. PYP is a putative 
photoreceptor for negative phototaxis in purple phototropic bacteria (85). A review by 
Cleland, Frey and Gerlt (72), has postulated more enzymes to involve LBHB in enzyme 
catalysis from kinetic isotopic studies performed on these enzymes. They have listed 
ketosteroid isomerase, triose phosphate isomerase, citrate synthase and mandelate 
racemase to employ a transition state proton i.e. a LBHB in their respective enzymatic 
mechanisms. 
 In this chapter, we discuss the discovery of a LBHB in adenine deaminase from 
Escherichia coli (ADE) (20). We have described the kinetic studies involving solvent 
isotope effects as well as proton inventory studies for ADE. We have used 1H-NMR 
spectroscopy complemented with mutagenesis to identify the putative residues that 
might be involving the LBHB associated with ADE. Our studies indicate that this LBHB 
is involved in a proton transfer event at the transition state for the deamination reaction 
and we have proposed the residues that might be involved with this LBHB.  
MATERIALS AND METHODS 
Materials.  All chemicals were purchased from Sigma-Aldrich unless otherwise 
stated.  The genomic DNA for E. coli str. K12 substr. MG1655 was purchased from 
ATCC.  E. coli BL21(DE3) and XL1-blue competent cells were obtained from 
Stratagene (Agilent).   The expression vector pET30(+) and Pfx DNA polymerase were 
purchased from Invitrogen.   All oligonucleotides were obtained from the Integrated 
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DNA Technologies (IDT) from the Gene Technology Lab at Texas A&M University 
(GTL-TAMU).  
Cloning, Mutagenesis and Purification. Adenine deaminase (ADE) from 
Escherichia coli was cloned as described previously (20). Mutagenesis was performed 
using the Quik-Change PCR protocol as per manufacturer’s instructions. All the 
plasmids were verified for the appropriate gene sequence at the Gene Technology 
laboratory, Department of Biology, Texas A&M University. The wild-type ADE and all 
mutants were expressed using the iron-free expression protocol and purified as described 
before (20). The pure fraction was pooled for every protein and tested for activity, and 
tested for Mn2+ content by ICP-MS.  
Preparation of Zn/Zn-ADE. The ADE was dialyzed with 10 mM 1,10-
phenanthroline in 50 mM phosphate buffer, pH 7.0 over 36 hours with 2 buffer 
exchanges. The resulting apo-protein was further purified using a PD-10 size exclusion 
column, and the proteins were analyzed by inductively coupled plasma mass 
spectrometry (ICP-MS) for the absence of any metal associated with the protein. Apo-
ADE was then reconstituted by adding the 20 fold-enzyme excess of zinc chloride 
(ZnCl2) as a zinc source (Zn
2+) previously dissolved in 50 mM phosphate buffer pH 7.0 
for 48 hours at 4oC. The excess metal was separated from the reconstituted protein by 
passing through a PD-10 size exclusion column. The reconstituted protein was tested for 
activity as well as tested by ICP-MS for metal incorporation. The reconstituted protein 
was concentrated using the 10 kDa vivaspin 6 concentrators (GE Healthcare) and 
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analyzed by NMR. For this study the mutants were H90N, D284A, E236Q, D285A, 
H473N and E474Q. 
NMR Analysis. The wild-type ADE and mutants expressed, purified and 
reconstituted were analyzed by 1H-NMR spectroscopy by Dr. Howard J. Williams, 
Department of Chemistry, Texas A&M University. After the reconstitution with zinc and 
kinetic analysis, the proteins were exchanged in 50 mM phosphate buffer, pH 5.5 for 
NMR analysis. The proteins were analyzed initially as reconstituted and later after 
addition of the ADE inhibitor 6-chloropurine (20). The typical ADE concentrations in 
these experiments ranged from 220-300 µM depending on the yield from the protein 
expressions and purifications. All NMR spectra were collected on a Bruker Avance III 
500 MHz NMR instrument equipped with an HCN cryoprobe. Samples were analyzed 
by 1H NMR (10% D2O) using the WATERGATE solvent (H2O) suppression program at 
1oC for 14-24 hours.  
Proton Inventory Kinetics. To determine the effect of varying proton 
concentration on the deaminase reaction, various proportions of H2O and D2O were 
made in the final reaction mixture. Mn/Mn-ADE was used for this study, since prior 
kinetic studies showed that the di-manganese, di-iron and di-zinc enzyme behave the 
same kinetically. The D2O concentrations in the assays were 0, 25, 50, 75 and 100 %. 
All assays were performed using the ammonia release coupling assay with glutamate 
dehydrogenase as described previously at the optimum pH 7.5 for ADE reaction in 50 
mM HEPES buffer at 30 oC using a SpectraMax 384 Plate Reader, from Molecular 
Devices (20). The assays were performed in duplicates. 
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Data Analysis.  All kinetic assays were analyzed using the non-linear least 
squares fitting program SigmaPlot 9.0. Initial velocity kinetic data were fit to equation 
2.1 where v is the initial velocity, [A] is the substrate concentration, Et is the total 
enzyme concentration, kcat is the turnover number and Km is the Michaelis constant. The 
inverse-concave proton inventories were fit to equation 4.1 for the kcat values obtained 
with increasing D2O concentrations. In this equation, vn is the activity at different 
D2O/H2O ratios, vo is the activity in the absence of D2O, n is the ratio of D2O/H2O, and 
ΦR is the fractionation factor for the reactant-state site. For the linear proton inventories 
for kcat/Km, equation 4.2 was used to fit the data. In this equation, vn is the activity at 
different D2O/H2O ratios, vo is the activity in the absence of D2O, n is the ratio of 
D2O/H2O, and Φ
T is the fractionation factor for the transition-state (86).  
v / Et = kcat [A] / (Km + [A])                                                       (Equation 2.1) 
vn = v0/(1 – n + nΦ
R)                                                              (Equation 4.1) 
vn = v0(1 – n + nΦ
T)              (Equation 4.2) 
RESULTS 
 ADE Properties. All the proteins were assayed for their adenine deaminase 
activity, since the buffer was exchanged from 50 mM HEPES, pH 7.5 to 50 mM 
phosphate buffer, pH 7.0 during the preparation of the apo-enzyme and the subsequent 
reconstitution was performed in phosphate buffer, 50 mM pH 7.0. Table 4.1 represents 
the kinetic constants and the metal-content of the wild-type and mutants ADE proteins 
reconstituted with Zn2+. The kinetic constants for the Zn/Zn-ADE wild type and the 
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mutant forms of ADE are in accordance with the Mn/Mn-reconstituted forms of ADE 
(20). 
Table 4.1: Kinetic constants of the various zinc reconstituted forms of ADE. 
ADE kcat (s
-1) kcat/ Km (M
-1s-1) 
 
Zinc content per 
monomer of ADE 
measured by ICP-MS 
Wild type 115 ± 5 (4.7 ± 0.3) x105 1.8 ± 0.2 
D284A 0.05 ± 0.01 130 ± 12 1.9 ± 0.2 
E236Q 0.06 ± 0.02 25 ± 7 1.6 ± 0.2 
H90N 4.1 ± 0.3 (1.8 ± 0.2) x103 1.7 ± 0.1 
D285A 30 ± 6 (0.9 ± 0.1) x105 1.8 ± 0.2 
H473N 110 ± 8 (4.5 ± 0.2) x105 2.1 ± 0.2 
D474N 121 ± 10 (4.9 ± 0.6) x105 2.0 ± 0.2 
All kinetic analysis were performed in phosphate buffer, pH 7.0 at 30oC 
 Proton Inventories. Varying amounts of D2O were added to adenine deaminase 
assay with the Mn/Mn-ADE (wild type) enzyme. Table 4.2 represents the kinetic 
constants obtained from the increasing D2O concentrations. Figures 4.1 and 4.2 
represent the data obtained from the proton inventory studies. In Figures 4.1 and 4.2, 
the blue line represents a straight line connecting the points at 0 and 100 % D2O and the 
red line represents the fit to the data. The data obtained for kcat was fit to equation 2, and 
the data for kcat/Km was fit to equation 3. The data for kcat appears to have an inverse-
concave shape, whereas the kcat/Km appears to be linear. Based on the fit to equation 2, 
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ΦR which is the fractionation factor for the reactant-state site equals (0.46 ± 0.01). Based 
on the fit to equation 3, ΦT which is the fractionation factor for the transition-state equals 
(2.34 ± 0.02). pH-rate profiles performed on Mn/Mn-ADE in H2O and D2O have shown 
two pKa values at 6.5 and 8.2. These pKa values are not affected by the solvent. Also 
pH-rate profiles suggest that pH 7.5 is the optimal pH for the deaminase activity for the 
various metal-reconstituted forms of ADE. Hence the proton inventory studies were 
performed at pH 7.5 (20). 
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Figure 4.1: Data for kcat for increasing D2O fractions for the adenine deaminase activity 
of Mn/Mn-ADE.  
The x-axis represents the fraction of the D2O in the final reaction mixture, and 
the y-axis represents the ratio of the kcat at the fraction of D2O to the kcat at zero D2O in 
the reaction mixture. The black circles represent experiment 1 where as open circles 
represent experiment 2. The blue dashed line is a straight line connecting the ratios at 0 
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and 100 % D2O concentrations. The red dashed line represents the data fit for kcat fit to 
equation 2. 
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Figure 4.2: Data for kcat/Km for increasing D2O fractions for the adenine deaminase 
activity of Mn/Mn-ADE.  
The x-axis represents the fraction of the D2O in the final reaction mixture, and 
the y-axis represents the ratio of the kcat/Km at the fraction of D2O to the kcat/Km at zero 
D2O in the reaction mixture. The black circles represent experiment 1 where as open 
circles represent experiment 2. The blue dashed line is a straight line connecting the 
ratios at 0 and 100 % D2O concentrations. The red dashed line represents the data fit for 
kcat fit to equation 3. 
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Table 4.2: Kinetic constants upon increasing the solvent D2O concentration for Mn/Mn-
ADE 
 
 
 
n 
Fraction 
of D2O 
 
Experiment 1 
 
Experiment 2 
kcat (s
-1) kcat/Km  
(M-1s-1) 
(x105) 
kcat (s
-1) kcat/Km  
(M-1s-1) 
(x105) 
0 230 ± 12 5.6 ± 0.5 212 ± 18 5.4 ± 0.4 
0.25 265 ± 24 7.2 ± 0.8 256 ± 18 7.1 ± 0.5 
0.50 310 ± 19 9.1 ± 0.9 305 ± 24 8.8 ± 1.0 
0.75 360 ± 29 10.9 ± 1.0 345 ± 18 10.8 ± 1.2 
1.0 470 ± 35 12.6 ± 1.1 468 ± 23 12.8 ± 1.4 
Experiment 1 and 2 are duplicates of the same experiment. Assay performed in 50 mM 
HEPES, pH 7.5 at 30oC. 
NMR Analysis. The 1H-NMR spectra were collected for the various proteins that 
were purified and kinetically characterized. All the NMR spectra were collected by Dr. 
Howard J. Williams. For wild-type ADE, the 1H-NMR spectra were collected at 1 oC 
and 25 oC initially. After observing a proton resonance around 17 ppm for the 
measurement at 1 oC and not for those at 25 oC, all subsequent experiments were 
performed at 1 oC. For wild type ADE, 1H-NMR spectra were obtained with the addition 
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of substrate and the inhibitor, 6-chloropurine (Figure 4.3). Spectra were collected for 16 
hours each. 
ppm 
 
Figure 4.3: 1H-NMR spectra of zinc reconstituted ADE: [1] wild type-ADE (230 µM) at 
pH 5.5 in 50 mM phosphate buffer collected at 1oC showing the downfield proton at 
17.2 ppm. [2] wild type-ADE (225 µM) + 3 mM adenine, at pH 5.6 in 50 mM phosphate 
buffer. Spectrum collected at 1oC showing the downfield proton at 17.4 ppm. [3] wild 
type-ADE (260 µM) + 3 mM 6-chloropurine, at pH 5.5 in 50 mM phosphate buffer. 
Spectrum collected at 1 oC, showing the downfield proton at 18.0 ppm. [4] wild type-
ADE wild type-ADE (250 µM) at pH 5.5 in 50 mM phosphate buffer. Spectrum 
collected at 25 oC showing loss of signal for the downfield proton. 
1 
2 
3 
4 
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 To quantify the downfield proton observed in the 1H-NMR spectra of ADE, the –
methyl group of methionine was used as a comparative standard. Since ADE has 13 
methionine residues, the integration was adjusted for a single –methyl group for a 
methionine residue by dividing the total integration by 13 for the methyl group 
resonance arising from the methionine residues of ADE. For Figure 4.3.1 when the 
proton at 17.2 ppm was assigned 1.00, the protons of the –methyl group of methionine 
were 121.31. Thus is the absence of substrate or inhibitor, the downfield proton amounts 
to 0.8% of a single proton. This indicates a rapid exchange of the downfield proton with 
solvent even at 1 oC. For Figure 4.3.2 when the proton at 17.4 ppm was assigned 1.00, 
the protons of the –methyl group of methionine were 66.54. Thus is the absence of 
substrate or inhibitor, the downfield proton amounts to 1.5% of a single proton. For 
Figure 4.3.3 when the proton at 18.0 ppm was assigned 1.00, the protons of the –methyl 
group of methionine were 9.42. Thus is the absence of substrate or inhibitor, the 
downfield proton amounts to 10.6% of a single proton. 
 To assign the proton associated with the LBHB various mutants were analyzed 
by 1H-NMR spectroscopy. Two sets of mutants were selected for this study, where 
residues critical for the deaminase activity were mutated (His-90, Glu-236 and Asp-284) 
and in the second set, residues critical for the catalase activity were mutated (His-473 
and Asp-474) as well as the highly conserved (Asp-285) of the DD-motif amongst 
various deaminases was also mutated. Figures 4.4 and 4.5 represent the 1H NMR 
spectra of the mutants. 
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Figure 4.4: 1H-NMR spectra of the zinc reconstituted metal ligand mutants of ADE. All 
spectra were collected at 1 oC, in 50 mM phosphate buffer. All spectra were collected for 
16 hours. [1] wild type-ADE (260 µM) + 3 mM 6-chloropurine, at pH 5.5, showing the 
downfield proton at 18.0 ppm. [2] ADE D284A mutant (280 µM) + 3.2 mM 6-
chloropurine, at pH 5.4, showing the absence of the downfield proton. [3] ADE E236Q 
(300 µM) + 3 mM 6-chloropurine, at pH 5.5, showing the absence of the downfield 
proton. [4] ADE H90N (265 µM) + 3 mM 6-chloropurine, at pH 5.6, showing the 
downfield proton at 18 ppm.  
 Similar strategy was used in quantification of the downfield protons for the 
various ADE mutants shown in Figures 4.4 and 4.5. No downfield proton was observed 
for the D284A and E236Q mutants. The H90N and D285A mutants, showed more than a 
single proton in the downfield region for the LBHB. This may result from the 
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perturbation of the active site resulting from these mutants, which are in close proximity 
to the binuclear metal center. For the H90N mutants, the net protons in the downfield 
resonance region amount to 9.8% of a single proton (Figure 4.4), whereas for the 
D285A mutant, the net protons in the downfield resonance region amount to 10.1% of a 
single proton (Figure 4.5). The H473N and D474N mutants display broad proton peaks, 
due to pH effects, and amount to 7.5% and 7.0% of a single proton respectively when 
quantified.    
ppm 
 
Figure 4.5: 1H-NMR spectra of the zinc reconstituted mutants of ADE. All spectra were 
collected at 1 oC, in 50 mM phosphate buffer with the addition of 3 mM 6-chloropurine. 
All spectra were collected for 16 hours. [1] wild type-ADE (260 µM) at pH 5.5, showing 
the downfield proton at 18.0 ppm. [2] ADE D285A mutant (270 µM) at pH 5.8, showing 
the downfield proton at 17.8 ppm. [3] ADE H473N (300 µM), at pH 5.8, showing the 
downfield proton at 17.5 ppm. [4] ADE D474N (285 µM) at pH 5.7, showing the 
downfield proton at 17.3 ppm.  
1 
2 
3 
4 
115 
 
DISCUSSION 
 Kinetic and Proton Inventory Analysis. The wild type-ADE and the various ADE 
mutants reconstituted with zinc display similar kinetic properties as those for the 
manganese and iron reconstituted ADE mutants (20). Previous studies done on Mn/Mn-
ADE have shown that at pH 7.5, there is an inverse solvent deuterium isotope effect of 
0.49 ± 0.02 (20). The inverse solvent isotope effect for ADE is consistent with the 
findings of other members of the amidohydrolase superfamily, involved in deamination 
reactions. Cook, Cleland and co-workers found that adenosine deaminase (48) exhibits 
an inverse solvent deuterium isotope effect of 0.45 on kcat/Km and 0.74 on kcat. Raushel 
and co-workers have found that cytosine deaminase exhibited an inverse solvent 
deuterium effect of 0.62 and 0.40 on kcat and kcat/Km respectively (8).  Proton inventory 
studies were employed to study the nature of the inverse isotope effects in ADE. Since 
the Zn-reconstituted and Mn-reconstituted forms of ADE exhibit similar kinetic 
characteristics, Mn-reconstituted ADE was used for the proton inventory studies. For 
inverse solvent deuterium effects, there are three conventional curves that can fit the 
inverse proton inventory profiles (86). The first being a convex curve that comprises of 
mechanistic models that have a single “tight” transition-site, second being a concave 
curve that represents systems having a single “loose” reactant-state site and lastly the 
linear profile that encompasses all the proton transfer steps from multiple sites on the 
enzyme (86). Equation 2 represents the measurement of the isotopic fractionation factor 
for the reactant site (ΦR). Fractionation factors are parameters that are used to define the 
contribution of a particular site in a particular molecular state in catalysis. ΦR is the 
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measure of the deuterium preference of the reactant state relative to the deuterium 
preference of the average-deuterium from the bulk water solvent. Since kcat does not take 
into account the binding of the substrate, only the ΦR can be calculated from the kcat 
profile. ΦT is the fractionation factor for the transition-state can be calculated from the 
kcat/Km profile as this kinetic parameter accounts for the binding of the substrate to the 
enzyme and can account for the transition state of the reaction. Equation 3 represents 
that measure of the ΦT obtained for smaller concave curves in kcat/Km profiles. 
 For the profile obtained for the kcat for the proton inventory study on ADE 
(Figure 4.1), the blue dashed line represents a straight line connecting the kcat of ADE at 
100 % H2O and 100% D2O. As the fraction of D2O increases, the experimentally 
obtained values of kcat in duplicates lie close to each other for every other fraction of 
D2O lie below this straight line. Thus the nature of the profile for the proton inventory 
for kcat is concave. The fractionation factor of the reactant state (Φ
R) obtained from this 
fit to equation 2 was 0.46 ± 0.01, indicates that the reactant state of the enzyme has 
single proton site responsible for catalysis and this proton transfer is the rate limiting 
step of the reaction. In ADA, it was concluded by Cleland that this proton was likely to 
be the proton that is transferred from Glu-217 to N1 of adenosine (49). In CDA, it was 
hypothesized by Raushel and co-workers that this proton was likely to be the proton that 
is transferred from Glu-217 to N1 of cytosine (8). For the proton inventory profile 
obtained for kcat/Km (figure 4.2), the blue line represents a straight line connecting points 
for 100% H2O and 100% D2O. The red line represents the data fit to equation 3, which 
represents a line of intermediate curvature for proton inventory profiles. The 
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fractionation factor of the transition-state site (ΦT) obtained from the fit from equation 3, 
was 2.34 ± 0.02, indicative that there is more than proton transfer event occurring during 
the transition state. The first is presumably the transfer of the proton from the protonated 
Glu-236 to the N-1 of adenine, and the second being the proton shuttling by Asp-284 
eventually protonating the leaving ammonia group. Similar protonation events are seen 
for ADA (34) and CDA (8). If there were multiple sites experiencing a tightened 
potential as the transition state was formed, a line of intermediate curvature would 
provide a better fit, hence the profile of kcat/Km was fit to equation 3. Thus the proton 
inventory profiles identify a single proton transfer as the rate limiting step of the adenine 
deaminase reaction, and also identify the two proton transfer events during the catalytic 
cycle. 
 Discovery of the Low-Barrier Hydrogen Bond of ADE. Extensive studies on the 
serine protease, chymotrypsin led researcher to identify the elusive low-barrier hydrogen 
bond (LBHB) implicated in enzyme catalysis. The LBHB is chymotrypsin exists 
between Asp-102 and His-57 of chymotrypsin, which is part of the proton relay system 
associated with the catalytic triad of the serine proteases. The proton associated with the 
LBHB has a characteristic downfield 1H-NMR signal between 17.0 – 18.0 ppm. In a 
proposal by Cleland, enzymes with lower fractionation factors, generally involve low 
barrier hydrogen bonds in their catalytic cycles. Since it has been previously shown that 
ADE, ADA and CDA three mechanistically characterized representative examples of 
deaminase enzymes from the AHS have low fractionation factors from their proton 
inventory studies, an attempt was made to identify a LBHB in this class of enzymes. 
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Prior studies on the LBHB from the research group of Frey and, Markley, have shown 
that the downfield protons are generally seen at lower pH and lower temperatures as it 
prevents exchange of the desired proton with solvent protons (76-81). Hence ADE 
samples were prepared with pH around 5.5 since it was the lowest pH that allowed ADE 
to remain soluble and all spectra were collected at 1 oC.  
 Since manganese and iron are both paramagnetic in nature, the use of Mn/Mn-
ADE or Fe/Fe-ADE for NMR analysis would prove futile. Since Zn in permissible for 
NMR, Zn/Zn-ADE was used in the NMR study. Also since Zn/Zn-ADE has similar 
kinetic properties to Mn/Mn-ADE and Fe/Fe-ADE for the deaminase reaction, the zinc-
reconstituted ADE would prove ideal for the NMR study. Figure 4.3 shows the 1H-
NMR spectra for the region 16.0 to 19.0 ppm for various wild type Zn/Zn-ADE 
conditions. For the wild type Zn/Zn-ADE at pH 5.5 and 1oC, a resonance peak is 
observed at 17.2 ppm consistent with the existence of a LBHB in ADE (Figure 4.3[1]). 
As the temperature increases from 1 oC to 25 oC the peak disappears, consistent with the 
findings of other enzymes possessing LBHB (76-81). In a review by Cleland, Frey and 
Gerlt (72) there is proposal that in a mechanism involving some unstable intermediate, 
the transition state for it will closely resemble the intermediate. A LBHB would be found 
in such systems in the intermediate or in an enzyme-inhibitor complex mimicking this 
state. To test this proposal, adenine (the substrate of ADE) and 6-chloropurine (an 
inhibitor of ADE), were added to ADE at pH ~ 5.5. In both cases the downfield proton 
corresponding to the LBHB, was observed between 17.0 and 18.0 as shown in figure 3. 
The signal to noise for the proton was marginally better with adenine as compared to the 
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sample of the enzyme by itself. The signal to noise was significantly better for the 
sample of the enzyme and inhibitor as compared to the enzyme alone. This finding was 
consistent to the proposal from the review by Cleland, Frey and Gerlt (72).  
 Adenine deaminase is a unique deaminase from the AHS. It catalyzes a 
promiscuous catalase type reaction along with its native adenine deaminase reaction. 
ADE is relatively large protein as compared to the other deaminases of the AHS. It 
contains approximately 600 amino acids. The catalytic components for the deaminase 
reaction, i.e. the binuclear metal center as well as the residues implicated in the 
hydrolytic deamination reaction are all located within the first 300 amino acids of the 
protein, which comprise the (β/α)8-barrel, a common structural fold for all the members 
of the AHS. Aspartate-284 and glutamate-236 for the Escherichia coli are critical 
residues for this reaction and mutation of these residues results in dramatic loss of the 
deaminase activity (20). Asp-284 and Glu-236 are metal binding residues as well but 
play a more important role in activating water for the hydrolytic attack as well as 
protonate the leaving groups and act as a proton relay system (20).  Towards the C-
terminal end of the protein, lies an invariant HD-dyad for all the binuclear adenine 
deaminase enzymes from the AHS. Mutation of Histidine-473 or aspartate-474 from the 
E. coli ADE results in complete loss of the catalase activity of the enzyme (21). Since 
ADE has two different set of residues identified in two different reactions, it was 
imperative to study the effect of these mutations on the downfield proton implicated as 
being the LBHB for ADE. To probe the effect on the deamination reaction, D284A, 
E236Q and H90N were chosen as the mutants to analyze. His-90 is a ligand to the 
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binuclear metal center but upon mutation to only Asn binds two metals in the active site. 
These mutants were previously shown to bind two equivalents of manganese or iron per 
monomer of enzyme (20) and the zinc reconstitutions showed that all these mutants 
bound two equivalents of zinc per monomer of enzyme. Another mutant D285A was 
considered for the NMR study, as it is part of a highly conserved DD-motif at the end of 
β-strand 8, for all the deaminase enzymes in the AHS. Based on studies on ADA (87) 
and ADE (20) as well as 6-MAD (24), the second aspartate residue is responsible for 
recognition of the leaving ammonia group as well as orienting the ammonia group in the 
proper position for protonation and leaving of the active site.  
 The 1H-NMR spectra in figure 4.4 represent the spectra for the mutants involved 
in the deaminase reaction. Upon mutation of the residues involved in activating the 
water for the hydrolytic attack, i.e. Asp-284 and Glu-236, there is a loss of the downfield 
proton implicated in the LBHB. Upon mutation of the His-90 the downfield proton is 
observed. The residues involved for proton shuttling in the catalase reation, His-473 and 
Asp-474 show the presence of the downfield upon mutation of the residues (figure 4.5). 
Asp-285 the residue implicated in the proton shuttling to the leaving ammonia group 
also shows the presence of the downfield proton (figure 4.5). Thus based on the 1H-
NMR spectra shown in figures 4.4 and 4.5 it is suggestive that the downfield proton 
coincides with the residues implicated in the activating water for the hydrolytic attack. 
The net quantification of the downfield proton amounts to 10% of a single proton when 
quantified with respect to the methyl group of the methionine residues of ADE in 
presence of the inhibitor 6-chloropurine. This value gets smaller in the absence of 
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inhibitor. This suggests that the downfield proton is readily exchangeable with solvent 
even at such low temperatures and pH. The broad shapes of the protons are attributed 
largely to the pH. In order to get sharper peaks, the pH needs to be reduced to 3 or lower 
based on studies on serine proteases, however due to limit in solubility of ADE at low 
pH values; such studies could not be performed. The observation of multiple peaks in the 
D285A and H90N mutants arises primarily from perturbation of the active site of ADE 
due to the close proximity of these residues to the binuclear metal center. H90 is ligand 
to one of the metals of the binuclear metal center and only the H90N mutants binds two 
metals in the active site. The D285 residue is implicated in orienting the leaving 
ammonia group and well as hydrogen bonding to the leaving ammonia group in the 
mechanism of ADE.  
 Thus based on the previously proposed chemical mechanism of deamination of 
adenine (shown in scheme 4.2), the activated hydroxide attacks the re-face of C-6 
forming a tetrahedral intermediate with R stereochemistry. This intermediate has a 
negative charge on the N-1 and shown in red of scheme 2 is the hydrogen bond shared 
between Glu-236 and the N-1 of the tetrahedral intermediate. In a review by Cleland, he 
suggests that for ADA, the putative LBHB would come from the proton being 
transferred to the N-1 of the tetrahedral intermediate (48, 49). In his proposal he suggests 
that upon attack by the hydroxide at C-6, the pKa of the N-1 increases relative to that of 
the protonated glutamate responsible for the proton transfer. This increase in the pKa 
accounts for the inverse isotope effects and the proton inventory profiles (49). Thus 
based on the proton inventory studies for ADE, 1H-NMR studies for wild type-ADE and 
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ADE mutants, the downfield proton seems to coincide with the deaminase reaction and 
seems to be associated with the residues that are involved in activating the water for the 
hydrolytic attack. The exact position of the LBHB remains uncertain but based on the 
preliminary studies, it seems consistent with the LBHB being associated with the proton 
being transferred from Glu-235 to the N-1 of the tetrahedral intermediate. This increase 
in signal associated with the inhibitor 6-chloropurine further reinforces this proposal. 
Currently there is an attempt to synthesize 15N-1 6-chloropurine to determine whether 
there is a splitting observed in the downfield proton arising from the 15N of the inhibitor. 
Positive results from this study would confirm the exact nature and position of the 
LBHB in ADE analogous to the study performed in chymotrypsin. LBHB has been now 
conclusively identified in 4 enzymes (serine proteases (75-82), phospholipases (83), 
tryptophan synthase (84) and photoactive yellow protein (85)) and proposed for at least 4 
other systems (72). The identification of the LBHB in ADE, as well as unpublished 
results from the Raushel lab on ADA (Ms. Alissa Goble) and CDA (Ms. Samantha 
Burrows) further extend the range of enzymes that utilize LBHB in catalysis. The 
findings amongst the deaminase enzymes from the AHS represent that first example of 
metal-dependent enzymes using LBHB in catalysis.  
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Scheme 4.2: Mechanism of the deamination of adenine. The bonds shown in red are the 
predicted downfield proton implicated in the low-barrier hydrogen bond in the adenine 
deaminase reaction. 
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CHAPTER V 
ENZYMATIC DEAMINATION OF THE EPIGENETIC BASE  
N-6-METHYLADENINE* 
 
Two enzymes from the amidohydrolase superfamily (AHS) were discovered to 
catalyze the deamination of N-6-methyladenine to hypoxanthine and methylamine. The 
methylation of adenine in bacterial DNA is a common modification for protection of the 
host DNA against restriction endonucleases. The enzyme from Bacillus halodurans, 
Bh0637, catalyzes the deamination of N-6-methyladenine with a kcat of 185 s
-1 and a 
kcat/Km of 2.5 x 10
6 M-1s-1. Bh0637 catalyzes the deamination of N-6-methyladenine 2 
orders of magnitude faster than adenine. A comparative model of Bh0637 was computed 
using the three dimensional structure of Atu4426 (PDB code: 3nqb) as a structural 
template and computational docking was used to rationalize the preferential utilization of 
N-6-methyladenine over adenine. This is the first identification of an N-6-methyladenine 
deaminase (6-MAD). 
 
 
 
 
 
 
 
*Reprinted with permission from “Enzymatic deamination of the epigenetic 
base N-6-methyladenine” by S. S. Kamat, H. Fan, J. M. Sauder, S. K. Burley, 
B. K. Shoichet, A. Sali and F. M. Raushel, JACS 133, 2080-2083, 2011. 
Copyright 2011 ACS Publications, American Chemical Society. 
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INTRODUCTION 
N-6-methyladenine is found in the genomes of all bacteria. Its prevalence in 
almost life forms resulted in it being considered as the 6th DNA base pair with 5-
methylcytosine being the 5th. The occurrence of N-6-methyladenine in most bacterial 
genomes varies from 1.4 – 2.0 % of the total adenine content. It functions as a signal for 
genome defense against restriction enzymes and is responsible of viability of most 
bacteria (88, 89). More recently, N-6-methyladenine has been implicated in DNA repair 
and replication, nucleotoid segregation, regulation of gene expression, control of 
transposition, and host-pathogen interactions (88, 89). In bacteria, DNA methylases like 
DNA adenine methylases (Dam) and cell-cycle regulated methyltransferases (CcrM) are 
responsible for the N-6 methylation of adenine (88). Previous studies with cell free 
extracts from various sources have suggested a cryptic activity where N-6-
methyladenine was converted to hypoxanthine (90-92). However there has been no 
enzyme known to recycle N-6-methyladenine in this manner to date. 
  The NCBI database has classified in cog 1001 predominantly enzymes belonging 
to the amidohydrolase superfamily (AHS). Members within this superfamily, hydrolyze 
a variety of bonds at carbon and phosphorus centers (7). Members of the AHS utilize 
one or two divalent metal ions in the active site of the characteristic (β/α)8 barrel fold to 
catalyze these hydrolytic reactions. All the members of cog1001 have conserved HxH 
motif at end of β-strand 1, conserved histidines at end of β-strands 5 and 6, a bridging 
glutamate at end of β-strand 4 and an aspartate at end of β-strand 8 (24). This represents 
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a prototypical binuclear metal center with a bridging glutamate like phosphotriesterase 
homology protein (PHP) (93) and adenine deaminase (ADE) (20). 
Cluster of Orthologus Group (COG) 1001 predominantly consists of enzymes 
annotated as adenine deaminase (ADE) (20). ADE is a very promiscuous enzyme that 
catalyzes the deamination of adenine to hypoxanthine and ammonia as well as the redox 
disproportionation of hydrogen peroxide to oxygen and water (21). COG 1001 also 
consists of members that are annotated as isoaspartyl dipeptidase (IAD) (22) and 
enamidase (23). There is however another cluster of sequentially related bacterial protein 
annotated as adenine deaminase but has less than 40 % sequence identity to 
experimentally validated ADE. There are also the some organisms that have more than 
one ADE lying in similar genomic contexts in the genome which is rather unusual. Most 
of these organisms are closely related bacillus species. 
  
 
 
 
Scheme 5.1: Reaction catalyzed by Bh0637 and other N-6-methyladenine deaminase (6-
MAD). 
In this chapter, we demonstrate a set of bacterial enzymes from COG 1001 that 
recycle N-6-methyladenine through the demethylaminase reaction (scheme 5.1), where 
they hydrolyze N-6-methyladenine to form hypoxanthine and methyl amine. These 
N
N
N
N
NH
H H
HN
N
N
N
O
+  CH3NH2
H2O
127 
 
enzymes come from closely related bacterial species and expand the bacterial purine 
salvage pathway for the utilization of N-6-methyladenine. 
MATERIALS AND METHODS 
Materials.  All chemicals were purchased from Sigma-Aldrich unless otherwise 
stated.  The genomic DNA for B. halodurans C-125 was purchased from ATCC.  E. coli 
BL21 (DE3) and XL1-blue competent cells were obtained from Stratagene (Agilent).  
The expression vector pET30(+) and Pfx DNA polymerase were purchased from 
Invitrogen.  All oligonucleotides were obtained from the Gene Technology Lab at Texas 
A&M University. 
Cloning of Bh0637 from B. halodurans (C-125).  The DNA sequence for Bh0637 
from B. halodurans C-125 was cloned (gi|15613200).  The gene for Bh0637 was 
amplified utilizing the primer pair 5’-
AAAGAGAATCATATGTGTGAACAAAAGTATCGCTGGACGAAAAAGC-3’ and 
5’-
AGAAGAAAGCTTTTAACGCATAATTGAAGGAAAGAGAACTGTTTTCTTATGA
AC-3’.  NdeI and HindIII restriction sites were introduced into the forward and the 
reverse primers, respectively.  The PCR product was purified with a PCR cleanup 
system (Qiagen), digested with NdeI and HindIII, and ligated into a pET30a(+) vector 
which was previously digested with NdeI and HindIII. Colony PCR was used to verify 
whether the colony had the gene-insert prior to sequencing.  The cloned gene fragment 
was sequenced to verify the fidelity of the PCR amplification. 
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Protein Expression and Purification.  The recombinant plasmid bearing the gene 
for Bh0637 was transformed into E. coli BL21 (DE3) competent cells by 
electroporation.  A single colony was grown overnight at 37 oC in 5 mL of LB medium 
containing 50 µg/mL kanamycin.  Five mL aliquots were used to inoculate 6 L of the 
same medium.  The cell cultures were grown at 37 oC and induced with 0.5 mM 
isopropyl-β-thiogalactoside (IPTG) when the A600 reached ~ 0.6 in the presence of 1.0 
mM MnCl2.  The cells were centrifuged and then resuspended in 50 mM Hepes, pH 7.5, 
containing 0.1 mg/mL phenylmethylsulfonyl fluoride and lysed by sonication.  The 
soluble proteins were separated from the cell debris by centrifugation at 12000 x g for 15 
minutes at 4 oC.  The nucleic acids were removed by dropwise addition of 2% w/v 
protamine sulfate.  After centrifugation, solid ammonium sulfate was added to 60% 
saturation to the supernatant solution.  The precipitated protein was dissolved in buffer 
and then applied to a High Load 26/60 Superdex 200 prep grade gel filtration column 
(GE HealthCare).  The active fractions were pooled and loaded onto a ResourceQ 
column (6 mL) and eluted with a gradient of NaCl in 20 mM Hepes, pH 7.5. The protein 
purity was confirmed by SDS-PAGE. 
Protein and Metal Analysis.  The protein concentration was estimated by 
measuring the absorbance at 280 nm using an extinction coefficient of 100,000 M-1 cm-1 
(39).  The metal content of the protein was determined by induced coupled plasma mass 
spectrometry (ICP-MS) (40). The protein samples for ICP-MS were digested with HNO3 
by refluxing for ~45 minutes to prevent protein precipitation during the ICP-MS run.  
The protein concentration was adjusted to ~1.0 µM in 1% v/v HNO3. 
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Substrate Screening. Various adenine derivatives were tested for changes in UV 
absorbance spectra after incubating 100 µM compounds dissolved in 20 mM Hepes 
buffer pH 7.5 with 1 µM purified Bh0637 for 2 hours. As a control the substrates 
without the enzyme was used to check for any degradation of substrate over time. The 
following substrates were tried: adenine, N-6-methyladenine, 2-hydroxyadenine 
(isoguanine), guanine, 2,6-diaminopurine, 6-chloropurine, 7-methyladenine, cytosine, 6-
methoxypurine, 6-methylmercaptopurine, 6-mercaptopurine, toxopyrimidine, 6-
methylpurine, adenosine, adenosine-5’-monophosphate, 2’deoxyadenosine, 5-amino-4-
imidazole-carboxyamide, deisopropyl-hydroxyatrazine, 5-acetylamino-6-amino-3-
methyluracil, 2-hydroxy-4-amino-6-(cyclopropylamino)-1,3,5-triazine (Scheme 5.2). 
The UV spectra were collected from 240 nm to 350 nm using a SpectraMax-340 UV-vis 
spectrometer. 
Kinetic constants. The deamination of adenine was determined using a coupled 
assay with glutamate dehydrogenase (GDH).  The formation of ammonia was followed 
at 340 nm using a SpectraMax-340 UV-vis spectrometer in the presence of 20 mM 
Hepes, pH 7.5, 0.15 mM NADH, 25 mM α-ketoglutarate (Calbiochem), 4 µg/mL GDH 
and various concentrations of adenine in a final volume of 0.25 ml (41). The 
demethylamination of N-6-methyladenine was followed at 270 nm (ε = 15,000 M-1cm-1) 
(90) for the loss of N-6-methyladenine. Various concentrations of N-6-methyladenine 
were added to final volume of 0.25 mL. The removal of methanethiol from 6-
methylmercaptopurine was monitored at 290 nm (ε = 20200 M-1cm-1) (94) and removal 
of methanol from 6-methoxypurine was monitored at 270 nm (ε = 3760 M-1cm-1) (95) 
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when various concentrations of the substrate were added to a final volume of 0.25 ml. 
All the assays were carried out at 30 oC.  
 
Scheme 5.2: Library of compounds tested against Bh0637 
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Mass spectrometry. The methylamine released from the demethylamination of N-
6-methyladenine by Bh0637 was identified using mass spectrometry using electrospray 
ionization (ESI) in the (+)-mode with acetonitrile as the solvent matrix. The mass 
spectroscopy was done at the Laboratory of Biological Mass Spectrometry, Texas A&M 
University. 
Preparation and Reconstitution of Apo-Enzyme. Apo-Bh0637 was prepared by 
dialyzing the enzyme purified against 10 mM 1,10-phenanthroline in 20 mM Hepes, pH 
7.0, for 36 hours with two changes of buffer.  The apo-enzyme was separated from 1,10-
phenanthroline using a PD-10 column (GE HealthCare) and then reconstituted with 2 
enzyme equivalents of Mn2+, Zn2+ or Fe2+ at 4 oC for 48 hours.  Iron was added 
anaerobically to the apo-enzyme to prevent air oxidation.  All samples were passed 
through a PD-10 column to remove any unbound metal. 
Redox testing of Fe/Fe-Bh0637. To measure the susceptibility of Fe/Fe-Bh0637 
to oxygen the enzyme reconstituted with iron was exposed to air and the kinetic 
constants for the demethylamination reaction with N-6-methyladenine were used to 
determine loss of any activity. [FeII/FeII]-Bh0637 was oxidized with the redox dye, 
thionine (Finn Scientific Inc.).  [FeII/FeII]-Bh0637 (1 μM) was incubated anaerobically 
with 1 to 20 µM (1-20 enzyme equivalents) of thionine in 20 mM Hepes, pH 7.5, at 
room temperature for 16 hours.  As a control 20 enzyme equivalents of thionine was 
added Mn/Mn-Bh0637 and assayed for the demethylamination activity. 250 µM 
hydrogen peroxide was added to 1.5 µM Fe/Fe-Bh0637 to check for any catalase activity 
132 
 
(20, 21). As a control the same amount of hydrogen peroxide was added to Mn/Mn-
Bh0637 and both samples were assayed for demethylamination activity. 
Sequence similarity networking and genomic analysis of COG 1001. Sequence 
similarity networking was used to classify and separate Cluster of Orthologous Group 
(COG) 1001 (11) using the software Cytoscape version 2.7.0 (12, 96). The COG 1001 
based on NCBI classification was split in groups based on primary sequence identity at 
an E-value 10-80 and further analyzed for substrate specificity and catalytic activity. 
Genomic context analysis of group 2 in COG 1001 was done using the Microbes Online 
program. 
  Data Analysis.  Initial velocity kinetic data were fit to equation 2.1 using 
SigmaPlot 9.0 where v is the initial velocity, [A] is the substrate concentration, Et is the 
total enzyme concentration, kcat is the turnover number and Km is the Michaelis constant. 
v / Et = kcat [A] / (Km + [A])                                      (Equation 2.1) 
RESULTS 
Sequence similarity networking and genomic analysis of COG 1001. COG 1001 
at E-value 10-80 forms 5 groups (Figure 5.1). Groups 1 and 4 previously studied by us 
are adenine deaminase (ADE) with a promiscuous catalase activity (20, 21). The split is 
due to the high constraint put on the E-value. Group 3 members are isoaspartyl 
dipeptidase (IAD) based on classification in NCBI and comparison of the primary 
sequence and conservation of residues to the crystal structure of IAD from E. coli (PDB: 
1ybq) (22). Group 5 members are enamidase based on classification in NCBI and 
comparison to primary sequence and conservation of residues to the crystal structure of 
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enamidase from Eubacterium bakeri (PDB: 2vun) (23). Members from group 2 are 
annotated as adenine deaminase or members of the amidohydrolase superfamily with 
unknown function in the NCBI database. They have less than 40 % sequence identity to 
the ADE from group 1. There are 32 sequences in group 2 from closely related bacillus 
species and there are at least 12 these organisms that have more than 1 ADE (Table 5.1). 
Genomic analysis of the protein sequences in group 2 reveals that these genes are co-
localized in the same operon as ADE that have been previously validated for function 
(20, 21). This suggested that the substrate used by these enzymes was similar to adenine 
and the product of the reaction would be hypoxanthine or something very similar.  
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Sequence similarity network representation of COG1001 obtained at E-
value 10
-80. Groups 1, 4 are ADE, group 3 is IADs and group 5 is enamidases. 
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Table 5.1: Members of group 2 of COG1001 
Organism 
 
Locus tag Gi number 
Bacillus halodurans C-125 
 
Bh0637 15613200 
Bacillus clausii KSM-K16 
 
ABC1075 56962849 
Geobacillus kaustophilus HTA426 
 
GK0271 56418806 
Anoxybacillus flavithermus WK1 
 
Aflv_0242 212638091 
Geobacillus thermodenitrificans NG80 
 
GTNG_0250 138893926 
Bacillus cereus Q1 BCQ_2842 
 
222096502 
Lysinibacillus sphaericus C3-41 
 
Bsph_0221 169825824 
 
Bacillus licheniformis ATCC 14580 
 
BL01492 52079144 
Bacillus amyliquefaciens FZB42 
 
RBAM_006960 154685151 
Bacillus subtilis str. 168 BSU06560 16077724 
 
Bacillus pumilus SAFR-032 
 
BPUM_0617 157691407 
Bacillus cereus ATCC 14579 
 
BC3012 30021127 
Bacillus cereus B4264 BCB_4264_A3029 
 
218233799 
Exiguobacterium sibiricum 255-15 Exig_0459 172056498 
 
Bacillus cereus G9842 BCG9842_B2218 218898088 
 
Bacillus thuringiensis str. Al Hakam BALH_2712 
 
118478348 
Bacillus cereus 03BB102 BCA_3097 225864990 
 
Bacillus cereus E33L BCZK2753 52142489 
 
Bacillus thuringiensis serovar 
konkukian str. 97-27 
 
BT9727_2766 49480044 
 
135 
 
Table 5.1 Continued 
Organism 
 
Locus tag Gi number 
Bacillus anthracis str. ‘Ames 
Ancestor’ 
GBAA3032 47528323 
 
Bacillus anthracis str. Ames BA_3032 30262986 
 
Bacillus anthracis str. Sterne BAS2818 49185824 
 
Bacillus cereus AH820 BCAH820_3026 218904142 
 
Bacillus weihenstephanensis KBAB4 BcerKBAB4_2823 163940762 
 
Oceanobacillus iheyensis HTE831 OB0751 23098206 
 
Picrophilus torridus DSM 9790 PTO1085 48478157 
 
Brevibacillus brevis NBRC 100599 BBR47_06120 226310199 
 
Rubrobacter xylanophilus DSM 9941 
 
 
Rxyl_1744 
 
108804579 
Geobacillus thermodenitrificans 
NG80-2 
 
GTNG_1889 138895539 
 
Geobacillus kaustophilus HTA426 GK1989 56420524 
 
Bacillus cereus AH187 
 
BACH_A3083 217960451 
 
 
Purification and Properties of Bh0637. Wild type Bh0637 over-expressed in E. 
coli and could be purified to homogeneity.  The protein identity was confirmed by N-
terminal amino acid sequencing at the Protein Chemistry Laboratory, Department of 
Biochemistry and Biophysics, Texas A&M University. ICP-MS analysis of Bh0637 
showed the protein had 2 equivalents of Mn2+ per monomer of Bh0637. There was no 
change in the metal content when the iron free expression protocol was used (20). Of the 
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various substrates incubated with Bh0637, a change in absorbance spectrum was 
observed in case of the adenine, N-6-methyladenine, 6-methylmercatopurine and 6-
methyoxypurine .The kinetic constants obtained for the all of these substrates are 
presented in Table 5.2. No change in kinetic constants was seen for the enzyme purified 
using the iron free expression. 
Table 5.2: The kinetic constants for the various substrates for Bh0637. 
Substrate 
 
 
kcat (s
-1) Km (µM) kcat/Km (M
-1s-1) 
 
Adenine 
 
 
4.7 ± 0.2      430 ± 40 (1.1± 0.2) x 104 
N-6-methyladenine 
 
 
135 ± 5 46 ± 4 (2.9 ± 0.2) x 106 
6-methylmercaptopurine 
 
 
5.8 ± 0.3 96 ± 9 (6.1 ± 0.4) x 104 
6-methoxypurine 
 
1.7 ± 0.1 113 ± 17 (1.5 ± 0.1) x 104 
 
Demethylamination of N-6-methyladenine by Bh0637. Bh0637 catalyzed the 
demethylamination of N-6-methyladenine a 100 fold better than the next substrate 
(Scheme 5.1). The resulting products hypoxanthine and methylamine were identified 
when N-6-methyladenine was incubated with Bh0637. Hypoxanthine was identified 
from the change in absorbance spectrum (Figure 5.2) and the spectrum matched that of 
authentic hypoxanthine.  Methylamine was identified using mass spectrometry. A peak 
at 32.1 Da in the ESI mass spectrometry (+)-mode matched the (M+H+) peak expected 
for methylamine (31 Da neutral mass). No products were obtained when N-6-
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methylamine was incubated without Bh0637. Bh0637 has specificity for a methyl group 
at N-6 position of adenine and also used 6-mercaptomethylpurine and 6-methoxypurine. 
The presence of hypoxanthine was detected spectroscopically in both cases. The other 
product methanethiol for 6-mercaptomethylpurine was detected using 5,5’-Dithiobis(2-
nitro-benzoic acid) (DTNB). Methanol from 6-methoxypurine was detected by checking 
for formation of NADH from NAD+ at 340 nm using alcohol dehydrogenase from 
Saccharomyces cerevisiae.  
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Figure 5.2: Absorption spectrum of 100 µM N-6-methyladenine (in red) and 100 µM N-
6-methyladenine + 1 µM Bh0637 (in black) (incubated for 5 minutes at 30oC). 
Demethylaminase activity of NYSGXRC 9208a. NYSGXRC 9208a was identified 
as a protein from Bacillus subtilis (gi: 16077724). It was cloned, expressed and purified 
by the protein production team at NYSGXRC. Like Bh0637, it lies in group 2 in COG 
1001 and has 71 % sequence identity to Bh0637. It also catalyzed the 
demethylamination of N-6-methyladenine with kcat = 151 ± 5 s
-1, Km = 60 ± 6 µM, 
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kcat/Km = (2.5 ± 0.2) x 10
6 M-1s-1. The metal content of this protein was 1.7 ± 0.2 
equivalents of Mn2+ per monomer of protein. 
Preparation and Reconstitution of Apo-Bh0637. Dialysis with 1,10-
phenantholine resulted in enzyme without any metal and a loss of more than 99 % of the 
demethylaminase activity. The resulting apo-enzyme could be reconstituted with Zn2+ 
and Fe2+. After 48 hours the demethylaminase activity was measured. The kinetic 
constants and the measured metal content by ICP-MS for these enzymes are represented 
in Table 5.3. 
Table 5.3: The kinetic constants for the demethylaminase activity for the various metal 
reconstituted forms of Bh0637. 
Metal kcat (s
-1) Km (µM) kcat / Km (M
-1s-1) 
 
(x 106) 
Metal content 
by ICP-MS 
Mn/Mn 
 
135 ± 5 46 ±4 2.9 ± 0.2 2.1 ± 0.2 
Zn/Zn 
 
185 ± 3  73 ± 2 2.5 ± 0.2 1.7 ± 0.2 
Fe/Fe 
 
151 ± 3 40 ± 3 3.8 ± 0.3 2.1 ± 0.1 
 
Redox Sensitivity of Fe/Fe-Bh0637. The Fe/Fe-Bh0637 was exposed to air to 
determine the sensitivity of Fe/Fe-Bh0637 to oxygen. Oxygen oxidized the iron center 
resulting in loss of activity. The loss of demethylaminase activity followed a first order 
exponential decay with rate constants of (0.228 ± 0.007) hour-1 for the loss of kcat and 
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(0.275 ± 0.008) hour-1 for kcat/Km. The loss of activities is shown in figure 5.3. Addition 
of a 100 fold molar excess of hydrogen peroxide to Fe/Fe-Bh0637 resulted in the 
complete loss of the demethylaminase activity. No oxygen evolution was observed as 
was observed in the case of ADE. The resulting metal content of Fe/Fe-Bh0637 treated 
with an excess of hydrogen peroxide was 0.4 enzyme equivalents of iron. No loss of 
activity was observed when the same amount of hydrogen peroxide was added to the 
Mn/Mn-Bh0637. The incubation on the Fe/Fe-Bh0637 treated with excess hydrogen 
peroxide with 2 equivalents of Zn2+, Mn2+ and Fe2+ (anaerobically) resulted in the 
reconstitution of the demethylaminase activity. 
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Figure 5.3: Loss of activity for Fe/Fe-Bh0637 when exposed to air. Aliquots from a 
stock were assayed with varying N-6-methyladenine concentrations with a fixed Bh0637 
concentration (1.5 nM) 
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 Redox Potential of Fe/Fe-Bh0637. The measurement of the redox potential for 
Fe/Fe-Bh0637 was determined using redox active dye, thionine (2 electron acceptor). In 
these titrations, both irons were assumed to be oxidized or reduced in pairs and that the 
ferrous state was the active form of the enzyme for the demethylaminase activity. All the 
titrations were done anaerobically to prevent any air oxidation of Fe/Fe-Bh0637. A 
figure of the titration is represented in figure 5.4. 4.0 ± 0.08 enzyme equivalents of dye 
were required to reduce the demethylaminase activity by 50 % to give the mid-point of 
the redox reaction. Assuming a 50:50 distribution of the di-ferrous and di-ferric forms of 
Bh0637 at this point, the equilibrium values were fit into the modified Nerst equation. 
Given that the value of thionine is +62 ± 2 mV (57), the redox potential for the 
interconversion of the ferrous and ferric forms of Bh0637 was +76 ± 3 mV. The addition 
of 20 fold excess thionine to Mn/Mn-Bh0637 did not inhibit or affect the activity and 
hence the dye must be oxidizing the iron center and not affecting the enzyme otherwise. 
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Figure 5.4: Redox titration for [FeII/FeII-Bh0637] (1 µM) with various enzyme 
equivalents of thionine. 
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DISCUSSION 
 Genomic Context and Sequence analysis for Group 2 of cog 1001. All the 
bacterial species containing the gene that lies in group 2 of cog 1001 are localized with 
the PUR gene cluster. This gene cluster codes for enzymes that form the ribose-purine 
bond, leading to the formation of coumpounds like guanosine, adenosine and inosine and 
are primarily involved in the purine salvage pathway. Authentic ADEs are localized 
within this gene cluster as well. The product of the ADE reaction, hypoxanthine results 
in the formation of inosine by the PUR gene cluster. In case of B. halodurans, the genes 
for ADE (Bh0640) (21) and Bh0637 are co-localized within this gene cluster. This 
indicates that these two enzymes use the same or similar substrate and that the product of 
the reaction catalyzed by both these enzymes must be very similar if not the same. Thus 
we assumed that Bh0637 would have an adenine like substrate and that the product 
would resemble hypoxanthine. A limited number of moieties resemble adenine in nature. 
Hence, a small highly focused library of about 20 compounds resembling adenine was 
generated. 
 Purine and pyrimidine deaminases ADE, adenosine deaminase (ADA), cytosine 
deaminase (CDA) and guanine deaminase (GDA) have two invariant aspartate residues 
at end of strand 8 forming a signature DD motif. The first aspartate is responsible for 
activation of the water for the hydrolytic reaction and also for the protonation of the 
leaving group as well as serving a metal binding residue for the α-metal (7). The 
function of the other aspartate remains unclear. In most of the X-ray structures of ADA, 
the second aspartate residue is in hydrogen bonding distance to the leaving ammonia 
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group. We speculated that this conservation of this DD is responsible for recognition of 
the –NH2 group on the purine or pyrimidine that is deaminated as well as for the 
orientation of the leaving ammonia. The members in group 2 of COG 1001 lack this DD 
motif at the end of strand 8. They have a single conserved aspartate at that position 
followed by a glycine, forming a DG motif. This led us to believe that the substrate for 
Bh0637 might be modified adenine with some modification at position 6.  
 Library for Screening Bh0637. Based on all the genomic context and sequencing 
it seemed that Bh0637 would have adenine like substrate. Hence a library of compounds 
shown in scheme 5.2 was selected with modifications on adenine at various positions. 
Of these adenine is the most common physiological molecule. N-6-methyladenine is 
physiologically prevalent. It accounts for 2.0 % of bacterial adenine. It has a variety of 
functions ranging from protection against restriction enzymes to cell replication and 
viability (88, 89). Adenosine is the ribosylated form of adenine needed for incorporation 
into DNA. 7-methyladenine is another methylated form of adenine found in bacterial 
genomes (97) and functions to protect bacterial genomes against restriction enzymes. 2-
hydroxyadenine (isoguanine) is the most common oxidative product of adenine resulting 
from oxidation from hydroxyl radicals (98). All other compounds are not physiologically 
prevalent but were used as probes to determine whether any of them have any activity 
and those scaffolds could be used to search for relevant physiological counterparts. 
 Substrate screening for Bh0637. Bh0637 showed spectral changes for adenine, 
N-6-methyladenine, 6-methylmercaptopurine and 6-methoxyadenine. Based on the 
kinetic constants obtained, N-6-methyladenine was a 100 fold better than the next best 
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substrate. N-6-methyladenine is a known physiological compound and is considered to 
be prevalent in all bacterial species. We predict this enzyme recycles N-6-methyladenine 
to form hypoxanthine which is taken up in the purine salvage pathway to form guanine 
nucleotides from inosine (15). Bh0637 also uses adenine to form hypoxanthine but not at 
the same rate as N-6-methyladenine. The Km for adenine is 10 fold higher than N-6-
methyladenine. Similar results were obtained for the NYSGXRC 9208a, B, subtilis (gi: 
16077724) which lies in the same group 2 in cog 1001. Thus we have 2 examples of 
proteins in that cog with similar substrate profiles and we conclude that N-6-
methyadenine is the natural substrate for the members of this group in cog 1001. 
 Metal Center Analysis. The different metal reconstituted forms of Bh0637 have 
similar activities towards the demethylaminase reaction. ICP-MS confirmed the presence 
of 2 equivalents of respective metal per monomer of Bh0637.  All the different metal 
reconstituted forms have similar demethylaminase activity. Mn/Mn-Bh0637 and Zn/Zn-
Bh0637 are stable under aerobic conditions. However, Fe/Fe-Bh0637 is unstable under 
aerobic conditions. More than 98 % of activity is lost over 12 hours when Fe/Fe-Bh0637 
is exposed to air. Air oxidation of the ferrous form results in an inactive ferric form of 
Bh0637. ICP-MS confirmed no metal lost over this time period, hence the loss of 
activity is only due to oxidation of the iron center. Mn/Mn-Bh0637 and Zn/Zn-Bh0637 
did not any activity over the same time. The use of strong oxidizing agent hydrogen 
peroxide resulted in the complete loss of activity of the Fe/Fe-Bh0637. The rapid 
oxidation of the ferrous form of Bh0637 resulted in the iron being oxidized and falling 
out of the active site. When a milder oxidizing agent like thionine was used, the iron is 
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only oxidized but does not fall out of the active site. This phenomenon was confirmed by 
ICP-MS. Addition of 2 equivalents of Mn, Zn or Fe (ferrous form) to the Fe/Fe-Bh0637 
resulted in complete reconstitution of the demethylaminase activity. This suggests that 
the metal either displaces the remaining ferric iron in the active or occupies the vacant 
active site and results in restoration of activity. Hydrogen peroxide does not damage this 
protein like ADE (20, 21). Lastly, the 2+ oxidation state of the metal is essential for 
catalytic activity.  The redox potential of Fe/Fe-Bh0637 of +76 ± 3 mV is significantly 
lesser than that of ADE (+ 209 mV). This also explains why Fe/Fe-ADE is air stable 
where as Fe/Fe-Bh0637 is easily air oxidized (21). 
 Homology Modeling and Docking of Bh0637. In collaboration with the Sali and 
Shoichet laboratories at the Department of Pharmaceutical Sciences, University of 
California, San Francisco, a homology model of Bh0637 was generated in order to 
ascertain the substrate specificity of Bh0637. The amino acid sequence of Bh0637 was 
first submitted to the PSI-BLAST server in NCBI to identify suitable template structures. 
A comparative model of the three-dimensional structure for Bh0637 was constructed 
based on the crystal structure of adenine deaminase (Atu4426, PDB code: 3NQB) which 
was the only template that produced a significant alignment with an E-value (6·10-20) 
better than the default threshold of 6·10-3.  
      The high-energy intermediate (HEI) library of KEGG molecules was docked to 
all eight comparative models of Bh0637 by DOCK 3.5.54. The model yielding the 
highest enrichment for N-6-methyladenine was selected to represent the binding mode of 
this substrate in Bh0637. A comparison of the binding site in the ligand-free template 
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structure of Atu4426 (PDB: 3NQB) and the binding site in the comparative model of 
Bh0637 is presented in Figure 5.5. In the Bh0637 model, Glu-233 and the six residues 
that coordinate the binuclear metal center (His-88, His-90, Glu-180, His-211, His-232 
and Asp-284) overlap with the aligned residues from the structural template. Several 
residues that likely interact with N-6-methyladenine are not conserved between the target 
and the template enzymes. Ser-97, His-122, Glu-123, Asp-290 and Gly-563 in Atu4426 
are replaced by Phe-92, Leu-117, Met-118, Gly-285 and Phe-550 in Bh0637, 
respectively. The substrate binding site of Bh0637 is thus more hydrophobic than that of 
Atu4426. A binding model for N-6-methyladenine in the active site of Bh0637 is 
presented in Figure 5.5. The tetrahedral intermediate was formed by attack of the 
bridging hydroxide on the C-6 carbon from the re-face of N-6-methyladenine. In this 
model, the N6 amino group hydrogen bonds with the side chain of Asp-284. The 
protonated N1 nitrogen hydrogen bonds with the side chain of Glu-233. In addition, the 
N7 nitrogen coordinates the -metal ion and the N9 nitrogen hydrogen bonds with the 
side chain of Thr-467. The N3 nitrogen is adjacent to the N nitrogen from His-555 (3.9 
Å), which was protonated during virtual screening. The methyl group of the substrate is 
not in close contact with any of the neighboring residues. However, if Gly-285 is 
replaced by a larger residue, such as the aspartate found at the equivalent position in 
Atu4426, the methyl group of the substrate will be within 4 Å of the side chain of the 
larger residue.    
      Besides N6-methyladenine, the top ranked compounds that were attacked by the 
hydroxide from the re-face were inspected visually. The docked pose of adenine is 
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nearly identical to that of N-6-methyladenine, but the relative rank of adenine (ranked 
282) is worse than that of N-6-methyladenine (ranked 176). The better ranking of N-6-
methyladenine over adenine is due to the more favorable van der Waals interactions 
between the methyl group in N-6-methyladenine and the hydrophobic residues in the 
substrate binding site, such as Phe-92 and Phe-550. As a consequence, the high-energy 
intermediate complex of N-6-methyladenine is more stable than that of adenine.  5 other 
compounds that scored well in computational docking were subsequently tested as 
substrates but found not to be deaminated at measureable rates. These compounds 
included 5-amino-4-imidazolecarboxyamide, toxopyrimidine, 5-acetylamino-6-amino-3-
methyluracil, 2-hydroxy-4-amino-6-(cyclopropylamino)-1,3,5-triazine, and 
deisopropylhydroxyatrazine. 
Physiological Relevance. For Bh0637 and Bsu06560, N-6-methyladenine is a 
100-fold better substrate than the next best compound based on the relative values of 
kcat/Km. N-6-methyladenine is a known physiological compound and is considered to be 
prevalent in all bacterial species.  Bh0637 and Bsu06560 thus recycle N-6-
methyladenine to form hypoxanthine, which is presumably taken up by the purine 
salvage pathway to subsequently form guanine nucleotides from inosine (15). These two 
enzymes can also use adenine to form hypoxanthine, but not nearly at the same rate as 
N-6-methyladenine.  The Km for adenine is 10-fold higher than for N-6-methyladenine. 
We conclude that N-6-methyadenine is the physiological substrate for members of 
subgroup 2 in cog1001 and thus these enzymes should now be annotated as 6-
methyladenine deaminases (6-MAD).  The prototypical adenine deaminases in B. 
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halodurans (Bh0640) and B. subtilus (Bsu14520) cannot use N-6-methyladenine as 
substrate (20, 21).  The kinetic constants for the deamination of adenine by Bh0640 are 
120 ± 4 s-1, 0.30 ± 0.04 mM and (4 ± 0.3) x 105 M-1 s-1 for kcat, Km and kcat/Km 
respectively.  The kinetic constants for the deamination of adenine by Bsu14520 are 140 
± 6 s-1, 0.38 ± 0.04 mM and (3.8 ± 0.3) x 105 M-1 s-1 for kcat, Km and kcat/Km respectively 
(21).   
        
 
 
 
 
 
 
 
Figure 5.5: Model of transition state into active site of Bh0637.  
The predicted binding pose of the high energy intermediate for the deamination 
of N-6-methyladenine in the modeled binding site of Bh0637 (transparent stick 
representation) superposed on the apo-crystal structure of Atu4426 (solid stick 
representation). Polar interactions between N-6-methyladenine and Bh0637 model are 
shown by red dashed lines. The residue numbering for Bh0637 is indicated, with the 
numbers for the corresponding residues in Atu4426 given in parentheses.   
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Strategy for Functional Annotation. It has been estimated that nearly one third of 
the currently sequenced genes have an unknown, uncertain, or incorrect functional 
annotation (2). We have demonstrated that Bh0637 and Bsu06560 catalyze the 
deamination of N-6-methyladenine.  Based on the conservation of residues, we further 
conclude that the rest of the enzymes in group 2 of Figure 5.1 will also catalyze the 
same enzymatic reaction; they are listed in the table 5.1.  The key pieces of information 
that led to the successful experimental annotation of these proteins included the 
following: recognition of adenine deaminase as the closest functional homologue, 
localization of the gene for this enzyme near the operon for purine synthesis, and 
identification of specific residues within the substrate binding site that could 
accommodate larger substituents attached to the N6 nitrogen.  These hints enabled a 
relatively modest compound library to be experimentally validated.  The construction of 
a homology model and the successful docking of N-6-methyl adenine in the active site 
provided the rationale for the preferential deamination of this compound relative to the 
much poorer substrate, adenine.     
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CHAPTER VI 
INTERMEDIATES IN THE TRANSFORMATION OF PHOSPHONATES TO 
PHOSPHATE BY BACTERIA* 
 
The reaction mechanism for the enzymatic conversion of methyl phosphonate to 
phosphate and methane in Escherichia coli has eluded researchers over the last three 
decades despite significant genetic and in-vivo studies.  The phn operon governs the C-P 
lyase activity in E. coli. The essential genes within the phn operon are phnGHIJKLM.  
The proteins encoded by phnGHM were over-expressed in E. coli and purified to 
homogeneity using standard protocols.  The proteins encoded by phnIJKL were soluble 
only when expressed as N-terminal fusion proteins with glutathione S-transferase (GST).  
PhnI catalyzes the formation of α-D-ribose-1-methylphosphonate-5-triphosphate 
(RPnTP) from MgATP and methylphosphonate in the presence of PhnG, PhnH, and 
PhnL after in situ cleavage of the GST-tags.  PhnI alone catalyzes the hydrolytic 
cleavage of MgATP to adenine and D-ribose-5-triphosphate.  PhnM catalyzes the 
hydrolysis of α-D-ribose-1-methylphosphonate-5-triphosphate to α-D-ribose-1-
methylphosphonate-5-phosphate (RPnP) and pyrophosphate with attack of water on the 
α-phosphoryl group of the triphosphate moiety of RPnTP.   
 
 
 
*Reprinted with permission from “Intermediates in the transformation of 
phosphonates to phosphate by bacteria” by S. S. Kamat, H. J. Williams and F. M. 
Raushel, Nature 480 (7378), 570-573, 2011. Copyright 2011 Macmillan 
Publishers Limited 
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PhnJ was reconstituted with an iron-sulfur cluster via the anaerobic addition of 
FeSO4, Na2S and Na2S2O4 under strictly anaerobic conditions.  The [Fe4S4]-reconstituted 
PhnJ GST-fusion protein catalyzes the radical cleavage of the phosphorus-carbon bond 
of α-D-ribose-1-methylphosphonate-5-phosphate to α-D-ribose-1,2-cyclic-phosphate-5-
phosphate and methane in the presence of S-adenosyl-L-methionine under strictly 
anaerobic conditions, upon in situ cleavage of the GST-tag. 
INTRODUCTION 
Carbon, nitrogen, oxygen, and phosphorus are essential elements required by all 
living organisms for survival.  Of these elements, phosphorus is incorporated as a 
derivative of phosphate where it is an integral component of nucleic acids, 
carbohydrates, and phospholipids.  Phosphorus has many roles in metabolic pathways 
and cell signaling.  Most organisms have evolved to obtain phosphorus, as phosphate, 
directly from the environment.   However, many gram-negative bacteria, such as 
Escherichia coli, have the capability of utilizing organophosphonates as a nutritional 
source of phosphorus under conditions of phosphate starvation via the cryptic C-P lyase 
activity (32, 33).  Phosphonates are organophosphorus compounds that contain a one C-
P bond.  This bond is chemically inert and hydrolytically stable. Phosphonates are 
ubiquitous and include antibiotics (fosfomycin and phosphonothrixin), herbicides 
(glyphosate) and industrial detergent additives (amino-trimethylene phosphonate).  It is 
estimated that more than 20,000 tons of phosphonates are released annually in the US 
alone from herbicide and detergent wastes (27, 28).  The large quantities of 
151 
 
phosphonates that are being deposited into the environment suggest that there needs to 
be a greater understanding of how these compounds are metabolized and degraded. 
In E. coli the catalytic machinery for the “C-P lyase” activity has been localized 
to the phn gene cluster, which is induced only under conditions of limiting phosphate by 
the global pho regulation system.  This operon consists of 14 genes denoted as 
phnCDEFGHIJKLMNOP.  Genetic and biochemical experiments have demonstrated 
that the phnGHIJKLM genes encode proteins that are essential for the enzymatic 
conversion of phosphonates to phosphate.  The genes phnCDEF encode proteins 
responsible for the binding and/or transport of phosphonates across cell membranes as 
well as regulation and modulation of the C-P lyase activity.  The genes phnNOP encode 
proteins that have auxiliary functions and these three proteins have been functionally 
characterized (27-28, 32-33, 100).  Wanner, Hove-Jensen and co-workers have shown 
that PhnN catalyzes the ATP-dependent phosphorylation of α-D-ribose-1,5-bisphosphate 
(PRbP) to α-D-ribose-1-pyrophosphate-5-phosphate (PRPP) (101).   Blanchard and co-
workers have shown that PhnO catalyzes the metal-dependent acetylation of 
aminoalkylphosphonic acids with acetyl CoA as the co-substrate (102).  Zechel, Hove-
Jensen and co-workers have shown that PhnP catalyzes the metal-dependent hydrolysis 
of α-D-ribose-1,2-cyclic phosphate-5-phosphate (PRcP) to PRbP (103).  These reactions 
are summarized in Scheme 6.1. At the start of our investigation there were no functional 
annotations for any of the seven proteins considered essential for C-P bond cleavage 
despite three decades of research on this pathway.  The primary difficulty in elucidating 
the reactions catalyzed by these enzymes has been the extremely poor solubility of the 
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essential proteins when removed from the cellular environment.  The protein encoded by 
phnH was the only protein to have been reported as soluble.  This protein has been 
crystallized and the three-dimensional structure (PDB id: 3fsu) has been solved (104). 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6.1: Reactions catalyzed by PhnO, PhnP and PhnN. 
In E. coli methyl phosphonate is converted to phosphate and methane as shown 
in Scheme 6.2 via the C-P lyase pathway.  This transformation is the equivalent to the 
addition of water during the cleavage of the carbon-phosphorus bond, but an enzymatic 
mechanism for the conversion of unactivated phosphonates to phosphate is unknown.   
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Scheme 6.2: Conversion of methyl phosphonate to phosphate and methane by the C-P 
lyase reaction. 
Despite computational and ligand binding studies, no clues were available that 
would have provided hints of the catalytic role of PhnH in the C-P lyase pathway.  PhnM 
was predicted to be a hydrophobic protein and this has led to the speculation that the 
phnGHIJKLM gene products form a membrane-associated enzyme complex that 
functions collectively to catalyze C-P bond cleavage.  Zechel, Hove-Jensen and co-
workers recently purified the gene products from the expression of the genes phnGHIJK 
as a soluble multi-protein complex (32, 105).  Walsh, Floss and co-workers have shown 
that C-P bond cleavage occurs with racemization of stereochemistry at the carbon center.  
This result suggests that the bond cleavage reaction proceeds via a radical-based 
mechanism (106) (Scheme 6.3).  Frost and co-workers isolated α-D-ribose-1-
ethylphosphonate from the extracellular medium after providing ethylphosphonate to E. 
coli as the sole phosphorus source (107, 108).  This transformation is illustrated in 
Scheme 6.4. Based on the functional annotations to the auxillary proteins (PhnNOP), 
and the previous literature available on the C-P lyase complex in E. coli, there were three 
conclusions that could be drawn at the start of this investigation: (a) there is a ribose 
donor/intermediate involved in the pathway for the metabolism of phosphonates (b) the 
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chemistry on this pathway is initiated at the C-1 position of the ribose moiety and (c) the 
C-P bond breaks via a radical mechanism.  Sequence analysis of PhnI indicated a weak 
similarity to purine and pyrimidine nucleosidases at very relaxed expectation values 
when BLASTED using the NCBI protein database.  PhnJ has four conserved cysteine 
residues at the C-terminal end of the protein with a highly conserved spacing between 
the four cysteine residues.  The conserved cluster of cysteine residues is suggestive of a 
metal binding site and a high probability of an iron-sulfur cluster (109).  PhnM is a 
member of the amidohydrolase superfamily (AHS) and is found within COG3454 of the 
Cluster of Orthologous Groups (COG) of proteins.  Enzymes within this superfamily of 
proteins catalyze hydrolysis reactions at carbon and phosphorus centers using a mono- or 
binuclear metal center (7).  PhnK and PhnL were predicted to be ATP-binding proteins 
of unknown function and perhaps function as permeases (110).   
 
 
 
Scheme 6.3: Racemization of the stereochemistry at the carbon center by the CP lyase 
reaction. 
 
Scheme 6.4: Formation of α-D-ribose-1-ethylphosphonate in E. coli from 
ethylphosphonate. 
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Therefore, the preliminary bioinformatic and sequence analysis yielded hints for 
three probable reactions for the metabolism of organophosphonates: (a) a nucleosidase-
type reaction catalyzed by PhnI – presumably involving the synthesis of aphosphonate-
ribose adduct; (b) a hydrolytic reaction catalyzed by PhnM; and (c) a radical-based 
reaction for the cleavage of the C-P bond catalyzed by PhnJ that would require an iron-
sulfur cluster (99). 
MATERIALS AND METHODS 
Materials.  All chemicals were purchased from Sigma-Aldrich unless otherwise 
stated.  The genomic DNA for E. coli str. K12 substr. MG1655 was purified from XL1-
blue competent cells (Strategene, Agilent).  E. coli BL21 (DE3), XL1-blue competent 
cells and Pfu Turbo polymerase were purchased from Stratagene (Agilent).   The 
expression vectors, pET28b(+), pET30a(+) and pET42a(+) were purchased from 
Novagen (EMD chemicals).  pET42a(+) vector contains a GST-tag for enhancing 
protein solubility and ease of purification. Pfx Platinum was purchased from Invitrogen. 
Green Go Taq was purchased from Promega. All oligonucleotides were purchased from 
the Integrated DNA Technologies (IDT) from the Gene Technology Lab at Texas A&M 
University (GTL-TAMU). 
Cloning of phnG from Escherichia coli K12 MG1655.  The DNA sequence for 
phnG from E. coli K12 MG1655 was cloned (gi|16131927).  The gene for phnG was 
amplified utilizing the primer pair 5’-
AAAAAAGGATCCATGCACGCAGATACCGCGACCCGCCAGCA-3’ and 5’-
AGAAGAAAGCTTTCATGCGTTGTCTCCGCGAACCATCGTAAAGAAGTCCGA-
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3’ using Pfu Turbo as described by manufacturer.  BamHI and HindIII restriction sites 
were introduced into the forward and the reverse primers, respectively.  The PCR 
product was purified with a PCR cleanup system (Qiagen), digested with BamHI and 
HindIII, and ligated into a pET30a(+) vector which was previously digested with BamHI 
and HindIII.  phnG was cloned into pET30a(+) and pET42a(+) vectors. 
Protein Expression and Purification of PhnG.  Preliminary solubility 
experiments indicated PhnG was soluble with an N-terminal poly-histidine tag 
(pET30a(+) vector) and hence this clone was used for the remaining studies with PhnG. 
The recombinant plasmid bearing the gene for phnG was transformed into E. coli BL21 
(DE3) competent cells by electroporation.  A single colony was grown overnight at 37 
oC in 5 mL of LB medium containing 50 µg/mL kanamycin.  Five mL aliquots were 
used to inoculate 3 L of the same medium.  The cell cultures were grown at 37 oC until 
the A600 reached ~ 0.3 - 0.4.  The temperature was reduced to 18 
oC and the culture was 
induced with 0.5 mM isopropyl-β-thiogalactoside (IPTG) when the A600 reached ~ 0.6.  
The cells were harvested by centrifugation 18 - 21 hours after induction.  The cells were 
resuspended in 50 mM HEPES, 150 mM NaCl and 20 mM imidazole at pH 8.5 (binding 
buffer), containing 0.1 mg/mL PMSF and lysed by sonication.  The soluble proteins 
were separated from the cell debris by centrifugation at 12000 x g for 15 minutes at 4 oC.  
The nucleic acids were removed by dropwise addition of 2% w/v protamine sulfate 
dissolved in the binding buffer.  After centrifugation, the supernatant solution was 
applied to a HisTrap column (GE Healthcare 5 mL) previously equilibrated with the 
binding buffer.  The protein was eluted by applying a gradient of 50 mM HEPES, 150 
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mM NaCl and 1 M imidazole at pH 8.5 (Elution buffer).  The fractions were analyzed 
for purity by SDS-PAGE. The appropriate fractions were pooled and dialyzed at 4 oC 
with 50 mM HEPES, 150 mM NaCl at pH 8.5.  The protein was concentrated using a 10 
kDa ultra-filtration membrane (Amicon) by centrifugation.  Typical yields for PhnG 
were 15 – 20 mg PhnG / L of LB media (~ 4 gm of cells/L of LB media). 
Cloning of phnH from Escherichia coli K12 MG1655.  The DNA sequence for 
phnH from E. coli K12 MG1655 was cloned (gi|16131926).  The gene for phnH was 
amplified utilizing the primer pair 5’-
AAAGAGAATCATATGACCCTGGAAACCGCTTTTATGCTTCCCGTG-3’ and 5’-
AGAAGAAAGCTTTCAGCACACCTCCACATGAGTGGTTCGCGG-3’ using Pfx 
Platinum.  NdeI and HindIII restriction sites were introduced into the forward and the 
reverse primers, respectively.  The PCR product was purified with a PCR cleanup 
system (Promega), digested with NdeI and HindIII, and ligated into a pET28b(+) vector 
which was previously digested with NdeI and HindIII.   
 Expression and Purification of PhnH.  The recombinant plasmid bearing the 
gene for phnH was transformed into E. coli BL21 (DE3) competent cells by 
electroporation.  A single colony was grown overnight at 37 oC in 5 mL of LB medium 
containing 50 µg/mL kanamycin.  Five mL aliquots were used to inoculate 2 L of the 
same medium.  The cell cultures were grown at 37 oC until the A600 reached ~ 0.3 - 0.4.  
The temperature was reduced to 18 oC and induced with 0.5 mM IPTG when the A600 
reached ~ 0.6.  The cells were harvested by centrifugation 18 - 21 hours after induction.  
The cells were resuspended in 50 mM HEPES and 20 mM imidazole at pH 8.0 (binding 
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buffer), containing 0.1 mg/mL PMSF and lysed by sonication.  The soluble proteins 
were separated from the cell debris by centrifugation at 12000 x g for 15 minutes at 4 oC.  
Nucleic acids were removed by dropwise addition of 2% w/v protamine sulfate.  After 
centrifugation, the supernatant solution was applied to a HisTrap column (GE Healthcare 
5 mL) previously equilibrated with the binding buffer.  The protein was eluted by 
applying a gradient of 50 mM HEPES and 1 M imidazole at pH 8.0 (elution buffer). The 
fractions were analyzed for purity by SDS-PAGE. The fractions were pooled and 
dialyzed at 4 oC into 50 mM HEPES at pH 8.0.  The protein was concentrated using a 30 
kDa ultra-filtration membrane (Amicon) by centrifugation.  Typical yields for PhnH 
obtained were 150 – 160 mg PhnH / L of LB media (~ 4 gm of cells/L of LB media). 
Cloning of phnI from Escherichia coli K12 MG1655.  The DNA sequence for 
phnI from E. coli K12 MG1655 was cloned (gi|16131925).  The gene for phnI was 
amplified utilizing the primer pair 5’-
AAAAAAGGATCCATGTACGTTGCCGTGAAAGGGGGCGAGAAG-3’ and 5’-
AGAAGAAAGCTTTTAGCCATGGTTCTGCTCCTGTTGCAGACGTTTGAG-3’ 
using Pfu Turbo.  BamHI and HindIII restriction sites were introduced into the forward 
and the reverse primers, respectively.  The PCR product was purified with a PCR 
cleanup system (Qiagen), digested with BamHI and HindIII, and ligated into a 
pET28b(+) and pET42a(+) vector which was previously digested with BamHI and 
HindIII.   
Protein Expression and Purification of PhnI.  Preliminary studies indicated PhnI 
was insoluble under all conditions expect when expressed as an N-terminal GST-fusion 
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protein. The recombinant plasmid (pET42a(+)) bearing the gene for phnI was 
transformed into E. coli BL21 (DE3) competent cells by electroporation.  A single 
colony was grown overnight at 37 oC in 5 mL of LB medium containing 50 µg/mL 
kanamycin.  Five mL aliquots were used to inoculate 6 L of the same medium.  The cell 
cultures were grown at 37 oC the A600 reached ~ 0.3 - 0.4. The temperature was reduced 
to 18 oC and induced with 0.5 mM IPTG when the A600 reached ~ 0.6.  The cells were 
harvested by centrifugation 18 - 21 hours after induction.  The cells were resuspended in 
100 mM HEPES, 0.5 M NaCl, 10% glycerol (v/v), 1 mM dithiothreitol (DTT) and 1 mM 
EDTA at pH 8.8 (binding buffer), containing 0.1 mg/mL PMSF,1 µL of protease 
inhibitor cocktail (Sigma P8340)/mL and 0.4 mg deoxyribonuclease I (Sigma 
DN25)/mL.  The cells were lysed by sonication.  The soluble proteins were separated 
from the cell debris by centrifugation at 12000 x g for 10 minutes at 4 oC.  After 
centrifugation, the supernatant solution was applied to a GSTrap column (GE Healthcare 
5 mL) previously equilibrated with the binding buffer.  The protein was eluted by 
applying a gradient of 100 mM HEPES, 0.5 M NaCl, 10% glycerol (v/v), 1 mM DTT, 1 
mM EDTA and  10 mM reduced glutathione at pH 8.8  (elution buffer).  The fractions 
were analyzed for purity by SDS-PAGE, pooled and concentrated using a 30 kDa ultra-
filtration membrane (Amicon) by centrifugation.  Typical yields for PhnI obtained were 
1 – 1.5 mg PhnI / L of LB media (~ 4 gm of cells/L of LB media). 
Cloning of phnJ from Escherichia coli K12 MG1655.  The DNA sequence for 
phnJ from E. coli K12 MG1655 was cloned (gi|16131924).  The gene for phnJ was 
amplified utilizing the primer pair 5’-
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AAAAAAGGATCCATGGCTAATCTGAGCGGCTACAACTTTGCCTAC-3’ and 5’-
AGAAGAAAGCTTTCATTGGTTTTTTGCCTCGCTCTGTTGGCGG-3’ using Pfu 
Turbo.  BamHI and HindIII restriction sites were introduced into the forward and the 
reverse primers, respectively.  The PCR product was purified with a PCR cleanup 
system (Qiagen), digested with BamHI and HindIII, and ligated into a pET28b(+) and 
pET42a(+) vector which was previously digested with BamHI and HindIII.   
Protein Expression and Purification of PhnJ.  Preliminary studies indicated PhnJ 
was insoluble under all conditions expect when expressed as an N-terminal GST-fusion 
protein. The recombinant plasmid (pET42a(+)) bearing the gene for phnJ was 
transformed into E. coli BL21 (DE3) competent cells by electroporation.  A single 
colony was grown overnight at 37 oC in 5 mL of LB medium containing 50 µg/mL 
kanamycin.  Five mL aliquots were used to inoculate 6 L of the same medium.  The cell 
cultures were grown at 37 oC the A600 reached ~ 0.3 - 0.4. The temperature was reduced 
to 18 oC and induced with 0.5 mM IPTG when the A600 reached ~ 0.6.  The cells were 
harvested by centrifugation 18 - 20 hours after induction. The cells were resuspended in 
100 mM HEPES, 0.5 M NaCl, 10% glycerol (v/v) and 1 mM EDTA at pH 8.8 (binding 
buffer), containing 0.1 mg/mL PMSF, 1 µL of protease inhibitor cocktail (Sigma 
P8340)/mL and 0.4 mg deoxyribonuclease I (Sigma DN25)/mL. The cells were lysed by 
sonication.  The soluble proteins were separated from the cell debris by centrifugation at 
12000 x g for 10 minutes at 4 oC.  After centrifugation, the supernatant solution was 
applied to a GSTrap column (GE Healthcare 5 mL) previously equilibrated with the 
binding buffer.  The protein was eluted by applying a gradient of 100 mM HEPES, 0.5 
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M NaCl, 10% glycerol (v/v), 1 mM EDTA and  10 mM reduced glutathione at pH 8.8  
(elution buffer).  The fractions were analyzed for purity by SDS-PAGE. The fractions 
were pooled and concentrated using a 30 kDa ultra-filtration membrane (Amicon) by 
centrifugation.  Typical yields for PhnJ obtained were 2 – 2.5 mg PhnJ / L of LB media 
(~ 4 gm of cells/L of LB media). 
Chemical Reconstitution of PhnJ.  EDTA was added to the purification buffers to 
remove all adventitious Fe bound to PhnJ. PhnJ eluted from the GSTrap column (6 – 8 
mg from 12 gm cells from 3 L LB media) was introduced into an anaerobic chamber 
(MBraun Lab Master SP glovebox , Barondeau Laboratory, Texas A&M University).  
Argon was bubbled through the PhnJ solution for an hour to remove most of the oxygen 
from the solution.  The PhnJ solution was concentrated using a 30 kDa ultra-filtration 
membrane (VWR chemicals) to 100 – 150 µM depending on the protein yield.  To this 
concentrated PhnJ solution, 5 mM ferrous sulfate was added dropwise over an hour (50 
fold excess). The mixture of PhnJ and Fe2+ was allowed to react for 3 hours.  5 mM 
sodium sulfide was added to the mixture of PhnJ and Fe2+ dropwise over an hour (50 
fold excess).  The mixture was allowed to react for another 3 hours. The insoluble 
ferrous sulfide was removed from the protein reconstituted with the [4Fe-4S]-cluster by 
centrifugation.  The unreacted iron and sulfide was further separated from the protein by 
ultra-filtration using a 30 kDa membrane (VWR chemicals).  1 mM sodium dithionite 
was added to the resulting protein to reduce the [4Fe-4S]-cluster to the active [4Fe-4S]+ 
form from the [4Fe-4S]2+ form.  PhnJ was further concentrated to 150 – 200 µM (600 – 
800 µL) using a 30 kDa ultra-filtration, to separate any residual sodium dithionite.  The 
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chemical reconstitution of the [4Fe-4S]-cluster of PhnJ was possible without interference 
from the N-terminal GST-fusion solubility tag. 
Cloning of phnK from Escherichia coli K12.  The DNA sequence for phnK from 
E. coli K12 was cloned (gi|16131923).  The gene for phnK was amplified utilizing the 
primer pair 5’-
AAAAAAGGATCCATGAATCAACCGTTACTTTCGGTCAATAACCTGACCACCT
TTACGCG-3’ and 5’-
AGAAGAAAGCTTTCAATTCTGCAAAACCGATGACACCAGCAGCTGTGTATAC
GGA-3’ using Pfu Turbo.  BamHI and HindIII restriction sites were introduced into the 
forward and the reverse primers, respectively.  The PCR product was purified with a 
PCR cleanup system (Qiagen), digested with BamHI and HindIII, and ligated into a 
pET30a(+) and pET42a(+) vector which was previously digested with BamHI and 
HindIII.   
Protein Expression and Purification of PhnK.  Preliminary studies indicated 
PhnK was insoluble under all conditions expect when expressed as an N-terminal GST-
fusion protein. The recombinant plasmid (pET42a(+)) bearing the gene for phnK was 
transformed into E. coli BL21 (DE3) competent cells by electroporation.  A single 
colony was grown overnight at 37 oC in 5 mL of LB medium containing 50 µg/mL 
kanamycin.  Five mL aliquots were used to inoculate 6 L of the same medium.  The cell 
cultures were grown at 37 oC until the A600 reached ~ 0.3 - 0.4. The temperature was 
reduced to 18 oC and induced with 0.5 mM IPTG when the A600 reached ~ 0.6.  The cells 
were harvested by centrifugation 18 - 21 hours after induction.  The cells were 
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resuspended in 100 mM HEPES, 0.5 M NaCl, 10% glycerol (v/v) and 1 mM DTT at pH 
8.8 (binding buffer), containing 0.1 mg/mL PMSF and 0.4 mg deoxyribonuclease I 
(Sigma DN25)/mL. The cells were lysed by sonication.  The soluble proteins were 
separated from the cell debris by centrifugation at 12000 x g for 10 minutes at 4 oC.  
After centrifugation, the supernatant solution was applied to a GSTrap column (GE 
Healthcare 5 mL) previously equilibrated with the binding buffer.  The protein was 
eluted by applying a gradient of 100 mM HEPES, 0.5 M NaCl, 10% glycerol (v/v), 1 
mM DTT and 10 mM reduced glutathione at pH 8.8  (elution buffer).  The fractions 
were analyzed for purity by SDS-PAGE gels.  The pure fractions (< 2 % impurities) 
were pooled and concentrated using a 30 kDa ultra-filtration membrane (Amicon) by 
centrifugation.  Typical yields for PhnK obtained were 1 – 1.5 mg PhnK / L of LB media 
(~ 4 gm of cells/L of LB media). 
Cloning of phnL from Escherichia coli K12.  The DNA sequence for phnL from 
E. coli K12 was cloned (gi|16131922).  The gene for phnL was amplified utilizing the 
primer pair 5’-
AAAAAAGGATCCATGATTAACGTACAAAACGTCAGTAAAACCTTCATCCTGC
ACCAGCAA-3’ and 5’-
AGAAGAAAGCTTTCATGAAGAGGCTCCCATTGGGTGCAGGCGGT-3’ using Pfu 
Turbo.  BamHI and HindIII restriction sites were introduced into the forward and the 
reverse primers, respectively.  The PCR product was purified with a PCR cleanup 
system (Qiagen), digested with BamHI and HindIII, and ligated into a pET30a(+) and 
pET42a(+) vector which was previously digested with BamHI and HindIII.   
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Protein Expression and Purification of PhnL.  The recombinant plasmid 
(pET42a(+)) bearing the gene for phnL was transformed into E. coli BL21 (DE3) 
competent cells by electroporation.  A single colony was grown overnight at 37 oC in 5 
mL of LB medium containing 50 µg/mL kanamycin.  Five mL aliquots were used to 
inoculate 6 L of the same medium.  The cell cultures were grown at 37 oC the A600 
reached ~ 0.3 - 0.4.  The temperature was reduced to 18 oC and induced with 0.5 mM 
IPTG when the A600 reached ~ 0.6.  The cells were harvested by centrifugation 18 - 20 
hours after induction.  The cells were resuspended in 100 mM HEPES, 0.5 M NaCl, 10% 
glycerol (v/v) and 1 mM  DTT at pH 8.5 (Binding buffer), containing 0.1 mg/mL 
phenylmethylsulfonyl fluoride and 0.4 mg deoxyribonuclease I (Sigma DN25)/mL.  The 
cells were lysed by sonication.  The soluble proteins were separated from the cell debris 
by centrifugation at 12000 x g for 10 minutes at 4 oC.  After centrifugation, the 
supernatant solution was applied to a GSTrap column (GE Healthcare 5 mL) previously 
equilibrated with the binding buffer.  The protein was eluted by applying a gradient of 
100 mM HEPES, 0.5 M NaCl, 10% glycerol (v/v), 1 mM DTT and 10 mM reduced 
glutathione at pH 8.5  (elution buffer).  The fractions were analyzed for purity by SDS-
PAGE gels. The fractions were pooled and concentrated using a 30 kDa ultra-filtration 
membrane (Amicon) by centrifugation. Typical yields for PhnL obtained were 8 – 10 mg 
PhnL / L of LB media (~ 4 gm of cells/L of LB media). 
Cloning of phnM from Escherichia coli K12.  The DNA sequence for phnM from 
E. coli K12 was cloned (gi|16131921).  The gene for phnM was amplified utilizing the 
primer pair 5’-GGGACTTCCATATGATTATCAATAACGTTAAGCTGGTGCTGG-3’ 
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and 5’-CCGGAATTCTCAGAACACCCTTTTACCCTGACG-3’ using Pfx Platinum.  
NdeI and EcoRI restriction sites were introduced into the forward and the reverse 
primers, respectively.  The PCR product was purified with a PCR cleanup system 
(Promega), digested with NdeI and EcoRI, and ligated into a pET30a(+) vector which 
was previously digested with NdeI and EcoRI.  
Protein Expression and Purification of PhnM. Preliminary studies indicated 
PhnM was insoluble under all conditions expect when the pH of the buffer exceeded 8.8. 
The recombinant plasmid bearing the gene for phnM was transformed into E. coli BL21 
(DE3) competent cells by electroporation.  A single colony was grown overnight at 37 
oC in 5 mL of LB medium containing 50 µg/mL kanamycin.  Five mL aliquots were 
used to inoculate 6 L of the same medium.  The cell cultures were grown at 37 oC the 
A600 reached ~ 0.3 - 0.4. The temperature was reduced to 18 
oC and induced with 0.5 
mM IPTG when the A600 reached ~ 0.6 in the presence of 1.0 mM ZnCl2.  The cells were 
harvested by centrifugation 18 - 20 hours after induction.  Protein expression was 
confirmed by SDS-PAGE.  The cells were centrifuged and then resuspended in 100 mM 
HEPES, 1 mM ZnCl2 at pH 8.8 (purification buffer), containing 0.1 mg/mL PMSF and 
lysed by sonication.   The soluble proteins were separated from the cell debris by 
centrifugation at 12,000 x g for 15 minutes at 4 oC.   The nucleic acids were removed by 
dropwise addition of 2% w/v protamine sulfate.   After centrifugation, solid ammonium 
sulfate was added to 60% saturation to the supernatant solution.   The precipitated 
protein was dissolved in purification buffer and then applied to a High Load 26/60 
Superdex 200 prep grade gel filtration column (GE Healthcare), which was previously 
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equilibrated with the purification buffer.   The fractions were pooled and loaded onto a 
ResourceQ column 6 mL (GE Healthcare) and eluted with a gradient of NaCl (0 – 1M) 
in 50 mM HEPES, pH 8.8.   The fractions were pooled and exchanged into 100 mM 
HEPES, 1 mM ZnCl2 at pH 8.8. Typical yields for PhnM were 4 - 5 mg / L of LB media 
(~ 4 gm of cells/L of LB media). 
Nucleosidase Reaction. To establish the substrate profile for PhnI, a library of 
nucleosides and nucleotides was initially developed. The compounds were incubated 
with 10 µM PhnI in 100 mM HEPES buffer containing 250 mM NaCl and 10 % v/v 
glycerol at pH 8.5 for 6 hours.  At the end of 6 hours, coupling enzymes capable of 
deaminating the free base released from the respective substrates were added and the 
UV-vis spectrum was observed from 240 – 350 nm using a SpectraMax-340 UV-vis 
spectrometer in a 1.0 mL quartz cuvette.  For inosine containing compounds 50 units of 
xanthine oxidase (Sigma) was added and the spectrum was collected. 
After initial spectroscopic screening, 10 µM PhnI was incubated with 2 mM 
adenine and guanine nucleoside di- and tri-phosphates overnight in the presence of 3 
mM Mg2+ in 100 mM HEPES buffer containing 250 mM NaCl and 10 % v/v glycerol at 
pH 8.5 at 30 oC.  The reactions with ATP and GTP were analyzed by HPLC.  0.25 mL of 
the reaction mixture was loaded onto a ResourceQ column 1 mL (GE Healthcare) pre-
equilibrated with 25 mM HEPES pH 8.0. The reaction mixture was eluted with a 0-1 M 
NaCl gradient over 10 column volumes using an AKTA 10 Basic FPLC system.  The 
ResourceQ column was caliberated with adenine and ATP or guanine and GTP 
standards prior to loading the reaction to determine the reaction products.  In order to 
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establish the products of the enzyme mixture the same reaction was carried out using 10 
µM PhnI, 20 µM PhnL, 40 µM PhnG and 40 µM PhnH for 5 mM ATP or GTP in the 
presence of 7 mM Mg2+ under the  same conditions. 
Nucleosidase Kinetics.  All kinetic assays were carried out in 50 mM HEPES 
buffer pH 8.5 at 30 oC in the presence of 1.0 mM Mg2+ using a SpectraMax-340 UV-vis 
spectrometer using a 96 well quartz plate.  The nucleosidase activity of PhnI with ATP 
and ADP were measured by coupling the nucleosidase activity to the deamination of the 
released free base with adenine deaminase (ADE) from E. coli (20).  In the assay, the 
ATP concentrations were varied from 0 – 300 µM and ADP concentrations were varied 
from 0 – 350 µM.  In the assay, the final PhnI concentration was 0.5 µM for kinetic 
assays with ATP and 1.0 µM for kinetic assays with ADP.  The final ADE concentration 
in the assay was 10.0 µM.  To test the kinetics of PhnI in the presence of PhnG, PhnH 
and PhnL with Factor Xa the following concentrations were used: PhnI = 0.1 µM, PhnG 
= 0.4 µM, PhnH = 0.4 µM, PhnL = 0.2 µM and Factor Xa = 10 units.  In this kinetic 
assay the methylphosphonate and Mg2+ concentrations were constant at 1 and 2 mM 
respectively.  All the kinetics of the ADE coupled assays were measured at 260 nm 
using a differential extinction coefficient of 4100 M-1cm-1 for the decrease in adenine 
concentration forming hypoxanthine. 
The nucleosidase activity of PhnI with GTP and GDP was measured by coupling 
the nucleosidase activity to the deamination of the released free base guanine by guanine 
deaminase (guaD) from E. coli (111).  In the assay, GTP concentrations were varied 
from 0 – 300 µM and GDP concentrations were varied from 0 – 300 µM.  In the assay, 
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the final PhnI concentration was 0.1 µM for kinetic assays with GTP and 0.5 µM for 
kinetic assays with GDP.  The final guaD concentration in the assay was 15.0 µM.  To 
test the kinetics of PhnI in the presence of PhnG, PhnH and PhnL in the presence of 
Factor Xa the following concentrations were used: PhnI = 0.1 µM, PhnG = 0.4 µM, 
PhnH = 0.4 µM, PhnL = 0.2 µM and Factor Xa = 10 units.  In this kinetic assay the 
methylphosphonate and Mg2+ concentrations were constant at 1 and 2 mM respectively.  
All of the guaD coupled assays were measured at 253 nm using a differential extinction 
coefficient of 3920 M-1cm-1 for the decrease in guanine concentration forming xanthine 
(112). 
The nucleosidase activity of PhnI with ITP and IDP was measured by coupling 
the nucleosidase activity to the oxidation of the released free base hypoxanthine to uric 
acid by xanthine oxidase from bovine milk (Sigma).  In the assay, ITP concentrations 
were varied from 0 – 300 µM and IDP concentrations were varied from 0 – 300 µM.  In 
the assay, the final PhnI concentration was 0.5 µM for kinetic assays with ITP and 1.2 
µM for kinetic assays with IDP. The final xanthine oxidase was 50 units per assay as 
described in Sigma catalog.  All the kinetics of the xanthine oxidase coupled assays were 
measured at 293 nm using an extinction coefficient of 12600 M-1cm-1 for the increase in 
uric acid concentration (113). 
Purification of D-ribose-5-triphosphate (RTP) and α-D-ribose-1-
methylphosphonate-5-triphosphate (RPnTP). The ResourceQ column (GE Healthcare) 
was pre-calibrated for the elution profiles of adenine, AMP, ADP and ATP to determine 
the volumes of elution of each.  Baseline separations were obtained for adenine, AMP, 
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ADP and ATP.  The binding buffer for these separations included ammonium 
bicarbonate (100 mM) pH 8.5 and the elution buffer was 1 M ammonium bicarbonate 
pH 8.5. The gradient was run over 10 column volumes.  Since both D-ribose-5-
triphosphate (RTP) and α-D-ribose-1-methylphosphonate-5-triphosphate (RPnTP) do not 
have any chromophore to check absorbance, these elution volumes were used as 
standards to collect fractions.  
The enzymatic synthesis of D-ribose-5-triphosphate (RTP) was carried out by 
incubating 15 µM PhnI with 5 mM ATP and 7 mM Mg2+ to a total volume of 1.0 mL for 
5 hours in 50 mM HEPES buffer containing 250 mM NaCl and 10 % v/v glycerol at pH 
8.5. 0.5 mL of the reaction mixture was loaded onto the ResourceQ column (two times) 
and the fractions corresponding to the elution volumes of ATP were collected.  The 
solvent was evaporated using a SpeedVac Concentrator (Savant) for about 6 hours. The 
final yields varied from 1.5 – 2.0 mg. The resulting solid was white in color and was 
stored at – 20 oC.  D-ribose-5-diphosphate (RDP) was enzymatically synthesized by the 
reaction of PhnI with ADP. All concentrations were the same except that ADP was used 
in place of ATP.  The purification was also the same except that the fractions eluting 
around ADP were collected instead of the fractions eluting around ATP from the 
ResourceQ column. The final yields were also the same. 
The enzymatic synthesis of α-D-ribose-1-methylphosphonate-5-triphosphate 
(RPnTP) was carried out by incubating 10 µM PhnI, 20 µM PhnL, 40 µM PhnG, 40 µM 
PhnH, 50 units Factor Xa, 1X Factor Xa buffer, 5 mM methylphosphonate, 5 mM ATP 
and 7 mM Mg2+ in 50 mM HEPES buffer containing 250 mM NaCl and 10 % v/v 
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glycerol at pH 8.5 in a total volume of 1.5 mL.  0.5 mL of the reaction mixture was 
loaded onto the ResourceQ column and all fractions eluting after the elution volumes of 
ATP were collected.  The solvent was evaporated using a SpeedVac Concentrator 
(Savant).  The final yields obtained varied from 1.8 – 2.2 mg. The resulting solid was 
white in color and was stored at – 20 oC.  
PhnM Kinetics.  All PhnM assays were performed using a Pi Colorlock (Gold) 
phosphate detection colorimetric system from Innova Biosciences according to the 
manufacturer’s instructions.  Since all reactions were performed in 50 mM HEPES 
containing 5 mM Mg2+, 1 mM Zn2+ and 5 units of inorganic pyrophosphatase from 
Baker’s yeast (Sigma) at pH 8.5, a calibration curve was made with this standard assay 
condition to account for any background phosphate in the assay.  All kinetic data was fit 
to standard Michaelis-Menten kinetics. 
 PhnM was shown to cleave the phosphodiester bond of α and β- phosphoryl 
groups of the triphosphate moiety of the putative substrates releasing pyrophosphate for 
a triphosphate substrate and phosphate for a diphosphate substrate.  For the kinetics with 
RTP, the RTP concentration in the assay was varied from 0 – 500 µM.  The PhnM 
concentration in the assay was 10 nM . For the kinetics of RPnTP, the concentration of 
RPnTP was varied from 0 – 750 µM, with a fixed PhnM concentration of 10 nM.  For 
both of these assays, end points for the kinetic assays were collected at 0, 3, 6, 9 and 12 
minutes.  Inorganic pyrophosphatase was added as a coupling enzyme to the assay to 
convert the pyrophosphate released from the substrate to phosphate to allow detection by 
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the Pi ColorLock (Gold) kit.  For RDP, the concentration of RDP was varied from 0 – 1 
mM, with the PhnM concentration being 1.0 µM in the assay.  
Purification of α-D-ribose-1-methylphosphonate-5-phosphate.  The enzymatic 
synthesis of α-D-ribose-1-methylphosphonate-5-phosphate was performed by incubating 
5 mM RPnTP with 10 µM PhnM, 5 mM Mg2+ and 1 mM Zn2+ in 50 mM HEPES pH 8.5.  
The reaction was monitored by quantifying the phosphate produced after adding 
inorganic pyrophosphatase from Baker’s yeast to the reaction over time in conjunction 
with 31P NMR. The reaction of PhnM with RPnTP was allowed to incubate at 30 oC for 
about 5 hours for complete turnover.  Zinc supplementation was essential for complete 
turnover of RPnTP. The reaction was filtered through a 10 kDa ultra-filtration membrane 
(VWR Chemicals) to remove the enzymes from the mixture.  At the end of the filtration 
the flow through was a mixture of α-D-ribose-1-methylphosphonate-5-phosphate and 
pyrophosphate containing 5 mM Mg2+ and 1 mM Zn2+ in 50 mM HEPES pH 8.5.  31P 
NMR was used to confirm the relative ratios of α-D-ribose-1-methylphosphonate-5-
phosphate and pyrophosphate.  The α-D-ribose-1-methylphosphonate-5-phosphate 
purified using this protocol was used as a substrate for all assays with PhnJ. 
Enzymatic assays with PhnJ.  All enzymatic assays with PhnJ were carried out in 
a glove box (MBraun Lab Master SP, Barondeau Laboratory, Texas A&M University) 
because of the air sensitivity of the iron-sulfur cluster of PhnJ. All buffers were degassed 
for oxygen and introduced into the glove box prior to any assay.  All assays in the glove 
box were carried out at 10 – 12 oC with oxygen concentration less than 5 ppm.  The 
buffer used for all assays with PhnJ was 150 mM HEPES, 500 mM NaCl, 10 % v/v 
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glycerol and 1X Factor Xa reaction buffer at pH 6.8.  All assays contained fixed 
concentrations of 2 mM S-adenosyl-L-methionine (SAM) and 1 mM dithionite.  The 
PhnJ concentrations in the assay varied from 100 – 160 µM (6.5 – 10 mg/mL).  The 
substrate, α-D-ribose-1-methylphosphonate-5-phosphate, concentration in the assay 
varied from 0.5 – 3 mM depending on the nature of the assay.  All the reactions were 
initiated by the addition of 50 units of Factor Xa.  All reactions were allowed to proceed 
for 3 – 5 hours anaerobically.  The reaction volumes were usually 1.0 mL.  At the end of 
the reaction most of the enzyme would have precipitated due to the poor solubility after 
cleaving the GST-tag. The precipitated enzyme was removed by centrifugation.  To the 
supernatant, 2 mg of activated charcoal (Sigma) was added to remove unreacted SAM 
and the products of SAM from the reaction for about 30 minutes.  2 mg of activated 
charcoal was found to be sufficient to remove any SAM and related compounds from 
control reactions performed earlier in the absence of PhnJ.  The activated charcoal was 
removed by centrifugation and the supernatant was filtered through a 10 kDa ultra-
filtration membrane to remove any enzyme that might have remained in solution.  The 
reaction was transferred into a NMR tube anaerobically and the NMR tube was sealed 
anaerobically.  All the reactions were analyzed by 31P NMR (Varian Inova 300 MHz and 
500 MHz) spectroscopy to check for products with help from Dr. Howard J. Williams or 
Dr. Chengfu Xu.  
UV-visible spectrum of PhnJ.  The chemically reconstituted PhnJ (2 mg/mL ~ 31 
µM) was transferred to a 1.0 mL anaerobic cuvette (Precision Cells Inc.) and sealed to 
prevent air from entering the cuvette. The UV-visible absorbance spectrum was 
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collected in a SpectraMax Plus 384 spectrophotometer from 260 – 700 nm.  After the 
spectrum was collected, PhnJ was treated with 1 mM dithionite anaerobically in the 
glove box for 1 hour. The excess dithionite was separated from PhnJ using a PD-10 
column (GE Healthcare).  The PhnJ fractions were collected and concentrated using a 30 
kDa ultra-filtration membrane.  The reduced form of PhnJ (1.7 mg/mL ~ 27 µM) was 
again transferred to the 1.0 mL anaerobic cuvette and the spectrum was collected.  
Gas Chromatography and GC-MS experiments with PhnJ. The samples for the 
GC and GC-MS experiments were prepared anaerobically in a glove box.  For the GC 
experiment the concentration of the reconstituted PhnJ was 150 µM.  The enzyme was 
premixed with 2 mM SAM, 1 mM dithionite, 1X Factor Xa buffer, 2 mM α-D-ribose-1-
methylphosphonate-5-phosphate in 150 mM HEPES containing 250 mM NaCl, 10 % v/v 
glycerol at pH 8.5. The reaction volume was 2.3 mL.  The reaction was transferred to a 
NMR tube in the glovebox and the NMR tube was sealed with a self-sealable rubber-cap 
and further sealed using parafilm to prevent any escape of the contents within the tube.  
The reaction was initiated by addition of 50 units of Factor Xa using a 1 ml 27G 3/8 
allergy syringe (BD). The reactions were allowed to proceed for 6 hours at 12 oC.  50 µL 
of the headspace (500 µL) was removed using a gas-tight Hamilton syringe and injected 
into the GC instrument (Hewlett Packard HP 6890 GC system with FID detector and 
manual injection) equipped with a 30 m X 0.32 mm I.D. SGE Solgel 1 column used in 
splitless injection mode, at constant 20 psig He carrier pressure, with a temperature 
program of 50 oC/1 min, to 100 oC @ 10 oC / min.  The same reaction was set up for the 
GC-MS experiment using a Thermo Electron Corporation DSQ quadrulpole GC-MS 
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instrument with Finnigan Trace GC Ultra chromatograph at 70 E.V. EI ionization.  The 
temperature program and injection mode were the same.  The column was a 30 m X 0.25 
mm I.D. SGE BP1 column operated at 1 mL/min constant flow He; with the exception 
that the PhnJ concentration was 160 µM in a final volume of 2.5 mL.  100 µL of the 
headspace was injected into the GC-MS instrument. The GC and GC-MS experiments 
were preformed with Dr. Howard J. Williams, at the Deparment of Entomology (Texas 
A&M University) (GC experiments) and U.S Department of Agriculture (College 
Station) (GC-MS experiments). 
HPLC analysis of the products of SAM.  The HPLC analysis for determining the 
reaction products of SAM with PhnJ was performed on an AKTA Purifier FLPC/HPLC 
system with a C18 column (Cosmosil 5C18-AR-II 4.6x150 mm Nacalai, USA).  All 
reactions were monitored at 260 nm using a linear gradient of 0 – 50 % buffer B over 10 
column volumes over 35 minutes at a flow rate of 1.0 ml/min.  Buffer A was 50 mM 
ammonium acetate pH 5.4 and buffer B was 50 % v/v methanol/water.  The loading 
volume for all the reactions was 250 µL. The C18-column was pre-calibrated with 0.5 
mM SAM, 0.5 mM 5’-deoxyadenosine (5DA) and 0.5 mM 5’-deoxy-5’-
methylthioadenosine (MTA) for the elution profiles of the standards.  
 For the reactions involving PhnJ, the concentrations of the components were: 
PhnJ = 60 µM, SAM = 0.5 mM, dithionite = 1 mM, α-D-ribose-1-methylphosphonate-5-
phosphate = 2 mM in 150 mM HEPES, containing 250 mM NaCl, 10 % v/v glycerol and 
1X Factor-Xa reaction buffer at pH 8.5.  The reaction was initiated by adding 50 units of 
Factor-Xa to the reaction.  The total reaction volume was 1.0 mL.  As controls, in one 
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reaction dithionite was eliminated and in another PhnJ was eliminated.  All the reactions 
were kept anaerobic for 3 hours after which the precipitated enzyme was removed by 
centrifugation.  The reaction was filtered through a 10 kDa ultra-filtration membrane and 
the flow-through was collected.  250 µL of this material was loaded onto the C18-
column and the HPLC traces were collected.   
Amino acid analysis of the products of SAM.  Amino acid analysis of the reaction 
products from SAM in the reaction catalyzed by PhnJ was performed in the Protein 
Chemistry Laboratory, Texas A&M University by Dr. Jinny Johnson using the 
AminoQuant method.  The AminoQuant analyzes the samples by pre-column 
derivatization of the amino acids with o-phthalaldehyde (OPA) and 9-fluoromethyl-
chloroformate (FMOC).  OPA reacts with primary amino acids and FMOC with 
secondary amino acids (proline).  The derivatized amino acids are separated by reverse 
phase HPLC and detected by UV absorbance with a diode array detector or by 
fluorescence using an in-line fluorescence detector. 
For the reactions involving PhnJ, the concentrations of the components were: 
PhnJ = 70 µM, SAM = 2.0 mM, dithionite = 1.0 mM, α-D-ribose-1-methylphosphonate-
5-phosphate = 1.0  mM in 150 mM HEPES, containing 250 mM NaCl, 10 % v/v 
glycerol and 1X Factor Xa reaction buffer at pH 8.5. The reaction was initiated by 
adding 50 units of Factor Xa to the reaction.  The total reaction volume was 1.0 mL.  As 
a control PhnJ was eliminated from the reaction mixture. All the reactions were kept 
anaerobic for 3 hours after which the precipitated enzyme was removed by 
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centrifugation.  The reaction was filtered through a 30 kDa ultra-filtration membrane and 
the flow through was collected. 
Detection of CH3OH in PhnJ Reconstitution Reaction. Alcohol dehydrogenase 
(ADH) from Saccharomyces cerevisiae (Sigma) was used to detect and quantify the 
amount of methanol (if any produced) from the reaction of α-D-ribose-5-phosphate-1-
methylphosphonate [PRPn] with [4Fe-4S]1+ reconstituted PhnJ in the presence of SAM, 
dithionite and Factor-Xa.  A standard calibration curve was generated for the change in 
absorbance at 340 nm using [NAD+] = 2 mM, [ADH] = 0.1 mg/mL and varying 
concentrations of methanol (10 – 100 µM) in 20 mM HEPES buffer pH 7.5 at 30 oC. For 
the PhnJ reaction; [PhnJ] = 150 µM, [SAM] = 2 mM, [dithionite] = 1m M, [PRPn] = 1.5 
mM, 50 units of Factor-Xa in 1X Factor-Xa buffer was used in and the enzyme was 
removed by ultrafiltration through 10 kDa membrane and the unreacted SAM and 5’-
deoxyadenosine were removed by treatment with activated charcoal at the end of the 
reaction. The remaining reaction was incubated with NAD+ and ADH at pH 7.5 and the 
changes in spectrum were measured at 340 nm for 5 hours for 30 oC. The control used 
for this test was all the ingredients except PhnJ. 
Detection of HCHO in PhnJ Reconstitution Reaction. The heterocyclic dye 
Purpald (Sigma) (114, 115) was used to detect and quantify the amount of formaldehyde 
(if any produced) from the reaction of α-D-ribose-5-phosphate-1-methylphosphonate 
[PRPn] with [4Fe-4S]1+ reconstituted PhnJ in the presence of SAM, dithionite and 
Factor-Xa. A standard curve was generated by using 100 % formalin (37 % w/v 
formaldehyde) as the source of formaldehyde and purpald by measuring the change in 
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absorbance at 550 nm. In this experiment the purpald (10 mM) was initially allowed to 
react with varying formaldehyde concentrations (0 – 15 µM) for 10 minutes and the 
reaction was quenched with NaIO4 (10 mM) after which the absorbance was measured. 
For the PhnJ reaction; [PhnJ] = 150 µM, [SAM] = 2 mM, [dithionite] = 1m M, [PRPn] = 
1.5 mM, 50 units of Factor-Xa in 1X Factor-Xa buffer. No effort was made to separate 
any ingredient at the end of the reaction. A reference for this was all the ingredients 
except PhnJ. 
NMR Analysis. All the NMR analysis in this study was performed by Dr. Howard 
J. Williams, Department of Chemistry, Texas A&M University. All products were 
analyzed by 1H, 13C (natural abundance) and 31P NMR. The samples for 31P NMR (D2O, 
85% H3PO4 corresponds δ = 0.00) were made in 50 mM HEPES, pH 8.5 – 8.8 in 10 % 
D2O and analyzed with a Varian Unity Inova 500 MHz NMR spectrometer or a Bruker 
Avance III 400 MHz NMR spectrometer. 1H and 13C NMR spectra were acquired on a 
Bruker Avance III 500 MHz NMR spectrometer equipped with an HCN cyroprobe. 
Data Fitting. All kinetic data was fit to equation 2.1 using non-linear least 
squares fitting program SigmaPlot 9.0. 
ʋ / Et = kcat[A] / (Km + [A])                                    (Equation 2.1) 
where ʋ is the initial velocity, [A] = substrate concentration, Et = total enzyme 
concentration, kcat = turnover number and Km = Michaelis constant. 
RESULTS AND DISCUSSION 
  Protein Isolation. The genes for the seven essential proteins encoded by the 
phnGHIJKLM gene cluster were cloned, expressed in E. coli and the proteins purified to 
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homogeneity individually.  The genes for PhnG, PhnK, PhnL and PhnM were amplified 
and individually ligated into a pET30a(+) vector.  Of these proteins only PhnG and 
PhnM were soluble after cell lysis.  PhnG was purified using a standard polyhistine-tag 
purification strategy and was stable in 150 mM NaCl at pH 8.5.  PhnM was cloned 
without a polyhistidine-tag and was largely insoluble at pH values below 8.5.   This 
protein was isolated using gel filtration and anion exchange chromatography at pH 9.0.  
Since PhnM is a member of the AHS, the growth cultures and purification buffers were 
supplemented with 1 mM ZnCl2.  The identity of PhnM and PhnG was validated by N-
terminal amino acid analysis of the purified proteins.  PhnK and PhnL were insoluble 
when expressed from a standard pET30a(+) vector.  These genes were subsequently 
recloned with N-terminal glutathione S-transferase (GST) solubility tags using a 
pET42a(+) vector.  These clones resulted in the expression of GST fused to the N-
terminus of the target protein with a linker containing a Factor-Xa cleavage site.  The 
PhnK and PhnL GST-fusion proteins were soluble and purified using a GST-affinity 
column (GE Healthcare).  These two proteins required 1mM dithiothreitol (DTT), 500 
mM NaCl and 10% glycerol, pH 8.8, for stability.  
A pET28b(+) vector was used for the initial cloning of the genes for PhnH, PhnI 
and PhnJ.  Of these proteins, only PhnH was soluble after cell lysis.  This protein was 
purified as described previously (104).  Since PhnI and PhnJ were insoluble, they were 
recloned into a pET42a(+) vector with a GST-tag using the same strategy as that for 
PhnK and PhnL.  The purification of PhnI required 1 mM EDTA, 1 mM DTT, 500 mM 
NaCl and 10% glycerol at pH 8.5.  PhnJ required 1 mM EDTA, 500 mM NaCl and 10% 
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glycerol at pH 8.8.  Of the seven proteins critical for cleavage of phosphorus-carbon 
bonds, PhnG, PhnH and PhnM were purified without any solubility tags.  PhnI, PhnJ, 
PhnK and PhnL were purified as N-terminal GST-fusion proteins.  The GST-fusion 
proteins precipitated within ~15 minutes after removal of the N-terminal GST-tag by 
Factor-Xa.  All protein purifications contained 100 mM HEPES buffer at the specified 
pH. 
Catalytic Function of PhnI. Prior experiments have hinted of a ribose 
intermediate during the metabolism of phosphonate substrates prior to the conversion to 
phosphate (103, 107-108).  Since PhnI showed a distant relationship to enzymes that are 
functionally annotated as nucleosidases, we incubated this protein (10 µM) with a small 
and focused library of nucleosides, nucleotides and other ribose bearing compounds such 
as NAD+, NADP and ADP-ribose at concentrations of ~2 mM for up to 6 hours in the 
presence of 3 mM MgCl2 at pH 8.5 (Scheme 6.5).   
The liberation of the free base was determined spectrophotometrically at 240-350 
nm in the presence of coupling enzymes (1 µM) that are capable of deaminating adenine 
(20), guanine (111) or cytosine (8).  Xanthine oxidase (50 Units) was added to all 
inosine containing compounds (113).  The only active substrates found in these 
preliminary screening assays were the purine nucleoside di- and tri- phosphates i.e. ATP, 
ADP, GTP, GDP, ITP and IDP.  The best substrates for PhnI were GTP and ATP with 
kinetic constants for the nucleosidase activity of ~104 M-1 s-1 for kcat/Km.  The products 
of this reaction were D-ribose-5-triphosphate (RTP) and the free base (adenine or 
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guanine when ATP and GTP were utilized).  The reaction catalyzed by PhnI with ATP is 
presented in Scheme 6.6.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6.5: Scaffolds of compounds tested against PhnI for nucleosidase activity 
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The RTP could be purified using a ResourceQ anion exchange column (GE 
Healthcare).  The structure of RTP was initially identified by 31P-NMR spectroscopy and 
further confirmed by one- and two-dimensional NMR spectra.  Various NMR spectra for 
RTP are presented in figures 6.1-6.7. 
 
  
 
 
 
Scheme 6.6: Reaction catalyzed by PhnI in the presence of MgATP. 
The formation of D-ribose-5-triphosphate from either ATP or GTP did not 
appear to be a productive pathway for the C-P lyase pathway since the phosphonate 
substrate was not connected to the ribose moiety.  We therefore incubated phosphate and 
a small library of phosphonate derivatives (5 mM) with MgATP in the presence of PhnI 
to determine if any of these compounds (rather than water) could displace adenine.  
Surprisingly, phosphate, pyrophosphate, methylphosphate and sulfate inhibited the 
displacement of adenine from ATP but no inhibition was observed with 
methylphosphonate, ethylphosphonate, phosphonoacetic acid or 2-
aminoethylphosphonate.  The apparent inhibition constant for phosphate at an ATP 
concentration of 0.1 mM was ~0.30 mM.  RTP and adenine were the only products 
formed in the presence of either phosphate or methylphosphonate.  There were no 
further changes in the reaction products whether we used the GST-tagged PhnI in the 
presence or absence of Factor Xa (116).   
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Figure 6.1: 31P NMR spectrum of D-ribose-5-triphosphate (RTP). The product of the 
reaction of PhnI (10 µM) with MgATP (5 mM) in 100 mM HEPES buffer pH 9.0. The 
spectrum shows the tri-phosphate moiety of RTP. 
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Figure 6.2: 1H NMR spectra of RTP (in 100 mM phosphate buffer pH 8.5, 10% D2O). In 
the 1H NMR spectra, α and β represent the two anomers of RTP. 
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Figure 6.3: 1H NMR spectrum of RTP acquired with WATERGATE solvent suppression 
(in 100 mM phosphate buffer, pH 8.5, 10% D2O, on a Bruker Avance III 500 MHz 
NMR). The inset shows the anomeric protons (H1) as doublets (H1-H2 coupling). The 
coupling constants determined for these were JH1α = 2.4 Hz and JH1β = 3.5 Hz. 
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Figure 6.4:  13C NMR spectrum of RTP (in 100 mM phosphate buffer, pH 8.5, 10% 
D2O). The numbers represent the numbering of the ribose carbon atoms.  Glycerol was 
an impurity with the RTP during the purification from the reaction buffer. 
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Figure 6.5: 13C NMR spectrum of RTP showing C-1 and C-4 of the ribose moiety (in 100 
mM phosphate buffer, pH 8.5, 10% D2O). The C-1 is a singlet (due to the lack of 
phosphorus coupling at C-1), whereas the C-4 is a doublet from the coupling of the 
phosphorus at C-5.  
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Figure 6.6:  COSY (1H-1H) NMR spectrum of RTP (in 100 mM phosphate buffer at pH 
8.5 on a Bruker Avance III 500 MHz NMR). 
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Figure 6.7:  HSQC (1H-13C) NMR spectrum of RTP (in 100 mM phosphate buffer at pH 
8.5 on a Bruker Avance III 500 MHz NMR). 
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Since it was previously postulated that the C-P lyase reaction involved a multi-
protein complex, all of the recombinantly purified proteins were added to the reaction 
mixture.  No new products were detected other than RTP and adenine.  Since PhnI, PhnJ, 
PhnK and PhnL were all GST-fusion proteins, Factor-Xa (50 Units) was added to the 
reaction mixture for in situ cleavage of the GST-tags.  With the addition of Factor-Xa, a 
new compound was observed by 31P NMR spectroscopy at 17.8 ppm.  Anion exchange 
chromatography was used to purifiy the newly formed compound.  One- and two-
dimensional NMR spectra were consistent with the formation of α-D-ribose-1-
methylphosphonate-5-triphosphate (RPnTP) as shown in Scheme 6.7.   A small amount 
of the β-anomer was also detected (approximately 5-10 % of the α-anomer).  In this 
transformation, all of the ATP was consumed but the overall yield of the phosphonylated 
product was approximately 30-35%; the rest of the ATP was converted to RTP.   
  
  
 
 
Scheme 6.7: Formation of RPnTP by PhnI in the presence of PhnGHL  
To determine whether all of the proteins were required for this transformation, 
each protein was removed individually from the reaction mixture.  The minimal set of 
proteins required for the nucleophilic attack of methylphosphonate on the anomeric 
carbon of MgATP to form adenine and form RPnTP were PhnI, PhnG, PhnH and PhnL.  
The kinetic constants for the reaction of methylphosphonate with ATP and GTP in 
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presence of PhnI, PhnG, PhnH and PhnL were ~105 M-1s-1 for kcat/Km (Table 6.1).  No 
reaction was observed with the fusion proteins and the GST-tags must be removed in 
situ for this activity.  The partitioning of ATP to RTP and RPnTP likely results from 
partially cleaved GST-tagged protein and the precipitation of PhnI, PhnK, and PhnL 
after cleavage of these tags.  The stoichiometry of the four proteins required for complex 
formation and the individual functions of PhnG, PhnH and PhnL are uncertain.  RPnTP 
was purified from an anion exchange column (ResourceQ 1 mL GE Healthcare) and 
figures 6.8-6.15 represent the NMR spectra of the isolated compound. 
Table 6.1: Kinetic constants for the nucleosidase reactions catalyzed by PhnI  
Substrate kcat (s
-1) Km (µM) kcat/Km (M
-1s-1) 
PhnI only 
GDP 0.20 ± 0.02 225 ± 37          (1.0 ± 0.1) x 103 
GTP 5.3 ± 0.2 64 ± 8 (8.3 ± 0.8) x 104 
ADP 0.065 ± 0.003 204 ±18 (0.32 ± 0.02) x 103 
ATP 1.40 ± 0.04 95 ± 12 (1.3 ± 0.2) x 104 
ITP 0.8 ± 0.1 108 ± 12 (7.4 ± 0.6) x 103 
PhnG + PhnH + PhnI + PhnL + Factor Xa 
GTP 27 ± 2 80 ± 10 (3.4 ± 0.3) x 105 
ATP 20 ± 1 56 ± 7 (3.5 ± 0.3) x 105 
All assays were performed at 30 oC at pH 8.5 
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Figure 6.8: 31P NMR spectra of RPnTP purified using anion exchange chromatography. 
The methylphosphoryl group is represented as 1-Pn. Inset, 31P-31P coupling of the 
triphosphate moiety of the RPnTP product. 
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Figure 6.9: 1H NMR spectrum of α-D-ribose-1-methylphosphonate-5-triphosphate 
(RPnTP) (in 100 mM phosphate buffer, pH 8.5 on a Bruker Avance III 500 MHz NMR).  
A small amount of the β-anomer is also formed in the reaction (10 % of the α-anomer). 
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Figure 6.10: 1H NMR spectrum of the ribose moiety of RPnTP using WATERGATE 
solvent suppression (in 100 mM phosphate buffer, pH 8.5 on a Bruker Avance III 500 
MHz NMR). The inset shows the anomeric protons split as a quartet (doublet of 
doublets) resulting from the phosphorus of the methylphosphonate attached to C-1. The 
coupling constants for the major product:  H1α are J(H1-H2) = 4.3 Hz and J(H1-P1) = 6.1 Hz. 
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Figure 6.11: 13C NMR spectrum of RPnTP (in 100 mM phosphate buffer, pH 8.5 on a 
Bruker Avance III 500 MHz NMR). The carbon atoms of RPnTP are labeled in the 13C 
NMR spectrum. There are two anomers observed in the 13C NMR spectrum with the α-
anomer being the major enzymatic product.  The six carbon atoms of the molecule are 
observed in this spectrum with the methyl group of the 1-methylphosphonate upfield 
from the ribose carbon atoms and split as doublet from the strong coupling to the 
phosphorus. 
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Figure 6.12: 13C NMR spectrum of RPnTP showing C-1 and C-4 of the ribose moiety (in 
100 mM phosphate buffer at pH 8.5 on a Bruker Avance III 500 MHz NMR).  Both C-1 
and C-4 are doublets for both anomers.  The inset shows the splitting of the C-1 anomers 
from the 1-methylphosphonate adduct to form RPnTP. 
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Figure 6.13: 13C NMR spectrum of RPnTP showing C-2 and C-3 of the ribose moiety (in 
100 mM phosphate buffer pH 8.5 on a Bruker Avance III 500 MHz NMR). The C-2 of 
the ribose moiety is a doublet and C-3 of the ribose moiety is a singlet.   
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Figure 6.14:  COSY (1H-1H) NMR spectrum of RPnTP (in 100 mM phosphate buffer at 
pH 8.5 on a Bruker Avance III 500 MHz NMR). 
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Figure 6.15: HSQC (1H-13C) NMR spectrum of RPnTP (in 100 mM phosphate buffer at 
pH 8.5 on a Bruker Avance III 500 MHz NMR). 
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Catalytic Function of PhnM.  PhnM is a member of the amidohydrolase 
superfamily (7).  Enzymes within this superfamily use a mono- or binuclear metal center 
to catalyze hydrolytic reactions at carbon and phosphorus centers.  PhnM is grouped 
within Cluster of Orthologous Group (COG) 3454.  This COG consists of approximately 
200 proteins of similar sequence from different bacteria.  All proteins from the 
amidohydrolase superfamily have a (β/α)8-barrel structural fold.  Sequence alignment 
analysis indicated that all of the enzymes in COG3454 have a highly conserved HxD 
motif at the end of β-strand 1, a histidine at the end of β-strand 5, a glutamate at the end 
of β-strand 6 and an aspartate at the end of β-strand 8.  These protein sequences lacks a 
clearly defined ligand from β-strand 4 that could serve to bridge two divalent cations and 
thus PhnM was predicted to bind a single divalent metal cation in the active site at the α-
metal binding site.  PhnM was previously predicted to be a hydrophobic membrane 
bound protein (32, 33).  Variation of the solution pH demonstrated that PhnM was 
soluble at pH values greater than 9.0.  At this pH PhnM was soluble and could be 
purified without a solubility or affinity tag.  Inductively coupled plasma mass 
spectrometry (ICP-MS) demonstrated that the purified PhnM contained ~1.2 equivalents 
of Zn2+ per monomer when Zn2+ was supplemented in the growth media during protein 
expression. 
 Previous studies have suggested that α-D-ribose-1-phosphonate-5-phosphate 
(PRPn) as a potential intermediate in the conversion of alkylphosphonates to phosphate 
by E. coli (103, 107).  Hence it was rational to assume that one of the proteins in the phn 
operon would catalyze the hydrolysis of the β- and γ-phosphoryl groups from RPnTP 
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that was isolated from the action of PhnI, PhnG, PhnH and PhnL. PhnM was the prime 
candidate to perform this hydrolytic reaction.  In addition to a set of highly conserved 
residues believed to coordinate the active site zinc, PhnM also possess five highly 
conserved arginine residues on the various loops that connect the eight β-strands and α-
helices.  These loops are essential in determining substrate specificity.  The positively 
charged arginine residues may participate in the coordination of the tri-polyphosphate 
moiety of the RPnTP substrate.  
 When PhnM was incubated with purified RPnTP in the presence of 1 mM ZnCl2 
and 5 mM MgCl2, 
31P-NMR identified 2 new reaction products, consistent with α-D-
ribose-1-methylphosphonate-5-phosphate (PRPn) and pyrophosphate (99).  This 
observation was consistent with the hydrolytic cleavage of α- and β- phosphoryl groups 
of the triphosphate moiety of RPnTP.  This reaction is shown in Scheme 6.8.   
 
 
 
 
Scheme 6.8: Reaction catalyzed by PhnM. 
The products of the reaction of PhnM were PRPn and pyrophosphate. The 
enzyme PhnM was filtered from the reaction and the products were characterized by 
NMR spectroscopy. Figures 6.16 - 6.22 represent NMR characterization of the products 
of the reaction characterized by PhnM. 
 
O
OHHO
OP
O
O
OP
O
O
OP
O
O
O
O P
O
O
CH3Mg
O
OHHO
OP
O
O
O
O P
O
O
CH3
OP
O
O
OP
O
O
O
Mg
+
PhnM
H2O
201 
 
 
Figure 6.16: The formation of PRPn and pyrophosphate (PPi) from RPnTP by PhnM. 
Spectrum collected at pH 8.5. Inset, proton coupled spectrum of PRPn showing multiplet 
corresponding to 1-Pn and triplet corresponding to 5-phosphate (major α-anomer and 
minor β-anomer) as well as inorganic phosphate (Pi). 
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Figure 6.17: 1H NMR spectrum of α-D-ribose-1-methylphosphonate-5-phosphate 
(PRPn) in 100 mM phosphate buffer pH 8.5 on a Bruker Avance III 500 MHz NMR.A 
small amount of the β-anomer is also formed in the reaction. 
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Figure 6.18: 1H NMR spectrum of the ribose moiety of PRPn using WATERGATE 
solvent suppression (in 100 mM phosphate buffer pH 8.5 on a Bruker Avance III 500 
MHz NMR). The inset shows the anomeric protons split as a quartet (doublet of 
doublets) resulting from the phosphorus of the methylphosphonate attached to C-1. The 
coupling constants for the major product are H1α are J(H1-H2) = 4.2 Hz and J(H1-P1) = 6.3 
Hz. 
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Figure 6.19: 13C NMR spectrum of PRPn (in 100 mM phosphate buffer pH 8.5 on a 
Bruker Avance III 500 MHz NMR).  The carbon atoms of the RPnP are identified in the 
13C NMR spectrum. The two anomers are clearly seen in the 13C NMR spectrum with 
the α-anomer being the major product of the reaction of PhnM with RPnTP in the 
presence of Zn2+.  
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Figure 6.20: 13C NMR spectrum of PRPn showing C-1 and C-4 of the ribose moiety (in 
100 mM phosphate buffer at pH 8.5 on a Bruker Avance III 500 MHz NMR).  The inset 
shows the splitting of C-1 by the phosphorus of the phosphonate moiety. 
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Figure 6.21: COSY (1H-1H) NMR spectrum of PRPn (in 100 mM phosphate buffer at pH 
8.5 on a Bruker Avance III 500 MHz NMR). 
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Figure 6.22: HSQC (
1
H-
13
C) NMR spectrum of PRPn (in 100 mM phosphate buffer at 
pH 8.5 on a Bruker Avance III 500 MHz NMR). 
To determine the exact position of the hydrolytic attack, the reaction was 
performed in a 1:1 mixture of H2O and H2O
18.  The O18 label was found exclusively in 
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the PRPn product.  This result was indicative of an attack of the activated hydroxide on 
the α-phosphorus of the triphosphate moiety of the substrate (figure 6.23). 
 
Figure 6.23: 31P NMR spectrum of PhnM reaction in H2O
18. PhnM (10 µM) with 1 mM 
RTP in the presence of 2 mM Mg2+ and 1 mM Zn2+ in 50 mM HEPES buffer pH 8.5 
containing 35 % H2O
18. The phosphoryl group of ribose-5-phosphate is at ~ 6.8 ppm and 
the pyrophosphate is at -5.0 ppm.  There are two resonances at ~6.8 ppm due to the 
partial O18-labelling of the phosphate.  There is no extra resonance for the pyrophosphate 
and thus the attack of water on the triphosphate moiety of RTP in on the α–phosphoryl 
group. 
All of the kinetic measurements were performed on this reaction using the Pi 
Colorlock (Gold) phosphate detection kit from Innova Biosciences according to the 
manufacturer’s instruction at pH 8.5.  The pyrophosphate produced in this reaction was 
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converted to inorganic phosphate by the addition of inorganic pyrophosphatase from 
Baker’s yeast (Sigma).  The kinetic constants obtained for the hydrolysis of RPnTP by 
PhnM were kcat = 6.4 s
-1, Km = 56 µM and kcat/Km = 1.1 x 10
5 M-1s-1.  Zn2+ and Mg2+ 
supplementation were essential for optimal activity of PhnM. To determine the substrate 
profile for PhnM, D-ribose-5-triphosphate (RTP) and D-ribose-5-diphosphate (RDP) 
were tried as substrates.  Both RTP and RDP were synthesized by the action of PhnI on 
ATP and ADP, respectively, and purified using anion exchange chromatography (99).  
Both RTP and RDP were substrates for PhnM.  In both cases D-ribose-5-phosphate was 
one product.  The other product was pyrophosphate for RTP and inorganic phosphate for 
RDP.  
 The kinetic constants for the hydrolysis of RTP by PhnM were kcat = 6.0 s
-1, Km 
= 98 µM and kcat/Km = 6.1 x 10
4 M-1s-1.  For RDP the kinetic constants were kcat = 0.08 s
-
1, Km = 200 µM and kcat/Km = 3.8 x 10
2 M-1s-1 (99).  Thus, the substrate profiles showed 
that the RPnTP was the best substrate and that PhnM hydrolyzes the triphosphate moiety 
to form the PRPn and pyrophosphate.  RTP is 100-fold more active than RDP.  The 
kinetic constants did not change for the hydrolysis of RPnTP when PhnG, PhnH, PhnI, 
PhnK, PhnL and Factor-Xa were added to the assay mixture.  Therefore there is no 
evidence that PhnM forms a complex with these other proteins.   
Catalytic Function of PhnJ. The deletion of phnJ from E. coli led to the 
identification of α-D-ribose-1-methylphosphonate (RPn) in the growth medium and this 
has led to the prediction that α-D-ribose-1-methylphosphonate-5-phosphate (PRPn) is 
the ultimate substrate for the actual C-P lyase reaction (103).  This conjecture was 
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consistent with our experimental results since this compound was synthesized from ATP 
and methylphosphonate by the combined actions of PhnI, PhnG, PhnH, PhnL and PhnM.  
Of the remaining two enzymes in the phn operon, the most likely protein to catalyze the 
actual carbon-phosphorus bond cleavage was PhnJ.  PhnJ has four conserved cysteine 
residues with a spacing of Cx2Cx21Cx5C near the C-terminal end of the protein.  These 
four conserved cysteine residues could form a metal-thiolate cluster or more likely, an 
iron-sulfur cluster.  The cleavage of PRPn to PRcP (or PRP) was assumed to require a 
radical mechanism and such reactions could be catalyzed by radical SAM enzymes.   
The radical SAM superfamily was first identified in 2001 by Sofia and co-
workers, based on the structural and mechanistic similarities of lysine aminomutase 
(LAM), biotin synthase (BioB), lipoic acid synthase (LipA) and pyruvate formate lyase 
activating enzyme (PflA).  Each of these enzymes uses a structurally conserved (β/α)8-
TIM barrel motif to produce a 5’-deoxyadenosyl radical from S-adenosyl-L-methionine 
(SAM) using a unusual [Fe4S4]-cluster which is redox active in the reduced [Fe4S4]
1+ and 
the oxidized [Fe4S4]
2+ oxidation states (117).  A recent comprehensive review by Frey et 
al. (118), has suggested that more than 2800 proteins belong to this superfamily.  A 
signature feature for the members of this superfamily is a Cx3Cx2C motif near the N-
terminal end of the protein.  These three cysteine residues nucleate the [Fe4S4]-cluster.  
This cluster binds SAM to the unique Fe that is not ligated to any three cysteine residues.  
The 5’-deoxyadenosyl radical generated from the reductive cleavage of SAM, abstracts a 
hydrogen atom from the substrate or the protein (to generate a protein radical) initiating 
the reaction.  With the successful reconstitutions of ThiC (119) (Cx2Cx4C), HmdA (120) 
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(Cx5Cx2C), and Dph2 (121), a more diverse combination of conserved cysteine residues 
can function for the assembly of the [Fe4S4]-cluster and perform similar radical 
reactions.  Another comprehensive review by Booker et al. (122), lists more examples of 
members of the radical SAM superfamily lacking the canonical Cx3Cx2C motif as well 
as enzymes possessing multiple iron-sulfur clusters.  Elp3, a component of the factor 
required for transcriptional elongation (Cx4Cx9Cx2C) is one such example.  Another 
example is PqqE, which is one of the six proteins required for the biosynthesis of 
pyrroloquinoline quinone.  This protein contains a non-canonical Cx2Cx27C motif 
binding a [Fe4S4]-cluster capable of producing a 5’-deoxyadenosyl radical upon 
reduction along with another cluster of the canonical Cx3Cx2C motif.   
Literature precedents have hinted at the formation of some sort of metal-thiolate 
cluster on PhnJ (99, 109), based on the highly invariant Cx2Cx21Cx5C motif at the C-
terminal of the protein.  PhnJ purified aerobically with a GST-tag, had a black color.  
This was presumably due the non-specific binding of iron sulfide from the degradation 
of an iron-sulfur cluster upon exposure to air.  Metal analysis using ICP-MS showed the 
presence of ~2.2 equivalents of Fe per monomer of PhnJ when purified aerobically.  
Thus PhnJ appeared to be capable of binding iron and sulfide.  The metals ions bound to 
the aerobically purified PhnJ were removed with the addition of EDTA to the 
purification buffers.  The apo-PhnJ was made anaerobic by passing argon through the 
protein solution and then an excess of sodium dithionite was added (5 mM).  PhnJ was 
incubated in the glove box for four hours.  Throughout the reconstitution experiments 
the oxygen concentration was maintained below 4 ppm.  Reconstitution of the [Fe4S4]-
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cluster was initiated by slow dropwise addition of a 50-fold enzyme excess of FeSO4.  
After equilibrating anaerobically for three hours, a 50-fold excess of Na2S was added 
and the mixture incubated for an additional three hours.  The excess iron and sulfide that 
formed insoluble iron sulfide (black solid) was removed by centrifugation, followed by 
ultrafiltration through a 10 kDa membrane.  The protein with the reconstituted iron-
sulfur cluster had a reddish-brown color.  The UV-visible absorption spectrum of PhnJ, 
reconstituted with iron and sulfide, had a broad absorption band centered at 403 nm that 
is indicative of a [Fe4S4]-cluster (99).  The absorption band disappears upon addition of 
1 mM dithionite, suggesting the reduction of the [Fe4S4]
2+ cluster to the [Fe44S]
1+ species, 
which is the active form for most radical SAM enzymes (117-122) (figure 6.24).  The 
discoloration was also indicative of the redox activity of the proteins within the radical 
SAM superfamily (117-122).  Quantitation of the UV-visible spectrum of PhnJ 
suggested that the chemical reconstitution yield was approximately 40%. Even though 
there were prior suggestions that PRPn was the ultimate substrate for PhnJ, the putative 
C-P bond cleaving enzyme from the gene knockout studies carried out by Zechel, Hove-
Jensen and co-workers (103), there were still two compounds that could have been 
potential substrates for cleavage by PhnJ of the C-P bond: PRPn and RPnTP.  Both of 
these compounds were incubated with 125 µM PhnJ that was chemically reconstituted 
with a [Fe4S4]-cluster, 2 mM SAM and 1 mM dithionite, under anaerobic conditions at 
pH 6.8.   
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Figure 6.24: UV-visible absorbance spectrum of PhnJ. PhnJ (31 µM) after anaerobic 
chemical reconstitution of the Fe-S cluster (solid line). The peak at 280 nm is due to the 
protein absorbance and the absorbance peak centered around 403 nm represents the 
[4Fe-4S]2+ cluster. The dotted line represents the absorbance spectrum of PhnJ (27 µM) 
reconstituted with a [4Fe-4S]2+ cluster after reduction with sodium dithionite to form the 
[4Fe-4S]+ cluster. 
The reactions were analyzed by 31P NMR spectroscopy but there was no change 
in the NMR spectrum for either substrate.  Since PhnJ was expressed and purified as an 
N-terminal GST-fusion protein, the reaction was supplemented with Factor-Xa to cleave 
the GST-tag.  No change in the 31P NMR spectrum was observed with RPnTP, but a new 
resonance appeared at 16.2 ppm using PRPn as a substrate (99).  The increase in the 
resonance at 16.2 ppm correlated with a decrease in the phosphonate resonance of PRPn 
at 16.6 ppm.  The new resonance splits into a triplet in the 1H-coupled 31P spectrum (99) 
demonstrating that the product is no longer a methyl phosphonate (figure 6.25).  The 
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new resonance was consistent with a cyclic phosphate and the proton coupling constant 
of 21 Hz indicates that the phosphate moiety of the product was esterified to the protons 
attached to C1 and C2 of the ribose.  This result was consistent with the findings of 
Zechel, Hove-Jensen and co-workers for the substrate of PhnP (103).  Thus, PhnJ 
requires a reduced [Fe4S4]-cluster and SAM to catalyze the formation of α-D-ribose-1,2-
cyclic phosphate-5-phosphate from PRPn.  The overall reaction is illustrated in Scheme 
6.9.  
 
 
Scheme 6.9: Reaction catalyzed by PhnJ in the presence of SAM. 
 Gas chromatography (GC) and GC-mass spectrometry (MS) were used to 
confirm the formation of methane.  All GC and GC-MS samples were prepared 
anaerobically.  Gas chromatographic analysis of the headspace above the liquid showed 
a single peak that co-eluted with a methane standard (Figure 6.26).  The formation of 
methane was confirmed by coupling the output of the GC to a mass spectrometer and 
detection of a mass of 16.  Thus, the two products formed from the action of PhnJ on 
PRPn are methane and PRcP.  To determine whether there were any byproducts of this 
reaction, an analysis was conducted to check for the formation of methanol and 
formaldehyde. Alcohol dehydrogenase was used to test the formation of methanol using 
NAD+.  A calibration curve was established based on the formation of NADH for 
215 
 
varying methanol.  The reaction showed no formation of methanol.  For the detection of 
formaldehyde, purpald was used. A standard curve was made and the reaction mixture 
showed no formation of formaldehyde.  The addition of SAM, PhnJ, a reductant 
(dithionite) and Factor-Xa were required for the formation of PRcP and methane from 
the [Fe4S4]
1+ reconstituted PhnJ under strictly anaerobic conditions.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.25: The formation of PRcP from PRPn in the presence of PhnJ and SAM (at 
pH 6.8). Inset, proton-coupled spectrum showing the formation of a new triplet that 
corresponds to the 1,2-cyclic moiety of PRcP (1,2,cP). The chemical shifts of the 
phosphate moiety on the fifth carbon atom of PRcP and PRPn are coincident with one 
another at 3.4 ppm. 
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To determine the fate of SAM during the reaction, HPLC and amino acid 
analysis were employed.  Amino acid analysis of the reaction products from SAM in the 
reaction catalyzed by PhnJ was performed by the Protein Chemistry Laboratory, Texas 
A&M University.  The control reaction showed less than 0.01 μM L-methionine.  In the 
reaction mixture with PhnJ (120 µM), 150 μM of L-methionine was detected.  This 
established that one of the products of SAM was methinonine. The HPLC analysis was 
used for determining the other reaction products of SAM with PhnJ.  All of the reactions 
were kept anaerobic for 3 hours after which the precipitated enzyme was removed by 
centrifugation.  HPLC analysis showed the formation of 5’-deoxyadenosine (Figure 
6.27) and amino acid analysis confirmed the formation of methionine.   
These products were only formed when PhnJ (with a reconstituted iron-sulfur 
center), Factor-Xa, SAM, dithionite and PRPn were added to the reaction mixture under 
strictly anaerobic conditions.  The omission any one of the above components resulted in 
no formation of 5’-deoxyadenosine.  The small number of turnovers per enzyme may 
reflect the poor solubility of PhnJ after proteolytic cleavage of the N-terminal GST-
fusion tag.  The concentration of PRcP, 5’-deoxyadenosine, methionine, and methane 
formed in the presence of PhnJ showed that 1-10 turnovers of product were formed per 
PhnJ.   
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Figure 6.26: Gas chromatographic analysis of PhnJ reaction. GC analysis for methane 
formation after incubation of PhnJ (150 µM), SAM (2 mM), dithionite (1 mM), and 
PRPn (2 mM) in the presence of 50 units Factor-Xa and 1X Factor-Xa buffer in a 
volume of 2.3 mL with a headspace of ~500 µL. (A) Methane standard (714 ng).  (B) 
Incubation of reaction mixture with deletion of PhnJ.  (C)  Incubation of reaction 
mixture with deletion of PRPn.  (D)  Incubation of entire reaction mixture.  (E) 
Incubation of the reaction mixture with deletion of SAM. (In samples B, C, D and E; 50 
µL of the headspace was injected in the GC instrument). 
218 
 
 
Figure 6.27: HPLC trace analysis for products of SAM by PhnJ. Standards for the 
detection of the reaction products from S-adenosyl-L-methionine (SAM) by PhnJ in 
presence of dithionite and Factor-Xa.  Standards (black traces): 0.5 mM S-adenosyl-L-
methionine (SAM) in 150 mM HEPES, 250 mM NaCl, 10 % v/v glycerol, 50 units 
Factor Xa and 1X Factor Xa reaction buffer at pH 8.5; 0.5 mM 5’-deoxyadenosine (5’-
DA) in 150 mM HEPES, 250 mM NaCl, 10 % v/v glycerol, 50 units Factor Xa and 1X 
Factor Xa reaction buffer at pH 8.5; 0.5 mM 5’-deoxy-5’-methylthioadenosine (MTA) in 
150 mM HEPES, 250 mM NaCl, 10 % v/v glycerol, 50 units Factor Xa and 1X Factor 
Xa reaction buffer at pH 8.5. The reaction products of SAM in the reaction catalyzed by 
PhnJ with PRPn:  (1) Reaction products after mixing 60 µM PhnJ, 0.5 mM SAM, 1 mM 
dithionite, 2 mM α-D-ribose-1-methylphosphonate-5-phosphate in 150 mM HEPES, 250 
mM NaCl, 10 % v/v glycerol, 50 units Factor-Xa and 1X Factor-Xa reaction buffer at 
pH 8.5.  (2) Same as 1 except PhnJ was omitted.  (3) Same as 1 except that dithionite 
was omitted.  (4) Same as 1 except Factor-Xa omitted. 5’-deoxyadenosine was identified 
as the major reaction product from SAM during the reaction with PhnJ. 
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Reconstitution of the C-P Lyase Pathway. PhnJ is a putative radical SAM 
enzyme and the working model for the cleavage of the C-P bond of the phosphonate 
moiety is Scheme 6.10.  The cleavage of the C-P bond is PRPn by PhnJ reconstituted 
with a [4Fe-4S]+ cluster and SAM is initiated by electron transfer from the Fe-S cluster 
to reductively cleave SAM and thus transiently generate L-methionine (L-met) and a 5’-
deoxyadenosyl radical (Ado-CH2
●). This radical may subsequently catalyze the 
formation of a protein radical (PhnJ-X●), presumably a cysteine-based thiyl radical. 
Thiyl radicals have been previously demonstrated in pyruvate-formate lyase (123, 124), 
methyl coenzyme M reductase (125) and ribonucleotide reductase (126). The thiyl 
radical may attack the phosphonate moiety of the substrate to liberate a methyl radical 
with the formation of a thioester intermediate. Intramolecular attack by the hydroxyl of 
the second carbon atom of the substrate would generate PRcP and the free thiol group. 
Methane would be formed through hydrogen atom abstraction from either 5-
deoxyadenosine or the putative cysteine residue. 
The mechanism for the conversion of alkyl phosphonates to phosphate in E. coli 
was elucidated.  PhnI (a novel nucleosidase), in the presence of PhnG, PhnH, and PhnL, 
catalyzes the formation of RPnTP from MgATP and methylphosphonate.  PhnM (an 
amidohydrolase) catalyzes the hydrolysis of RPnTP to form pyrophosphate and PRPn.  
PhnJ can be chemically reconstituted with a [Fe4S4]-cluster with ferrous sulfate, sodium 
sulfide and sodium dithionite under strictly anaerobic conditions.  The reconstituted 
PhnJ catalyzes the homolytic cleavage of the C-P bond of PRPn to form PRcP and 
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methane in the presence of SAM.  The C-P lyase pathway is summarized in Scheme 
6.11.  
 
 
 
 
 
 
 
 
 
Scheme 6.10: Working model for the transformation of PRPn to PRcP 
 
 
Scheme 6.11: Reaction pathway for the conversion of methyl phosphonate to methane 
and PRcP. 
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CHAPTER VII 
SUMMARY AND CONCLUSIONS 
 
Adenine deaminase (ADE) catalyzes the conversion of adenine to hypoxanthine 
and ammonia.  The enzyme isolated from Escherichia coli using standard expression 
conditions was largely inactive towards the deamination of adenine (kcat ~2 s
-1).  When 
iron was sequestered with a metal chelator (2,2’-dipyridyl) and the growth medium was 
supplemented with Mn2+ prior to induction, the purified enzyme was substantially more 
active for the deamination of adenine with values of kcat and kcat /Km of 200 s
-1 and 5 x 
105 M-1s-1, respectively.  The apo-enzyme was prepared and reconstituted with Fe2+, 
Zn2+, or Mn2+.  In each case, two enzyme-equivalents of metal were necessary for 
reconstitution of the deaminase activity.  This work provides the first example of any 
member within the deaminase sub-family of the amidohydrolase superfamily (AHS) to 
utilize a binuclear metal center for the catalysis of a deamination reaction.  [FeII/FeII]-
ADE was oxidized to [FeIII/FeIII]-ADE with ferricyanide with inactivation of the 
deaminase activity.  Reducing [FeIII/FeIII]-ADE with dithionite restored the deaminase 
activity and thus the di-ferrous form of the enzyme is essential for catalytic activity.  No 
evidence for spin-coupling between metal ions was evident by EPR or Mössbauer 
spectroscopies.  The three-dimensional structure of adenine deaminase from 
Agrobacterium tumefaciens (Atu4426) was determined by X-ray crystallography at 2.2 
Å resolution and adenine was modeled into the active site based on homology to other 
members of the amidohydrolase superfamily.  Based on the model of the adenine-ADE 
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complex and subsequent mutagenesis experiments, the roles for each of the highly 
conserved residues were proposed. Solvent isotope effects, pH rate profiles and solvent 
viscosity were utilized to propose a chemical reaction mechanism and the identity of the 
rate limiting steps. 
Adenine deaminase (ADE) from the amidohydrolase superfamily of enzymes 
catalyzes the conversion of adenine to hypoxanthine and ammonia.  The enzyme isolated 
from Escherichia coli using standard expression conditions was largely inactive towards 
the deamination of adenine (kcat  ~2 s
-1).  Molecular weight determinations by mass 
spectrometry provided evidence that multiple histidine and methionine residues were 
oxygenated.  When iron was sequestered with a metal chelator and the growth medium 
supplemented with Mn2+ prior to induction, the post-translational modifications 
disappeared.  The enzyme expressed and purified under these conditions was 
substantially more active for the deamination of adenine, with values of kcat and kcat /Km 
of 200 s-1 and 5 x 105 M-1s-1, respectively.  Apo-enzyme was prepared and reconstituted 
with two equivalents of FeSO4; ICP-MS and Mössbauer spectroscopy demonstrated that 
this protein contained two high-spin ferrous ions per monomer of ADE.  In addition to 
the adenine deaminase activity, [FeII/FeII]-ADE catalyzed the conversion of H2O2 to O2 
and H2O.  The values of kcat and kcat/Km for the catalase activity are 200 s
-1 and 2.4 x 104 
M-1s-1 respectively.   
[FeII/FeII]-ADE underwent more than 100 turnovers with H2O2 before the enzyme 
was inactivated due to oxygenation of histidine residues critical for metal binding.  A 
model is proposed for the disproportionation of hydrogen peroxide by [FeII/FeII]-ADE 
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that involves the cycling of the binuclear metal center between the di-ferric and di-
ferrous oxidation states.  Oxygenation of active site residues occurs from the release of 
hydroxyl radicals.  The three-dimensional structure of [FeII/FeII]-ADE was determined 
by X-ray diffraction methods.  This is the first report of a redox reaction for any member 
of the amidohydrolase superfamily.   
Adenine deaminase (ADE) is a member of the amidohydrolase superfamily 
(AHS). ADE has shown to catalyze two distinct reactions, the hydrolytic deamination of 
adenine and the redox disproportionation of hydrogen peroxide for diiron ADE. Kinetic 
studies for ADE yield similar inverse solvent isotope effects as adenosine deaminase and 
cytosine deaminase, which are the other kinetically characterized members of the AHS. 
Proton inventory studies on ADE show two distinct patterns, for kcat and kcat/Km, 
suggesting involvement of two distinct protons in the kinetic mechanism. A single 
downfield proton with a chemical shift (δ ~ 17.0 to 18.0 ppm) consistent with those 
identified for low-barrier hydrogen bonds (LBHBs) was identified using 1H-NMR 
analysis for the Zn/Zn-ADE. LBHBs have been found to be critical in other enzymes and 
have been extensively studied for serine proteases. Here we use mutagenesis and 
inhibitor studies coupled to 1H-NMR analysis to reveal the nature of the downfield 
proton and found it was associated with the deaminase activity. The exact assignment of 
the downfield proton still remains unknown; however this study reports the first instance 
of any metalloenzyme possessing a LBHB in catalysis. Previous experiments performed 
on serine proteases in the identification of the LBHB might prove useful in finding the 
LBHB of ADE.  
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Two enzymes from the amidohydrolase superfamily (AHS) were discovered to 
catalyze the deamination of N-6-methyladenine to hypoxanthine and methylamine. The 
methylation of adenine in bacterial DNA is a common modification for protection of the 
host DNA against restriction endonucleases. The enzyme from Bacillus halodurans, 
Bh0637, catalyzes the deamination of N-6-methyladenine with a kcat of 185 s
-1 and a 
kcat/Km of 2.5 x 10
6 M-1s-1. Bh0637 catalyzes the deamination of N-6-methyladenine 2 
orders of magnitude faster than adenine. A comparative model of Bh0637 was computed 
using the three dimensional structure of Atu4426 (PDB code: 3nqb) as a structural 
template and computational docking was used to rationalize the preferential utilization of 
N-6-methyladenine over adenine. This is the first identification of an N-6-methyladenine 
deaminase (6-MAD). 
The reaction mechanism for the enzymatic conversion of methyl phosphonate to 
phosphate and methane in Escherichia coli has eluded researchers over the last three 
decades despite significant genetic and in-vivo studies.  The phn operon governs the C-P 
lyase activity in E. coli. The essential genes within the phn operon are phnGHIJKLM.  
The proteins encoded by phnGHM were over-expressed in E. coli and purified to 
homogeneity using standard protocols.  The proteins encoded by phnIJKL were soluble 
only when expressed as N-terminal fusion proteins with glutathione S-transferase (GST).  
PhnI catalyzes the formation of α-D-ribose-1-methylphosphonate-5-triphosphate 
(RPnTP) from MgATP and methylphosphonate in the presence of PhnG, PhnH, and 
PhnL after in situ cleavage of the GST-tags.  PhnI alone catalyzes the hydrolytic 
cleavage of MgATP to adenine and D-ribose-5-triphosphate.  PhnM catalyzes the 
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hydrolysis of α-D-ribose-1-methylphosphonate-5-triphosphate to α-D-ribose-1-
methylphosphonate-5-phosphate (RPnP) and pyrophosphate with attack of water on the 
α-phosphoryl group of the triphosphate moiety of RPnTP.  PhnJ was reconstituted with 
an iron-sulfur cluster via the anaerobic addition of FeSO4, Na2S and Na2S2O4 under 
strictly anaerobic conditions.  The [Fe4S4]-reconstituted PhnJ GST-fusion protein 
catalyzes the radical cleavage of the phosphorus-carbon bond of α-D-ribose-1-
methylphosphonate-5-phosphate to α-D-ribose-1,2-cyclic-phosphate-5-phosphate and 
methane in the presence of S-adenosyl-L-methionine under strictly anaerobic conditions, 
upon in situ cleavage of the GST-tag. 
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